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Abstract 
 
Porphyrin molecules are efficient generators of singlet oxygen and are used as 
photosensitisers in PDT. They are also known to accumulate in tumour tissue due 
to the hyperpermeability of tumour vasculature and poor lymphatic drainage, 
thus exhibiting a passive tumour targeting property. 
Functionalised tetraazamacrocycles based around the cyclam and cyclen 
structures form thermodynamically stable and kinetically inert complexes with 
metal ions such as copper(II) and gadolinium(III), and are used in vivo for both 
imaging and radiotherapy (MRI, PET, radiotherapy). 
 
Three convergent synthetic routes have been used to successfully synthesise 
novel molecules which combine these two elements, and therefore open up the 
possibility of combining imaging and therapy (PET-PDT and MRI-PDT) or dual 
therapy (radiotherapy-PDT) in one tumour avid compound. 
A series of novel macrocyclic chelators based around the cyclen framework have 
been successfully synthesised, each containing a functional handle for further 
elaboration of the structure. The amino bearing derivatives have been 
successfully coupled to a porphyrin compound via reductive amination and 
Buchwald-Hartwig coupling reactions, giving four new examples of porphyrin-
cyclen conjugates. 
A Suzuki coupling methodology has been used to synthesise a porphyrin-cyclen 
conjugate with an aryl-aryl linkage which exhibits enhanced stability towards 
acidic conditions. 
The compounds have been characterised by NMR, mass spectrometry and 
UV/vis spectroscopy.  
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Abbreviations 
 
 
ATP   adenosine triphosphate 
Boc   tert-butoxycarbonyl 
Cyclam  1,4,8,11-tetraazacyclotetradecane 
Cyclen   1,4,7,10-tetraazacyclododecane 
DBU   1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC   N,N‟-dicyclohexylcarbodiimide 
DCE   1,2-dichloroethane 
DCM   dichloromethane 
DDQ   2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEPT   distortion enhancement by polarisation transfer  
diTs   ditosyl 
DMAP   4-dimethylaminopyridine 
DMF   N,N-dimethylformamide 
DMSO   dimethylsulfoxide 
DNA   deoxyribonucleic acid 
DQF COSY  double quantum filtered correlation spectroscopy 
DTPA   diethylenetriaminepentaacetic acid 
ESI   electrospray ionisation 
HIV   human immunodeficiency virus 
HpD   hematoporphyrin derivative 
IR   infrared 
LUMO  lowest unoccupied molecular orbital 
MALDI  matrix assisted laser desorption ionisation 
MR   magnetic resonance 
MRI   magnetic resonance imaging 
NBS   N-bromosuccinimide 
NMR   nuclear magnetic resonance 
PDT   photodynamic therapy 
PET   positron emission tomography 
PS   photosensitiser 
RT   room temperature 
 iv 
SPECT  single positron emission computed tomography 
TFA   trifluoroacetic acid 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
TMSI   trimethylsilyliodide 
TPP   5,10,15,20-tetraphenylporphyrin 
UV   ultraviolet 
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 1 
Chapter One: Introduction 
1.1 Introduction 
 
Cancer is an umbrella term used to describe many diseases characterised by the 
uncontrolled growth of abnormal cells. These cells invade adjoining parts of the 
body and may eventually spread to other areas via the lymphatic system or the 
blood – a process called metastasis. Cancer is one of the leading causes of death 
in the world and in 2007 was responsible for 7.9 million deaths worldwide. 
Metastases are a major cause of death from cancer.
1
 
 
In light of this, early detection and treatment of cancer is of vital clinical 
importance. The development of non-invasive imaging techniques such as 
positron emission tomography (PET), single photon emission computed 
tomography (SPECT) and magnetic resonance imaging (MRI) have enabled 
clinicians to accurately locate and identify tumour masses throughout the human 
body, and hence allow more efficient application of the chosen treatment.  
 
The three conventional treatments for cancer, radiotherapy, chemotherapy and 
surgery, are still the most common modalities used clinically to remove or 
destroy malignant tumour masses, while more selective treatments such as 
photodynamic therapy (PDT), hyperthermia, sonodynamic therapy and 
immunotherapy have been introduced. Often, the limitations of a particular 
treatment, or the side effects for the patient, limit the effectiveness of the therapy 
and this has led to combination therapy regimes, whereby the patient receives 
two or more modalities either concurrently or sequentially.
2
 
 
A single bifunctional compound which could combine tumour detection and 
imaging with destruction of the malignant cells would be of great clinical benefit. 
A scenario could be envisaged whereby the tumours are located, imaged and 
treated all in one session, by administration of a single drug. The design and 
development of synthetic routes to such compounds is the general aim of this 
work.    
 2 
1.2 Photodynamic therapy 
 
Photodynamic therapy (PDT) is a treatment regime used primarily for cutaneous 
tumours and cancers of the head and neck, but also for cancers of the lung, 
digestive tract and genitourinary tract.
3 
It is used both palliatively and curatively
4
 
as a single mode of therapy and in conjunction with other cancer treatments 
including surgery.
4
 Treatment of cancer by PDT involves administration of a 
light activated drug called a photosensitiser (PS), which is non-toxic in the 
absence of light. The photosensitiser initially distributes to many different 
tissues, but is selectively retained longer in tumour masses. After a period of time 
(normally 24-96 hours),
4
 the ratio of photosensitiser in cancerous versus healthy 
tissue reaches an optimal level, and the volume of the tumour is irradiated with 
light in the visible or near IR region, activating the photosensitiser. Once 
activated, a reaction between the excited state photosensitiser and molecular 
oxygen takes place within the tissue. These reactions produce reactive oxygen 
species, which subsequently attack biological molecules in the immediate 
locality of the photosensitiser, causing oxidative damage, and ultimately leading 
to cell death.
5
  
 
1.2.1 Photochemistry of PDT 
 
The main cytotoxic agent in PDT is thought to be singlet oxygen (
1
O2),
6
 and the 
mechanism by which this is formed by the photosensitiser is shown in Figure 1. 
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Figure 1: Modified Jablonski diagram depicting production of singlet oxygen 
 
 
The photosensitiser sits in a singlet ground state (S0), but upon absorption of a 
photon of light of the required energy (a), it is excited, populating a short lived 
(~10
-6
s)
 
singlet excited state (S1).
7
 This high energy state can relax by emission 
of a fluorescent photon (c) or by energy transfer upon collisions with nearby 
molecules in a non-radiative pathway called internal conversion (b). Since the 
lifetime of the singlet excited state is very short, fluorescent emission is 
statistically the most likely relaxation process. However, the molecule may 
undergo intersystem crossing (d) to an excited triplet state (T1), and although this 
process is quantum mechanically forbidden, it does occur to a significant extent 
for many photosensitisers. Once in the triplet state, relaxation can again occur by 
radiative emission of a phosphorescent photon (e), or by interacting non-
radiatively with another molecule in close proximity (c). Since the triplet state 
lifetime is much longer (10
-2
s) than the singlet state,
7
 the interaction with other 
molecules is more likely to occur. There are two types of reaction pathway that 
are possible from the triplet state and these are depicted in figure 2.  Firstly, type 
I photoreactions (g) are redox processes involving direct electron or hydrogen 
transfer between the excited photosensitiser and oxygen or an organic 
biomolecule. These reactions lead to the production of the highly reactive 
hydroxyl radicals (OH
·
), via superoxide anions  (O2
-
). Once formed the hydroxyl 
 4 
radicals will react with organic biomolecules in the immediate vicinity, leading 
to cellular damage.
5
 
Secondly, the triplet state photosensitiser can undergo type II photoreactions (f) 
which lead to production of  singlet oxygen (
1
O2), the species that is usually the 
main cytotoxic agent in PDT. Molecular oxygen has a triplet ground state, giving 
it the correct symmetry to interact with the triplet photosensitiser. Thus, in 
aerobic environments, singlet oxygen is produced, which attacks local 
biomolecules, causing oxidative damage to cellular components, and leading to 
cell death.
5
  
 
Type II photoreactions
3P* + S P- + S+
P- + O2 P + O2
-
3P* + 3O2
1P + 1O2
1O2 + S S(O)
Type I photoreactions
h + 1P 3P*
OH
.
1P -singlet (ground) state photosensitiser S - organic biomolecule
3P* - triplet (excited) state photosensitiser O2 /
3O2 - ground state (triplet) oxygen
P- - reduced photosensitiser O2
- - superoxide anion
S+ - oxidised organic biomolecule 1O2 - singlet oxygen
S(O) - oxidised organic biomolecule
 
Figure 2: Summary of type I and type II photoreactions
5
 
 
Type II photoreactions are thought to predominate in PDT,
7
 although there is 
evidence that under certain circumstances, such as hypoxic environments, type I 
photoreactions may be dominant.
8
 
 
 5 
1.2.2 Singlet oxygen (
1
O2) 
 
Ground state (triplet) oxygen has two unpaired electrons in separate antibonding 
orbitals, a representation of which is shown in Figure 3. The first excited singlet 
state lies ~22 kcal.mol
-1
 higher in energy with the two outermost electrons 
having paired spins and occupying the same orbital. This is the state which is 
referred to in this report as singlet oxygen (
1
O2), and indeed is thought to be the 
cytotoxic species in PDT.
6
 The high reactivity of this state is due to the two outer 
electrons filling a π antibonding orbital, destabilising the molecule. There is 
however a second excited state of oxygen, again a singlet state that is ~ 35 
kcal.mol
-1
 above the ground state, in which the two outermost electrons reside in 
separate orbitals but with paired spins. This state is actually chemically 
unreactive because it decays to the lower singlet state by fast vibronic relaxation 
with surrounding molecules.
7
 This is a spin allowed transition, conferring a 
lifetime of ~10
-11 
s (in aqueous environments) which is too short to allow 
chemical reaction with other molecules. In contrast, the lower singlet state cannot 
decay to the ground state as quickly since this involves a spin forbidden (singlet - 
triplet) transition, and is thus a relatively long lived species, with a lifetime of 1-3 
μs in aqueous environments in the laboratory.9 However, this is reduced 
dramatically in cellular systems
9
 to 250 ns in the cytoplasm and 100 ns in lipid 
membranes. For PDT applications, this means that singlet oxygen cannot 
practically diffuse more than 45 nm in tissue and since this is considerably less 
than a single cell diameter, the initial site of production determines the site of 
photodamage and also which biological structures are attacked. 
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Figure 3: Electronic configuration of oxygen species 
 
1.2.3 Biological targets of 
1
O2 
 
Singlet oxygen is known to attack many subcellular structures including nucleic 
acids, proteins, enzymes and membranes.
10
 Nucleic acids are fragmented by 
attack at thymine or uracil containing sites,
11
 and DNA repair enzymes are 
sensitive to oxidation.
12
 Enzymes and proteins are damaged by photochemical 
reaction at binding/active sites resulting in loss of biological function.
11
 
Specifically, histidine, cysteine, methionine and tyrosine residues are attacked by 
singlet oxygen.
11
 Cellular membranes, such as mitochondria and nuclear 
membranes are severely damaged by oxidation of unsaturated fatty acids and 
cholesterol. The reduction of the intracellular ATP pool has been followed by 
31
P 
NMR in the first few hours after PDT treatment, indicating the degradation of the 
mitochondrial membrane.
13
  
By attacking these targets 
1
O2 mediates cell death in a direct manner by both 
necrosis and apoptosis. Necrosis is a degenerative process resulting in cell death 
from acute tissue injury. The plasma membrane becomes degraded and cannot 
control the flow of ions and water in and out of the cell, which leads to osmotic 
 7 
swelling, and bursting of the cell.
11
 Apoptosis, however, is a naturally occurring 
process also known as programmed cell death, and is part of the normal 
development of the body. Damage to the cellular components by photooxidation 
can cause a change in the delicate balance of positive and negative signalling that 
keeps cells healthy, and induce the apoptotic process. Additionally, PDT may 
destroy tumours by attacking the vasculature, effectively starving the tumour of 
nutrients and oxygen.
14
  
 
1.2.4 Porphyrins as photosensitisers in PDT 
 
Porphyrins are aromatic, planar macrocycles consisting of four pyrrole units 
linked by carbon bridges. They are efficient producers of singlet oxygen in 
aerobic environments and hence, are good candidates for photosensitisers. The 
porphyrin core comprises a conjugated π system, containing 18 electrons and 
giving rise to strong absorption in the visible region. The uv/visible absorption 
spectrum of a typical free base porphyrin shows an intense band between 390-
420 nm (Soret band) and four less intense bands at higher wavelengths (Q 
bands), conferring their characteristic deep red/purple colour. Transmittance of 
light through tissue at wavelengths below 600 nm is reduced due to strong 
absorption by endogenous biomolecules such as haemoglobin. Furthermore, the 
penetration depth of light through tissue increases with wavelength, from ~0.5 
cm at 630 nm to ~1 cm at 800 nm. Photosensitisers that absorb above 800 nm are 
often inefficient at producing singlet oxygen due to insufficient energy of their 
triplet states. Thus, the optimal absorption range for a  photosensitiser is between 
600-800 nm for clinical efficacy.  The highest wavelength absorption band in a 
porphyrin spectrum is usually between 600-700 nm and this, allied to their 
inherent non-toxicity in the absence of light, are two of the main reasons why 
they are used in PDT. Another reason is that porphyrins exhibit a higher affinity 
for malignant over healthy tissue. This was first reported in the 1940s by Auler
15
 
and Figge
14
 who demonstrated that hematoporphyrin exhibited an affinity for 
neoplastic tissue over healthy tissue in vivo. Following this finding, Lipson et 
al.
16
 developed a closely related compound called hematoporphyrin derivative 
(HpD) that showed an even higher affinity for tumour tissue, leading to its use in 
 8 
the diagnosis of cancer by using the fluorescent emission of the porphyrin to 
detect tumours. In the 1960s it was realised by several groups
17-19
 that the 
combination of HpD and light could destroy tumour cells, and this line of 
research developed over many years eventually leading to the use of porphyrin 
based molecules as photosensitisers in clinical PDT. In 1995, a purified version 
of HpD called Photofrin
TM
 was licensed for clinical use against cancer and has 
since been approved in over forty countries for treatment of cancers of the lung, 
as well as the genitourinary and digestive tracts. As shown in Figure 4, 
Photofrin
TM 
1 consists of a complex mixture of oligomers. It has an absorption 
band at 630 nm that is used for activation during PDT, but there is considerable 
ongoing research in developing second generation photosensitisers with 
improved photochemical properties. One such compound is meso-tetra-
(hydroxyphenyl)chlorin 2 (Figure 4) which has been approved for use in the 
European Union, Norway and Iceland for palliative treatment of head and neck 
cancers, under the generic name Temoporfin
TM
. This has a chlorin core structure 
where one of the double bonds exocyclic to the core π-system has been reduced, 
resulting in a bathochromic shift and intensification of the longest wavelength  
absorption band to 652 nm. To date, these are the only two porphyrin based 
agents licensed for PDT of cancer, although benzoporphyrin derivative monoacid 
ring A 3 (Figure 4) is currently marketed under the name Visudyne and used for 
age related macular degeneration. Tin etiopurpurin 4 (Figure 4) is one of many 
other porphyrin photosensitisers currently undergoing clinical trials for cancer 
therapy. 
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Figure 4: Porphyrin based photosensitisers 
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1.2.5 Selectivity of porphyrin photosensitisers 
 
There is a „triple effect‟ associated with the selectivity of PDT treatment using 
porphyrin based  photosensitisers. First, is the previously mentioned affinity of 
the porphyrin for tumour cells over healthy cells, second, the area/volume of 
irradiation can be very accurately controlled using fibre optics and endoscopy, 
and third, due to the high reactivity of 
1
O2, tissue destruction occurs within a very 
narrow radius of production. In spite of this, the main side effect to PDT comes 
in the form of heightened skin sensitivity to light, which can last for many weeks 
after treatment.
5
 This is due to healthy cells retaining a level of photosensitiser, 
up to and beyond the activation point of the treatment. The accumulation of 
porphyrin based photosensitisers in tumours is not yet fully understood, however, 
some of the commonly accepted factors that play a role are: 
 
Leaky tumour vasculature and poor lymphatic drainage 
 
The fast rate of growth of tumours leads to angiogenesis and new vasculature 
to supply them with nutrients. This fast rate of growth leads to a deficiency in 
pericyte function, and tumour blood vessels are usually leaky, thin walled 
and have an irregular diameter.
20
 In addition to this, tumours are known to 
have a poor lymphatic clearance system, either due to obstructions or 
underdevelopment.
21
 The combination of these factors is thought to cause the  
photosensitiser to leak out of the blood stream and be retained in the tumour 
stroma due to the inadequate lymphatic drainage.
22, 23 
 
 
pH of interstitial fluid in tumours. 
 
Cancer cells require a lot of energy, thus high levels of aerobic glycolysis are 
maintained, which leads to production of lactic acid. This in turn lowers the 
pH of the interstitial fluid in the tumour, which is thought to lead to retention 
of weakly acidic photosensitisers.
24
  
 
Serum protein binding. 
 
 11 
Serum proteins such as albumin are known to be carriers of endogenous 
porphyrins in the blood
25-27
 and it has been shown that amphiphilic 
photosensitisers also bind to these proteins.
28
 In conjunction with the 
overexpression of the low density lipoprotein receptor on cancer cells, it is 
thought that serum proteins facilitate the transport and delivery of the 
photosensitiser to the cell via binding to this receptor.
28
 
 
Many other theories have been proposed,
28-31
 but the common theme is that the 
photosensitiser is not seeking out a specific target on the tumour cell, but is 
selectively retained inside the tumour. The photosensitiser is not selectively 
targeting tumour mass, so following administration, it is initially accumulated in 
all cells before being processed at different rates in healthy and malignant cells. 
 12 
1.3 Tetraazamacrocycles 
 
Functionalised tetraazamacrocycles based around the core structures 1,4,8,11-
tetraazacyclotetradecane (cyclam) and 1,4,7,10-tetraazacyclododecane (cyclen), 
shown in Figure 5, are currently being used in many biomedical areas, including 
biomimetics,
32
 radioactive diagnosis
33
 and treatment of cancer,
34
 anti-human 
immunodeficiency virus (HIV) agents,
35
 and magnetic resonance imaging (MRI) 
contrast agents.
36
 Underpinning the use of such compounds in these applications 
is the formation of stable complexes with a range of metal cations.  
 
N N
NN
HH
H H
N N
NN
HH
H H
5
Cyclam
6
Cyclen
 
Figure 5: Structures of cyclam and cyclen 
 
1.3.1 Factors for strong binding of metal ions 
 
According to Busch,
37
 there are two main characteristics of macrocycles required 
to bind a metal ion strongly, namely complementarity and constraint, and these 
are described together as multiple juxtapositional fixedness. For an optimally 
stable complex both factors should be maximised. 
 
1.3.2 Complementarity 
 
This can be described as how well the metal „fits‟ into the macrocycle cavity, and 
encompasses size, shape and electronic properties of the ligand. For a metal 
complex to be at its most stable, there will be an optimal combination of the 
 13 
following factors: 
 
 number of donor atoms 
 electronic properties of donors 
 geometrical arrangement 
 metal ion – donor atom bond distance 
    
Due to the finite number of possibilities for these interactions, Busch described 
complementarity as a first order effect, implying it can only ultimately confer a 
finite amount of stability to the complex.
37
 
 
1.3.3 Constraint 
 
Constraint is concerned with the number of donor atoms and the flexibility 
between them, and deals with ligand rigidity and complexity. Two aspects have 
been identified and studied: topology and rigidity 
 
1.3.3.1 Topology –  “the interconnectedness of ligand donor atoms”37 
 
It is known that the binding constant of a ligand increases with the number of 
donor atoms, which is known as the chelate effect.
37
 Cyclam and cyclen each 
contain four nitrogen donors, and form metal ion complexes which are more 
thermodynamically stable than complexes comprising four monodentate ligands. 
This can be explained
37
 by an increase in entropy of a system such as that shown 
in Scheme 1. As the four monodentate ligands are displaced from the metal ion 
by the polyamine ligand, there is an increase in disorder; there are two molecules 
on the left hand side of the reaction but five on the right, giving a favourable 
entropic increase in stability.   
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Scheme 1: Entropy and the chelate effect 
 
 
Additionally, if the ligand is assumed to bind in a stepwise fashion, as each 
metal-ligand bond forms, the effective concentration of the remaining donor 
atoms increases.
38
 It has been shown that in a nickel(II) system with a 
polydentate nitrogen donor ligand, the nickel-nitrogen bond cleavage rate is the 
same as for a monodentate ligand.
39
 This leads to the conclusion that the second 
donor atom must bind more quickly than the first, or the chelate would be lost at 
a rate equal to the monodentate system. An accepted explanation is that the 
effective concentration of the second donor atom increases after the first one is 
bound to the metal ion. This is due to a tethering effect, bringing the second 
donor closer to the metal ion and making it more likely to bond than an unlinked 
donor. (Figure 6)  
 
M N
H2
NH2
M NH3
NH3
Chelate Monodentate  
Figure 6: Tethering effect leading to increased effective concentration of the ligand
38
 
 
Thus, coordination is said to be an associative process, with the first donor 
binding helping the second one to bind and so on. The reverse process of ligand 
dissociation is equally affected. When one donor atom has dissociated from the 
metal ion the tethering effect gives it a high effective concentration and hence the 
 15 
rate of bond reformation is higher than the rate of dissociation of the second 
donor atom. The overall result is an extra kinetic stability conferred upon the 
complex when compared to the analogous monodentate complex. 
 
When the donor atoms are part of a macrocycle, a further energy stabilisation is 
observed called the macrocyclic effect.
40
 This can be rationalised by the 
difficulty of dissociation of the first donor atom from the metal ion. A 
polydentate acyclic ligand is able to dissociate from a metal by successive 
stepwise breaking of metal ligand bonds, beginning at a terminal donor atom. 
However, a macrocycle contains no end donor atom, thus ligand distortion must 
occur to facilitate cleavage of a ligand-metal bond as shown in Figure 7. The 
activation energy required for this process makes dissociation very slow, and it 
has been shown that the macrocyclic effect arises mainly from this extra kinetic 
stability gained.
37
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Figure 7: Comparison of first donor dissociation between a chelate and a macrocycle
38
 
 
 
1.3.3.2 Rigidity – “how fixed in space the donor atoms are”37 
 
It has been shown that rigid ligands with donor atoms fixed in a favourable 
orientation to bind the metal ion, form more stable complexes than those of more 
flexible ligands.
41
 This is understood to stem from the rigidity holding the donor 
atom in position such that they cannot move and deform the ligand shape. This 
tightly restricted movement about the median bond values of distance and angle 
gives a lower possibility of bond deformation and hence, bond dissociation. 
The cyclam and cyclen macrocycles provide four nitrogen donor atoms for 
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complexation of a host metal cation, however, substitution of the secondary 
amines can be undertaken to increase the number of donor atoms. This gives 
these macrocycles and their derivatives the ability to act as ligands for a range of 
metal cations which require coordination numbers of between four and eight, 
including the transition metals and the lanthanoids.  
 
1.4 Use of cyclam and cyclen derivatives in medical imaging and therapy 
 
1.4.1 Positron emission tomography (PET) 
 
This technique is used to identify the position of a radioactive tracer within the 
human body. A positron is the antimatter equivalent of an electron, and positron 
emission occurs when a nuclear proton changes into a positron (β+), a neutron 
and a neutrino.
42
 Since it is the position of the tracer that is being detected, the 
radionuclide must be delivered to the neoplastic site before a diagnostic image 
can be obtained. 
 
The imaging regimen requires the patient to be administered with a tracer which 
typically consists of a tumour avid biomolecule attached to a positron emitting 
radionuclide. After administration, a suitable time is allowed to elapse to allow 
the radionuclide to locate within the tumour mass, and the patient is then placed 
within a detector. 
 
Inside the body, a positron travels a small distance (1-2mm) before it comes into 
contact with a tissue electron and the particles annihilate, with their combined  
mass being converted into energy (according to E=mc
2
).
42
 This leads to the 
emission of two γ ray photons of 511keV which travel away from each other at 
180 ± 0.25° as shown in Figure 8.
43
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Figure 8: Schematic showing positron emission and subsequent annihilation with an 
electron
43
 
 
The slight variation from 180° is caused by residual motion of the positron and 
electron at the point of annihilation. Some of the photons will be absorbed by 
surrounding nuclei and some will be scattered by tissue, but when two photons 
are detected simultaneously at 180°, the position of the annihilation event that 
generated them can be calculated (Figure 9). After 500000 detections, 
distribution of the tracer can be calculated by tomographic reconstruction.
42
  
 
 
 
Figure 9: Schematic showing a PET scanner detecting divergent γ rays to generate a 3D 
image of the location of the PET tracer.
43
 
 
There are many radionuclides which are used for PET imaging including several 
isotopes of copper.
44
 The details of these radioactive copper isotopes are shown 
in Table 1.  
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Table 1: Radioactive isotopes of copper and their uses in medicine
44
 
 
Isotope Half 
Life 
Imaging 
(emission energy, abundance) 
Therapy 
(energy, range in tissue) 
60
Cu 20 min PET (β+, 873keV, 93%  
61
Cu 3.3 hr PET (β+, 527keV, 62%  
62
Cu 9.7 min PET (β+, 1315keV, 98%  
64
Cu 12.7 hr PET (β+, 278keV, 19% β- 190keV, 0.95mm 
66
Cu 5.4 min  β- 1109keV, 5.6mm 
67
Cu 62 hr SPECT (91, 7%; 93keV, 16%; 185, 48%)  β- 121keV, 0.61mm 
 
 
60
Cu, 
61
Cu, 
62
Cu and 
64
Cu are all positron (β+) emitters which can be used  for 
PET imaging.
45
 
60
Cu, 
61
Cu, 
62
Cu are used to measure blood flow and hypoxia 
while the longer half life of 
64
Cu has led to the development of 
64
Cu labelled 
monoclonal antibodies and peptides for tumour imaging via active targeting.
45
 
 
However,
 64Cu is also a β- emitter which makes it suitable for radiotherapy of 
cancer and it is this dual functionality which has made this isotope especially 
worthy of study. 
66
Cu and 
67Cu are also β- emitters with 67Cu having the most 
appropriate half life for therapeutic purposes.
45
 
 
1.4.1.1 Tetraazamacrocycles in PET 
 
The PET imaging technique relies on the radionuclide being delivered selectively 
to the target area (the tumour), and this can be achieved by using a bifunctional 
chelator which is covalently attached to a targeting biomolecule, such as a 
protein or antibody, while strongly binding the radionuclide. The tight binding of 
the radionuclide is required to achieve high thermodynamic stability in vivo 
whilst also being kinetically inert.
46
  
 
Most bifunctional chelators used for 
64/67
Cu isotopes are based around the cyclam 
and cyclen macrocycles because in addition to the complexes meeting the 
previously stated requirements of kinetic and thermodynamic stability, such 
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ligands can rapidly coordinate metal ions, show aqueous solubility and have high 
resistance to transmetallation in vivo.
44,47,48
 Cyclam and cyclen derivatives that 
have been investigated for use as copper chelators for PET imaging and 
radiotherapy are shown below (Figure 10).
44
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Figure 10: Cyclam and cyclen derivatives studied as 
64/67
Cu
2+
 chelators for use in PET 
imaging and radiotherapy
44
 
 
 
The compounds in Figure 10 show how the structure of the chelators has been 
changed in order to study the effect on biodistribution and overall efficacy in the 
search for an effective bifunctional chelator. The most stable oxidation state of 
copper is +2 and so the radionuclide is used in this form.
49
 Since copper(II) can 
form complexes with coordination numbers between four and six,
49
 the 
substitution of the macrocycles with coordinating pendant arms allows not only 
control of the denticity of the complex, but also the overall charge. The 
macrocycles without pendant arms form positively charged complexes as do the 
phosphonate ester derivatives. The carboxylate pendant arms are deprotonated 
upon complexation so the macrocycles containing these groups can form 
complexes which are neutral or overall negatively charged, depending on the 
number of carboxylate groups present. The overall charge on the complex has 
been shown to affect biodistribution and clearance rates in vivo and the numbers 
and types of donor atoms affects the kinetic and thermodynamic stability of the 
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complex.
44
 The rigidified macrocycles have been shown to exhibit very high 
association constants as well as long half lives of dissociation, but the kinetics of 
complexation of Cu(II) are slower than the non-rigidified macrocycles.
44
  
Figure 11 shows the structures of two bifunctional chelators which are currently 
undergoing trials for PET imaging and radiotherapy and illustrates the different 
approaches used to connect such chelators to targeting biomolecules.
50
  
Compound 17 has been conjugated to an anticolorectal carcinoma monoclonal 
antibody and radiolabelled with 
64
Cu for evaluation as a PET tracer.
50
 The carbon 
backbone of the macrocycle has been substituted with a linking group to connect 
to the monoclonal antibody. The common alternative is shown by the benzoic 
acid derivative 18 (Figure 11) in which the linking group is attached to one of the 
amino functionalities in the macrocycle.
51
 This compound is undergoing 
evaluation as a 
67
Cu based radiopharmaceutical for cancer therapy and has been 
attached to AB35, a monoclonal antibody directed against carcinoembryonic 
antigen.
51
  
The point of attachment of the linking group is clearly dependent on many 
factors, such as synthetic considerations and the number of pendant arms 
required for complexation of the radiometal. Additionally, the linker group itself 
can have a direct effect on the pharmacokinetic properties of the bifunctional 
chelator as well as the stability of the metal complex.
46
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Figure 11: Two cyclam based chelators currently undergoing trials for PET imaging and 
radiotherapy
50, 51
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1.4.2 Magnetic resonance imaging (MRI) 
 
MRI is a diagnostic medical technique used to identify pathological regions 
within the body. The fundamental property attenuated during an MRI scan is the 
magnetic moment of the hydrogen atom nuclei (protons) in tissue water. In the 
absence of a magnetic field, the magnetic moments of proton nuclei are oriented 
in a random fashion, but on application of a strong external magnetic field, they 
precess around an axis which is aligned parallel or antiparallel with the direction 
of the applied field.
52
 This creates two states, a low energy state which is aligned 
with the field and a high energy state opposed to the field, where the energy 
difference between the two states is given by: 
 
ΔE=ħν        where  ħ=Planck‟s constant 
ν=Larmor or resonance frequency 
 
This frequency is unique for protons and proportional to the applied magnetic 
field. The lower energy state is more populated than the higher one, and this is in 
accordance with and described by Boltzmann statistics. A pulse of 
electromagnetic radiation at the Larmor frequency is then used to excite nuclei 
from the low to the high energy state. Subsequently, these protons relax back to 
the lower state by emission of a pulse of electromagnetic radiation, and it is this 
pulse that can be detected, measured and converted into a signal. More 
accurately, it is the difference in the total electromagnetic radiation absorbed 
(nuclei excited) and emitted (nuclei relaxing) that is measured, so the signal 
intensity is proportional to the population of the two energy states. The 
macroscopic property being visualised on a magnetic resonance image is the 
distribution and concentration of water in body tissues.
52
 This gives a contrast 
between tissue of different types, such as bone and skin, but also differentiates 
between healthy and malignant tissues. An example of an image generated in this 
way is shown in Figure 12. 
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Figure 12: An example of an image created by MRI
52 
 
1.4.3 Contrast agents in MRI 
 
Contrast agents are used in MRI to generate a more intense signal contrast 
between different types of tissues.
36
 They are compounds that are administered 
before excitation of the protons, and perturb the natural rate of relaxation of 
water protons in their immediate vicinity, thus generating a brighter image. 
When a proton is in the high energy state, it relaxes via two mechanisms : spin-
lattice and spin-spin relaxation. 
 
 Spin-lattice relaxation is otherwise known as the longitudinal relaxivity 
and is effectively the transfer of energy from an excited water proton to 
nearby local  molecules and can be measured as the T1 relaxation time.
52
 
 Spin-spin relaxation is also known as transverse relaxation and is the 
transfer of energy from the excited proton to another low energy proton, 
resulting in the excitation of the second proton. It is measured as the T2 
relaxation time.
52
 
 
A contrast agent works by aiding the relaxation of the excited protons, increasing 
the rate of relaxivity and reducing either T1 or T2. The commercial gadolinium 
based contrast agents are known as T1 agents because their mode of action is to 
increase the rate of spin-lattice relaxation and reduce T1. 
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1.4.3.1 Tetrazamacrocycles in magnetic resonance imaging 
  
A range of T1 contrast agents based around the highly  paramagnetic 
gadolinium(III) ion are currently being used for diagnostic imaging of the central 
nervous system (especially brain tumours), multiple sclerosis and breast cancer.
53 
 
Some examples of compounds that are used clinically are shown in Figure 13.
36
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Figure 13: Examples of Gd(III) based contrast agents approved for use in the clinic
36 
 
The paramagnetism of gadolinium(III) created by seven unpaired f electrons is 
the property exploited in these contrast agents.
36,52,53
 This facilitates the 
relaxation of excited protons through a hyperfine interaction with the unpaired 
electrons in the gadolinium valence shell. Effectively, the excess energy is 
transferred from the proton to the gadolinium (III) ion and this reduces the T1 
relaxation time, leading to a brighter image.
53
 However, Gd
3+
 is highly toxic in 
vivo
52
 and so needs to be bound strongly in a chemical complex in such a way 
that renders it unable to leach out, while allowing local water molecules to 
approach closely enough to facilitate their proton relaxation. In the commercial 
agents, as shown in Figure 13, the Gd
3+
 ion is held in nine coordinate geometry, 
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with the octadentate ligands leaving one free coordination site for the inner 
sphere water molecule. Both acyclic and macrocyclic (cyclen based) chelators 
are used, but the macrocyclic ligands show significantly enhanced kinetic 
stabilities.
36
 In the macrocylic compounds the highly oxophilic Gd
3+
 ion is bound 
by four nitrogen donors in the macrocycle and four oxygen atoms from the 
pendant arms, conferring enough kinetic and thermodynamic stability for use in 
vivo. Due to the size of the metal ion, it sits just above the mean ligand plane, 
giving enough access for a local water molecule to bind in a dynamic reversible 
way.
36
 Thus, the mode of action of the contrast agent is to aid relaxation of the 
excited protons in this bound water molecule (inner sphere water), which then 
exchanges with a local water molecule. This dynamic equilibrium allows the 
contrast agent to affect the signal intensity of surrounding tissue water.
52
 
 
These types of low molecular weight gadolinium complexes are extracellular 
agents, distributing into the intravascular and interstitial space, and hence are 
known to be non-site specific agents.
54
 They passively accumulate in body tissue, 
enhancing the relaxivity and hence the signal, of the local environment. Contrast 
agents that target certain types of tissue have been reported in the last few years, 
including agents that accumulate in the liver, lymph nodes and atherosclerotic 
plaques.
55-57
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1.5 Aims of this project 
 
The aim of this work is to develop a synthetic route which allows access to 
molecules containing a porphyrin and a cyclam or cyclen derived macrocycle. 
As already explained, porphyrin molecules are efficient generators of singlet 
oxygen and are used as photosensitisers in PDT. They are also known to 
accumulate in tumour tissue due to the hyperpermeability of tumour vasculature 
and poor lymphatic drainage. Due to this, porphyrins exhibit a passive tumour 
targeting property.  
 
Tetraazamacrocycles based around cyclam and cyclen are excellent ligands for a 
variety of metal ions including copper(II) and gadolinium(III) among others. As 
already explained, the macrocycles can be substituted with pendant arms, giving 
them the correct denticity and electronic properties to coordinate these metal ions 
very strongly. The complexes formed with these metal ions are 
thermodynamically stable and kinetically inert and so can be used in vivo for 
both imaging and radiotherapy. 
 
A molecule combining these two elements would therefore have the possibilities 
of combining imaging and therapy (PET-PDT and MRI-PDT) or dual therapy 
(radiotherapy-PDT) in one tumour avid compound.  
 
Clinically, the advantages of having access to such compounds are : 
 
 The optimisation of PDT treatment by more accurate location of the 
porphyrin using the imaging modality. This would allow more accurately 
directed light to the areas containing the photosensitiser. 
 Longer residence times of the imaging modality in vivo due to the 
retention of the porphyrin, giving an enhanced window of opportunity for 
imaging the patient. 
 Selective retention of the porphyrin in tumour mass would allow location 
and identification of metastases by the imaging component. 
 26 
 Imaging of the accumulation of the porphyrin in tumour mass could be 
used to optimise the timing of activation of the photosensitiser, hence 
improving the efficacy of the treatment. 
 The effects of PDT treatment could be observed by use of the imaging 
modality. 
 A patient could be given a single drug for a combination of radiotherapy 
and PDT. 
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1.6 Porphyrins combined with imaging and therapy agents 
 
In 1983, Wong et al. radiolabelled hematoporphyrin derivative (HpD) with 
99m
Tc, with a view to using the known accumulation of HpD in tumour tissue to 
develop a targeted imaging agent.
58
 Subsequent studies showed that the 
compound did indeed accumulate in mammary tumour adenocarcinomas of 
mice.
59
 However, the compound was only stable for three hours and the 
99m
Tc 
ion was shown to be coordinated by the carboxylic acid chains on the porphyrin 
periphery as opposed to the porphyrin macrocycle itself.
59
 Based on this 
research, Murugesan et al. synthesised the carboxylic acid bearing porphyrins 
shown in Figure 14.
60, 61
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Figure 14: Examples of porphyrins used as ligands for 
99m
Tc ions
60, 61
 
 
 
These compounds were used to coordinate 
99m
Tc and similar results were 
obtained with respect to their accumulation in abdominal carcinoma of mice and 
mammary tumours in rats. The 
99m
Tc ion was once again shown to be 
coordinated by the carboxy chains on the porphyrin periphery and the 
compounds were stable for only four hours.
60, 61
 This prompted the incorporation 
of more efficient ligands into the porphyrin structure to enhance the in vivo 
stability of the 
99m
Tc ion.
62
 Scheme 2 shows the synthetic route used to 
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synthesise a porphyrin bearing four cyclam coordinated 
99m
Tc ions. In vivo 
distribution studies were carried out on compound 27 in mammary tumour 
bearing rats and tumour to muscle ratios compared favourably with a range of 
tumour seeking radiopharmaceuticals in current usage. The compound was also 
stable for more than five hours, giving a significant improvement over the 
previous studies. It is interesting to note that although the authors conclude that 
this compound shows potential for tumour imaging, no reference is made to the 
possibility of a targeted combined PDT-radiotherapy usage.
62
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Scheme 2: Cyclam bearing porphyrins synthesised to coordinate 
99m
Tc
3+
 ions for targeted 
PET imaging
62
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Hindre et al. synthesised the porphyrin-Gd DTPA conjugate 28, as shown in 
Figure 15, with a view to targeted MRI of tumour cells.
63
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Figure 15: Structure of DTPA-porphyrin conjugate synthesised by Hindre et al. for tumour 
targeted MRI
63
 
 
They compared the porphyrin conjugate 28 with free Gd DTPA in animal models  
and found that the compound was still selective retained in tumour mass, leading 
to reduction of T1 relaxation times in both lymphoblastic leukaemia cells and HT 
29 human colonic cancer cells, 24 hours after administration. MR imaging 
showed an enhancement in contrast between the tumour and adjacent tissue after 
use of this compound. In addition, they measured an enhanced relaxivity in the 
conjugate compared to Gd DTPA which they suggest was caused by the larger 
size of the molecule reducing the rotational correlation time of the compound. 
Being published in a specialist MRI journal, the report includes only a brief 
discussion of the synthesis of this compounds. However, since four DTPA 
ligands are joined to the porphyrin yet only two are used to coordinate 
gadolinium ions, it seems logical that the original synthetic target was a 
porphyrin with all four chelators acting as ligands, although this is not discussed 
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in the paper.
63
 Gadophrin 2 an analogous compound (Figure 16), has been 
synthesised by a different group with similar imaging results.
64
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Figure 16: Structure of Gadophrin 2, a necrosis avid MRI contrast agent
64
 
 
Later studies on both of these compounds have shown that they are avid only for 
non-viable (usually necrotic) tissues and not viable tumour cells,
64-66
 although 
this has led to their use for imaging of myocardial infarction.
67-69
  
 
Pandey and co-workers have synthesised several compounds for PDT-imaging 
purposes, similar to the aims of this project.
70
 Their systems have all been based 
around derivatives of the naturally occurring chlorophyll a and so have 
absorption bands in the region 660-700nm, making them good candidates for 
PDT.
70
 
 
To create a PDT-PET agent, they used this porphyrin template to attach a 
positron emitting radionuclide (
124
I), synthesising compound 33 in three steps as 
shown in Scheme 3.
71
 The behaviour exhibited by the porphyrin of selective 
retention in tumour tissue was used as the „targeting‟ modality. 
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Scheme 3: Synthesis of a bifunctional PDT-imaging (PET) agent
71
 
 
After administration to RIF tumour bearing CH3 mice, they found that the 
photosensitiser distribution could be imaged by PET and that the compound 
localised in mitochondria.
71
 Although the maximum intensity occurred 24 hours 
after administration, the best image contrast was found at 48h due to rapid 
clearance of the compound from the liver, spleen and intestine compared to the 
tumour. The compound exhibited photosensitising properties, with 80% of mice 
tumour free after 60 days.
71
  
 
 In another study, the same group
72
 synthesised compound 34 as shown in Figure 
17 in order to create a dual PDT-MRI agent, once again exploiting the selective 
porphyrin retention in tumour tissue for „targeting‟. This was administered to 
tumour bearing mice in a liposomal formulation. The compound proved to be 
 32 
tumour avid and enhanced the tumour image by 57% (24 hours postinjection) 
with no enhancement for fat and minimal enhancement for muscle tissue. This 
enhanced image remained at a measurable level  for more than 24 hours post 
injection, whereas the commercial agent Gd DTPA (Magnavist®) clears the body 
within 1 hour and shows little contrast after 30 minutes. The T1 relaxivity was 
measured at 18.70 mM
-1
s
-1 
compared to 3.25 mM
-1
s
-1 
for Gd DTPA. The 
photosensitising ability of the porphyrin was not compromised by the proximity 
of the Gd
3+
 ions and C3H mice bearing RIF tumours were treated by PDT, with 
80% being reported as tumour free after 90 days.
72
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Figure 17: A porphyrin substituted with two Gd
3+
 acyclic chelators for targeted PDT-MRI
72
  
 
Pandey et al. also combined the same porphyrin core 36 with the cyanine dye 
IR820 35, as shown in Scheme 4.
73
 The cyanine dye has the required 
photophysical properties for fluorescence imaging but has no tumour specificity. 
Hence, the role of the porphyrin was as a tumour localising agent as well as a 
photosensitiser, giving a dual PDT-fluorescence imaging compound. The 
investigators found that compound 37 degraded when irradiated at wavelengths 
in the porphyrin absorption band, but it remained intact when irradiated at the 
correct wavelength for the cyanine dye to absorb. After administration to CH3 
mice bearing RIF tumours, the conjugate showed uptake in tumour and skin up to 
48 hours by reflectance spectroscopy, but after 72 hours had cleared from the 
skin to negligible levels while remaining in the tumour at high enough 
concentrations to be used for imaging the tumour mass. The photosensitising 
 33 
ability was retained with 8/10 mice tumour free after 90 days post irradiation.
73
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Scheme 4: Synthesis of a porphyrin-cyanine dye conjugate for PDT-fluorescence imaging
73
 
 
More recently, the group of Lu synthesised the bifunctional polymer conjugate 
41 containing a chlorin photosensitiser and a macrocyclic gadolinium contrast 
agent as shown in Scheme 5.
74
 
 
Poly(L-glutamic acid) was used as the carrier molecule and was loaded via 
reaction of the free amines on the contrast agent and the chlorin photosensitiser 
with the activated esters on the polymer. The reaction was done stepwise with the 
relative ratio 16:2 (contrast agent:photosensitiser) in order to achieve the correct 
dosage for both imaging and therapy. Athymic nude mice bearing human breast 
carcinoma xenografts were administered with the polymer conjugate which 
preferentially accumulated in the solid tumour, an effect which is known to 
derive from the hyperpermeability of the tumour vasculature.
74
 MRI showed a 
gradual accumulation of the conjugate in tumour, and a strong enhancement of 
inner tumour tissue was reported at 18 hours post injection. PDT was performed 
immediately after the MR images were taken and tumour regrowth was 
significantly delayed in comparison to a control group, leading the authors to 
conclude that the conjugate is effective for both tumour detection and minimally 
invasive therapy.
74
 
 34 
 
 
NNH
HNN
HOOC
HOOC
O
H
NH2N
N
N
N
N
O
HN
HO
OHO
O
OHO
NH2
6
H
N
H
C C
O
CH2
CH2
C
OH
O
H
N
H
C C
O
CH2
CH2
C O
H
N
H
C C
O
CH2
CH2
C O
O
NH
HN
N
N
N
N
O
O
O
O
O
O
Gd
N
NH
HN
N
HOOC
HOOC
O
N
H
HN
H
N
H
C C
O
CH2
CH2
C
OH
O
H
N
H
C C
O
CH2
CH2
C O
N
O O
O
++
1. DMAP, DMF, rt
2. Gd(OAc)3, pH 5.0-5.5
m n
m x y
38 39 40
41
 
Scheme 5: Synthesis of a polymer loaded with photosensitiser and contrast agents for 
combined PDT-MRI
73
 
 35 
1.7 Reported syntheses of linked porphyrin-cyclam/cyclen conjugates 
 
Apart from the two examples of cyclam/cyclen derivatives appended to 
porphyrins already discussed, 
62,73
 there are several other instances of such 
molecules being reported in the literature.  
Weiss and co-workers
75
 synthesised the porphyrin-cyclam compound 44 for use 
as a heterobimetallic mimic for cytochrome c oxidase by the route shown in  
Scheme 6. For a magnetic interaction between the two metal centres to occur, the 
requirement was for a cofacial arrangement of the two macrocycles with a 
flexible linking group. The route chosen involved condensing porphyrin 42,  
containing an aromatic amine on the ortho position of a phenyl ring, with acrolyl 
chloride to leave an available activated olefin. This was subsequently reacted 
with the ring amine of cyclam in a conjugate addition. Both reactions gave 
acceptable yields although the authors could not selectively form the porphyrin 
complex of iron(III)
 
from this bis ligand. The iron(III) was complexed by the 
activated olefin porphyrin before reaction with the cyclam macrocycle. The 
copper(II) was finally inserted into the cyclam ligand at the end of the 
synthesis.
75
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 Scheme 6: Synthesis of a cyclam appended porphyrin as a cytochrome oxidase c model
75
 
 
Takeda and Setsune
76
 were also interested in a dinucleating system with a 
cofacial arrangement of the macrocycles for biomimetic models. They used the 
route shown in Scheme 7 to synthesise porphyrin-cyclen conjugate 47. 
Alkylation of an inner nitrogen group in the porphyrin macrocycle was chosen in 
order to force the macrocycles into the desired cofacial position. This was 
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achieved by nucleophilic substitution of diphenyl sulfonium tetrafluoroborate by 
2,3,7,8,12,13,17,18-octaethyl porphyrin 45, followed by anion exchange. The 
desired product 47 was then obtained by reaction of cyclen with the aliphatic 
iodide protruding from the porphyrin core. Good yields were reported for both 
reactions.
76
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Scheme 7: Alkylation of the inner amine of a porphyrin with cyclen in order to furnish a 
cofacial arrangement of the two macrocycles
76
 
 
 
Studies of compound 44 synthesised by Weiss et al.
75
 had shown that there was 
no interaction between the two metal centres and so Guilard and Boitrel
77
 
designed compound 51 as shown in Scheme 8. This molecule comprises a 
cyclam ligand strapped to a porphyrin molecule in order to force the macrocycles 
to have a cofacial arrangement. The reaction sequence uses the αβαβ 
atropoisomer of the tetraaminophenyl porphyrin 48 to selectively react two 
amines with the acyl chloride functionalities on the phenylene linking group. The 
orientation of the phenyl rings on the porphyrin leads to the selectivity of this 
reaction - the reactive amine groups have a trans arrangement to one another 
with respect to the porphyrin core. Having protected two amines, the remaining 
ones are then reacted in a sequence analogous to that used by Weiss et al.
75
 
Treatment with acrolyl chloride gave compound 50 - a porphyrin with two 
activated ester groups which were then reacted with cyclam to afford the desired 
porphyrin 51.
77
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Scheme 8: Synthesis of a cyclam strapped porphyrin
77
 
 
Analogous compounds were synthesised by the group of Collman
78
 and were 
reported around the same time as the Boitrel paper.
77
 They began from the αααα-
atropoisomer of the tetraaminophenyl porphyrin and condensed this with acrolyl 
chloride to give four activated esters all protruding upwards from the porphyrin 
macrocycle. These were reacted with cyclam and cyclen to give compound 52, 
comprising cofacial macrocycles but with each of the amino groups on the 
cyclen/cyclam attached to the porphyrin (Figure 18).
78
  
 
Similar methodology was used by Rose et al.
79
 to synthesise so called „barrel‟ 
porphyrins which contained two cyclen macrocycles strapped in the same way (4 
positions), one on either face of the porphyrin.  
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Figure 18: Strapped porphyrin-cyclam compound synthesised by Collman et al.
78
 
 
Smith et al.
80
 used a diamino substituted diphenyl porphyrin 53 as their starting 
material, a molecule which showed no atropoisomerism at room temperature and 
so facilitated easier synthesis (scheme 9). Treatment with chloroacetoyl chloride 
gave the activated chloromethyl porphyrin 54 which was subsequently reacted 
with dioxocyclam to yield compound 55. The dioxocyclam was chosen due to 
the lower reactivity of the amide nitrogens, thus negating the need to protect two 
of the the amine groups of cyclam in a trans fashion.
80
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Scheme 9: Synthesis of a strapped dioxocyclam porphyrin
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1.8 Summary 
 
Porphyrin molecules are efficient generators of singlet oxygen when activated by 
light of an appropriate wavelength and are used as photosensitisers in 
photodynamic therapy. They exhibit a passive tumour targeting property, 
accumulating in tumour tissue due to the hyperpermeability of tumour 
vasculature and poor lymphatic drainage. 
 
Cyclam and cyclen macrocycle derivatives are excellent ligands for metal ions 
such as copper(II) and gadolinium(III) among others. The complexes formed 
with these metal ions are thermodynamically stable and kinetically inert and are 
used in vivo for PET, MR imaging and radiotherapy. 
 
The aim of this work was to develop a synthetic route which allows access to 
compounds containing a porphyrin photosensitiser and a cyclam/cyclen based 
macrocyclic ligand. Such a compound would have uses in tumour targeted 
imaging and therapy (PET-PDT and MRI-PDT) or dual therapy (radiotherapy-
PDT).  
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1.9 Synthetic overview 
 
The overall aim of this project is to develop a compound that contains a cyclen or 
cyclam based macrocyclic chelator and a porphyrin as shown in Figure 19, for 
use as a combination imaging-therapy agent.  
 
Porphyrin
Photosensitiser
Cyclen/ cyclam based
chelator
Linking group
 
Figure 19: Schematic showing the aim of the synthesis 
 
As already discussed, porphyrin compounds exhibit the physicochemical 
properties required to be used as photosensitisers in PDT. Cyclen macrocyclic 
chelators are form stable and inert complexes with gadolinium(III) and are used 
as MRI contrast agents, while cyclam complexes of copper(II) exhibit a similarly 
high level of thermodynamic and kinetic stability and are used in PET.  
 
Based on a convergent synthetic strategy, the porphyrin and the cyclam/cyclen 
macrocycle must contain compatible functional groups to link them together. 
Additionally, the cyclen macrocycle must contain carboxylate containing 
pendant arms to offer the correct denticity for complexation of gadolinium(III).  
 
The synthetic route must be general enough to allow coupling of both porphyrins 
and cyclam/cyclen macrocycles with differing substitution patterns. This is 
important because it will allow substituents to be changed, altering properties 
such as solubility or the balance between hydro- and lipophilicity.  
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Chapter 2: Synthesis of cyclen and cyclam macrocyclic chelators 
 
2.1 Synthesis of cyclen based bifunctional chelators 
2.1.1 Aims 
The aim was to synthesise the bifunctional macrocycles 56, 57, 58 and 59 as 
shown below (Figure 20). 
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Figure 20: Bifunctional chelator target molecules 
 
The target compounds 56, 57, 58, 59 and 60 are all cyclen macrocycles 
functionalised with a reactive group on a pendant arm for subsequent attachment 
of a porphyrin moiety. In order to leave several reaction possibilities open for the 
porphyrin attachment, functional groups with different reactivity were chosen. In 
the case of 56 and 57 this is an alkyl and an aromatic amine respectively, which 
can be used as a nucleophilic species, whereas 58, 59 and 60 contain an aromatic 
bromide group, useful for palladium mediated coupling reactions. Cyclen based  
macrocycles are known to form kinetically inert and thermodynamically stable 
complexes with metal ions, such as gadolinium(III). Carboxylate containing 
pendant arms are often used as the additional donor groups, so the target 
molecules 59 and 60 contain three such arms in order to facilitate formation of a 
stable, neutral metal complex. (Figure 20). However, these groups cause 
solubility problems during organic synthesis and so in targets 56, 57 and 58 these 
groups are protected as tert-butyl or methyl esters. Deprotection of the esters to 
form the metal ion complex could then be carried out.      
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As an alternative strategy, compounds 59 and 60 contain the same linking 
functionality (aromatic bromide) as 58 but have already been complexed with a 
lanthanoid metal prior to being attached to the porphyrin. 
 
2.1.2 Asymmetric substitution of cyclen/ cyclam macrocycles 
 
In order to access the target molecules, the four equivalent amine groups in the 
symmetric macrocycle cyclen  must be functionalised in an asymmetric manner. 
The ways in which this has been achieved in the chemical literature can be 
broken down into three main categories: 
 
1. Direct selective functionalisation of one amine, followed by 
derivatisation of the remaining three. 
2. Direct functionalisation of three of the amines followed by substitution of 
the remaining one. 
3. Protection – selective derivatisation – deprotection routes.  
 
 
2.1.2.1 Direct substitution of one amine group on free base cyclam and 
cyclen 
 
This is usually done with a large excess of macrocycle over the electrophile to 
ensure the major product is mono-N-substituted. There are many examples of 
cyclam and cyclen which have been monoalkylated in this way, incorporating a 
wide variety of functionality within the substituents.
81-85
 Some examples of these 
are shown in Figure 21. Meunier et al.
81
 used such a method to incorporate 
carboxylic acid and pyridyl side chains onto both cyclam and cyclen. The 
reactions used electrophilic species incorporating halide leaving groups, a five to 
tenfold excess of macrocycle and were heated to 110 °C in DMF. The choice of 
solvent played a key role by causing the unreacted cyclam/cyclen to precipitate 
out of solution upon cooling and therefore facilitated easier isolation of products 
61 and 62, which were obtained in yields between 40%-80% based on the 
 43 
electrophile. Helps et al.
82
 synthesised the aromatic derivatives 63-65 shown in 
Figure 21 using the same tenfold excess of macrocycle and an excess of 
inorganic base (potassium carbonate) in chloroform at ambient temperature. The 
polarity difference of the unreacted cyclam and the product was exploited to 
wash out the starting material from the crude reaction mixture using ethereal 
solvent. Yields were between 70-80% and the excess macrocycle was recovered. 
Similar methods have been used to incorporate an alkyl chain 66
83
 and a 
bipyridyl group 67
84
 using ethanol and aqueous methanol as solvent respectively 
along with a fivefold excess of macrocycle.  Duimstra et al.
85
 have used this 
method to derivatise cyclen with a pendant arm containing a sugar residue in a 
base free reaction at ambient temperature in DMSO (compound 68).   
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Figure 21: Examples of monofunctionalised cyclam / cyclen derivatives
81-85
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In an attempt to produce cyclen based lanthanide chelators with a functional 
handle, Kruper and co-workers
86
 noticed an unexpected selectivity towards mono 
alkylation when using a stoichiometric ratio of macrocycle to electrophile. The 
reactions were carried out in anhydrous, non polar, aprotic solvents such as 
dichloromethane or chloroform stabilised with pentene. Their highest reported 
yields were obtained when using sterically hindered secondary bromide 
electrophiles in a 1:1 ratio with free base cyclen – Figure 22. It is noteworthy that 
the products 70, 72 and 74 were isolated as the monohydrobromide salts, and 
indeed the selectivity in these reactions appears to stem from the relative basicity 
of the secondary amines in the macrocyclic ring. Table 2 shows the pKa values 
for the four amines on the cyclam and cyclen molecules.
87
 The first two 
protonation constants are significantly higher than the last two, for both 
macrocycles. Hancock and co-workers
87
 assign this drop to the build up of strain 
energy as three protons are placed within the macrocyclic ring. This is comprised 
of both electrostatic repulsion and van der Waals repulsion between the protons. 
The net result is that the first two amines on cyclam and cyclen are basic but the 
third and fourth are not and Kruper et al.
86
 used this trend to interpret their highly 
selective reactions. Since the reactions were performed in the absence of base, 
the first alkylation is followed by protonation of the second amine. The 
remaining amines are non-basic and also non-nucleophilic and so the crude 
products show mainly mono-substituted products with only small amounts of 
dialkyl species present. These are removed by column chromatography and the 
pure hydrogen bromide salts 70, 72 and 74 were isolated. Indeed the authors state 
that performing the reactions with base present reduced the selectivity and yields. 
The steric hindrance present in the electrophiles 69, 71 and 73 is clearly a factor 
in the success of the reactions, probably slowing the second alkylation down 
considerably in comparison to the competing protonation. This is confirmed by 
the much lower yield of the last entry in Figure 22 which uses an unhindered 
alkyl bromide 75, with a resulting loss of yield of product 76. The solvent plays 
an important role with nonpolar aprotic solvents preferred to polar solvents 
which they report as promoting proton transfer and subsequent loss of 
selectivity.
86
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Table 2: Successive pKa values for cyclam and cyclen
87
 
 
 pK 1 
 
pK2 pK3 pK4 
Cyclen 10.6 9.6 1.5 0.7 
Cyclam 11.6 10.6 1.6 2.4 
 
The pK values in the table refer to the following equilibria: 
   pK1  :L ↔ LH
+
        pK2  :LH
+
 ↔  [LH2]
2+    
   
   pK3   :  [LH2]
2+
 ↔ [LH3]
3+
    pK4  :[LH3]
3+
 ↔ [LH4]
4+
     L = free base cyclam/cyclen     
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Figure 22: Cyclen derivatives synthesised by Kruper et al.
86
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In 2002, Li and co-workers
88
 found that the results reported by Kruper et al.
86
 
could not be maintained when the electrophile is unhindered or containing 
reactive functional groups.
88
 They reported a method which is compatible with a 
wide range of functional groups such as ethers, esters, alcohols, alkenes and 
larger moieties such as sugars and crown ethers as shown in Figure 23. Their 
synthesis proceeds by slow addition of the electrophile to a double excess of 
macrocycle and a five-fold excess of inorganic base, in anhydrous acetonitrile at 
60 °C. After workup and flash chromatography on silica gel they report yields of 
monosubstituted  cyclam and cyclen macrocycles 77-86 in the range 66-93% .  
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Figure 23: Monofunctionalised cyclam/cyclen compounds synthesised by Li and co-
workers
88
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2.1.2.2 Direct substitution of three amine groups on free base cyclam and 
cyclen 
 
Free base cyclam and cyclen can be directly alkylated on three of the amine 
groups by careful control of stoichiometry and reaction conditions to maximise 
the yield (Figure 24). The Mishra group
89
 developed a methodology to substitute 
both macrocycles with ethyl ester bearing pendant arms on three of the available 
amines by slow addition of 2.24 equivalents of electrophile in dichloromethane 
solution at ambient temperature. They reported yields of 72% and 74% for 
compounds 87 and 88 respectively and it is interesting to note that the reaction is 
base free.  Faulkner and co-workers
90
 alkylated cyclen with three tertiary butyl 
containing pendant arms using 3.3 equivalents of electrophile and excess 
inorganic base in a similar procedure, to give 89 in an isolated yield of 42%. It is 
noteworthy that neither of these procedures required column chromatography to 
isolate the product, which was obtained by recrystallisation.  
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Figure 24: Cyclam / cyclen compounds synthesised by Mishra et al.
89
 and Faulkner et al.
90
 
 
A comprehensive study by Li et al.
91
 led to the development of a more general 
method of selectively trialkylating cyclen, with improved isolated yields of 
products. They examined the effect of solvent and base on the synthesis of the 
tris-tert-butyl ester shown in Scheme 10. 
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Scheme 10: Optimised synthesis of 1,4,7-(tris-methoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane
91
 
 
The optimum conditions were found to be chloroform solvent, 3.5 equivalents of 
electrophile and ten equivalents of triethylamine as auxiliary base. Although this 
method is just an optimisation of the previous work, the yield of 77% of 90 is 
significantly higher than previously reports. The generality of the method was 
illustrated by using a series of electrophiles to synthesise compounds 91-94 as 
shown in Figure 25. 
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Figure 25: Trialkylated cyclen derivatives synthesised by Li et al.
91
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2.1.3 Protection – selective derivatisation – deprotection routes 
 
2.1.3.1 Protection of three amine functionalities by trivalent species 
 
Handel et al.
92
 developed a synthetic methodology for monoalkylation of cyclam 
and cyclen by using a phosphoryl group to temporarily block three of the amine 
groups on the macrocycle. This was followed by reaction of the fourth amine 
with an electrophile before removal of the protecting group, Scheme 11. 
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Scheme 11: Monoalkylation of cyclen using a phosphoryl protecting group
92
 
 
The phosphoryl species was inserted into the free base macrocycle 6 by reaction 
with hexamethyl phosphoric triamide. This lead to the tautomeric equilibrium of 
95 and 96 (phosphorus(III) and (V) oxidation states) which was then oxidised by 
CCl4 at low temperature (0-5 °C) to give the phosphonium chloride salt, 97. 
After basic hydrolysis, the resulting phosphonium oxide species, 98 was treated 
with benzyl bromide in a stoichiometric ratio in DMF at 100 °C to yield 99 
followed by acidic removal of the phosphoryl protecting group to give 100. 
Although there are several steps, the overall yield was reported as 90%, but the 
drawback to this method is intolerance of many functional groups within the 
electrophile due to the harsh acidic conditions used to remove the protecting 
group. The same group
93
 also developed an analogous method using a boron 
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protecting group by using the reagent tris(dimethylamino) borane. The reaction 
sequence is applicable to both cyclen and cyclam but a higher yield was reported 
for the cyclam derivative 101. Ultimately, though the scope is limited due to the 
use of strong base (
n
butyl lithium) required to facilitate alkylation of the final 
amine in the macrocylic ring.( 
Scheme 12) 
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Scheme 12: Use of a boron protecting group for monoalkylation of cyclam/cyclen
93
 
 
Another type of protection-alkylation-deprotection sequence is possible by direct 
substitution of three of the ring amines by protecting groups. Two common 
functionalities used for this purpose are tosyl
94
 and tertbutoxycarbonyl.
95
 As 
shown in Scheme 13, compound 103 has been synthesised in 56% yield by slow 
addition of a double excess of p-toluenesulphonyl chloride to a chloroform 
solution of cyclen 6 with excess triethylamine present.
94
 A double excess of the 
electrophile was found to give the optimum yield since this ratio diminishes 
formation of the tetra-N-substituted macrocycle which caused the separation of 
the desired product to be much more difficult. As shown in Scheme 14, tri-N-
tertbutoxycarbonyl protected cyclen 106 has been synthesised using a similar 
procedure, again with slightly less than the expected 3:1 ratio of electrophile to 
macrocycle.
95
 Both of these procedures give a reliable route to monoalkylated 
cyclen and cyclam and some examples of their use are shown in Scheme 13 and 
Scheme 14. Their scope is ultimately limited by the nature of the deprotection 
conditions required to furnish the free macrocycle. The tosyl deprotection 
conditions involve using boiling concentrated sulphuric acid or 48% HBr 
solution under reflux conditions. The tertbutoxycarbonyl deprotection did not 
require heating but still involves strongly acidic conditions (trifluoroacetic acid 
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or 48%  HBr solution) and so both of these routes are only possible for 
electrophiles containing functionalities which are compatible with strong acids.   
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Scheme 13: Asymmetric substitution of cyclen using tosyl protecting groups
94
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Scheme 14: An example of N-Boc protecting groups used in the synthesis of asymmetrically 
substituted cyclen
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2.1.3.2 Protection – selective derivatisation – deprotection using bisaminal 
methodology 
 
This methodology inserts a two carbon bridge into the free base macrocycle, 
rigidifying the structure and effectively protecting three of the amines so that one 
can be selectively alkylated. The bridge is then removed to leave the free base 
macrocycle with only one functionalised amine group-Scheme 15. The glyoxal 
adducts of cyclam 112 and cyclen 109, were first reported by Weisman et al. in 
1980.
97
 Since then the syntheses of these molecules has been optimised and they 
are now prepared by adding a solution of one equivalent of glyoxal (40% aq) to a 
methanolic solution of the free base macrocycle at 0-5 °C.
98
 This methodology 
gave access to 109 and 112 in high yields (85-95%) as shown in Scheme 15.  
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Scheme 15: Use of bisaminals to monofunctionalise cyclam and cyclen macrocycles
98
 
 
The tetracyclic structures have cis configuration about the central two carbon 
bridge, which has been confirmed by temperature dependent NMR 
experiments.
97, 99
 The result of this configuration is that the molecule sits in a 
folded geometry giving rise to a concave and a convex face. This leaves two  
non-adjacent nitrogen lone pairs facing away from the concave face (endo) and 
the other two pointing away from the convex face (exo) and their reactivity 
towards electrophiles is governed by this alignment.
100
 The two exo lone pairs 
are much less sterically hindered than the endo ones and they act as nucleophiles 
 53 
whereas the two endo ones do not. The cyclam bisaminal is chiral due to a C2 
symmetry axis orthogonal to the central carbon-carbon bridge, and  hence exists 
as a pair of enantiomers which interconvert at ambient temperature.
99
 Alkylation 
is typically carried out in dry acetonitrile with a slight excess of electrophile at 
room temperature.
98
 The products of this reaction are two enantiomeric 
quaternary ammonium salts. Dialkylation is a much slower process and isolation 
of the monosubstituted product is aided by precipitation from solution, 
facilitating isolation by a simple filtration / washing procedure. After successful 
monosubstitution of one amine, the two carbon bridge can be removed by 
treatment with hydrazine or inorganic base such as potassium hydroxide which 
gives just the single monoalkylated macrocycle as the product (Scheme 16)  
 
 
Scheme 16: Schematic showing the cis configuration about the central two carbon bridge, 
and the effect on the orientation of the nitrogen lone pairs 
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2.1.4 Synthesis of 1-aminoethyl-4,7,10-(tris-methoxycarbonylmethyl)-
(1,4,7,10-tetraazacyclododecane) (56) 
2.1.4.1 Synthetic strategy 
 
The synthetic routes used to obtain compound 56 are shown in Scheme 17 below. 
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Scheme 17: Synthetic routes for the synthesis of compound 56 
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Compound 56 is comprised of a cyclen macrocycle substituted with three ester 
containing pendant arms and one ethyl amine arm, and so the free base cyclen 
macrocycle needed to be asymmetrically functionalised. 
The amine pendant arm needed to be introduced onto the macrocycle in a 
protected form so that the nucleophilic amine did not interfere with subsequent 
reactions. The acid labile tert-butoxycarbonyl (Boc) group was chosen as the 
protecting group. To facilitate selective unmasking of the amine once the 
macrocycle had been functionalised, the type of esters needed to be chosen so 
that they were less susceptible to acidic conditions than the Boc group and for 
this purpose methyl ester arms were chosen.  
 
The initial approach to obtaining macrocycle 56 was to alkylate three of the 
amines with the ester arms, isolating the product 90 and then subsequently 
alkylating the fourth amine with the N-Boc protected arm. However, this route 
was unsuccessful and so the sequence of reactions was reversed, monoalkylating 
cyclen with the N-Boc pendant arm followed by alkylating the remaining three 
amines with the ester pendant arms. A literature search showed that this reaction 
sequence was already known
101
, and it was indeed successful in obtaining 
compound 116. However, the drawback to this route was its inefficiency with 
respect to the starting macrocycle cyclen, which is relatively expensive and used 
in excess. So an alternative route was explored using the selective alkylation of 
the bisaminal intermediate 109. Compound 109 was selectively monoalkylated 
with the N-Boc amine arm 119, and the rigidifying bridge removed to furnish 
compound 115, hence providing an alternative route to the target compound 56.  
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2.1.4.2 Results and discussion 
 
The initial attempts to synthesise the aminoethyl cyclen derivative 56 were via 
the trifunctionalised cyclen intermediate 90, as shown in Scheme 18 below. 
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Scheme 18: Attempted synthesis of compound 116 
 
Compound 90 was synthesised by dropwise addition of methyl bromoacetate to a 
solution of cyclen in acetonitrile with NaHCO3 present. A triple excess of the 
electrophile was used and after three days of stirring at room temperature, 
compound 90 was isolated, after aqueous work up and chromatography, in 50% 
yield. Bromoethylamine hydrobromide 118 was then treated with Na2CO3(aq) 
followed by Boc anhydride to protect the amine and furnished compound 119 in 
80% yield.
102
 
Subsequent attempts at alkylating the remaining free amine on the macrocycle 
with N-Bocbromoethylamine were, however, unsuccessful. Initially a one to one 
molar ratio of macrocycle to electrophile was used, with one equivalent of 
sodium carbonate as base and the reaction was attempted at room temperature. 
Close monitoring by TLC showed no appreciable reaction occurring even when 
left for four days, so the reaction was heated gently to 60 °C. This caused one 
main product to be formed, which was duly isolated by column chromatography. 
The compound exhibited a complex NMR spectrum, but the lack of peaks 
characteristic of the tertiary butyl group in both the 
1
H and 
13
C spectra clearly 
indicated it was not the desired compound 116. The proton spectrum showed 
very broad, unassignable signals in the region where the macrocyclic ring 
protons were expected and typical ring carbon signals were also present in the 
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13
C spectrum, indicating that the compound did contain the macrocyle unit. 
However, the complexity of the signals gave rise to the possibilities that either a 
mixture was still present or more than one macrocycle could be present in the 
compound. Careful analysis by TLC was consistent with a single product and 
showed that the compound had not degraded during work up and isolation. An 
intense new signal was also observed in the 
13
C spectrum at 160ppm, alongside 
the original ester signals which was also consistent with the macrocycle 
dimerising/polymerising, a possible route for which is shown in Scheme 19 
below.   
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Scheme 19: Postulated mechanism of dimer formation 
 
The amide bond linking the two macrocycles in 120 would be expected to give a 
signal around 160-170ppm in the 
13
C spectrum. Although this product was not 
identified, the clear implication was that the macrocycle was not reacting with 
the electrophile to give the desired product. Since the electrophile was consumed 
in the reaction, there remains a possibility of a competing elimination mechanism 
as depicted in Scheme 20. The base involved could be either the starting 
macrocycle 90 or the inorganic base added to the reaction. The product would be 
nucleophilic and hence unreactive to any remaining compound 90.  
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Scheme 20: Proposed elimination reaction between compounds 119 and 90 
 
 
Further attempts at alkylation were carried out at room temperature using an 
excess of the electrophile and also using a small amount of KI to improve the 
reactivity of compound 119, but none of these were successful.   
A similar problem was encountered by Duimstra et al.
85
 when they were  
attempting to synthesise the cyclen derivative 122 (Scheme 21). As shown in 
route a, the initial approach was to react the trisubstituted cyclen 123 with the 
sugar appended alkyl bromide 124. However, the reaction was still incomplete 
after four days at ambient temperature, and byproducts were beginning to form. 
On applying heat, the sugar containing arm degraded and they were forced to 
change their synthetic route.  
As shown in route B, alkylation of the free base macrocycle with compound 124 
was successful and although compound 68 could not be isolated, the desired 
product 122 was obtained after subsequent alkylation of the remaining secondary 
ring amines. The ester groups were hydrolysed and the metal ion complex 125 
formed in 18% yield over four steps.  
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Scheme 21: Literature report showing two approaches to asymmetric substitution of amines 
on a cyclen macrocycle
85
 
 
An analogous problem was encountered by Sammes et al.
90
 as shown in Scheme 
22. They were aiming to synthesise the target molecule 126 by reacting 
trisubstituted macrocycle 127 with the N-iodoethyl substituted acridone 128. 
Compound 127 was dissolved in acetonitrile and K2CO3 added, followed by slow 
addition of the electrophilic species 128, and gentle heating for 36 hours. 
However, the product isolated was the elimination product 129 which was 
formed in very high yield. They do not discuss this failure in the paper, but turn 
to a route analogous to that used by Duimstra et al.
85
 and successfully obtain 126 
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by monoalkylating free base cyclen with the acridone derivative 128 followed by 
trialkylation of the remaining amines on the macrocycle with the tertiary butyl 
containing arms (Scheme 22 – route b). This time the yields were reported and 
they isolated monoalkylated intermediate species 130 in 69% yield and the target 
compound 126 in 84% yield in the subsequent reaction.  
 
These two examples show that alkylation of the fourth amine on the macrocycle 
is not a trivial procedure even with reactive electrophiles such as in the latter case 
with iodinated species 128.  
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Scheme 22: Literature report of an elimination reaction by the free amine on a cyclen 
macrocycle
90
 
 
Hence a new route was required to synthesise the required aminoethyl substituted 
cyclen 56, and like the two groups discussed, the first obvious option was to 
reverse the synthetic steps in order to put the single N-Boc protected amine arm 
onto the macrocycle before the ester arms (Scheme 23). Indeed, a search of the 
literature found that the desired compound 116 had been synthesised previously 
by Mishra et al.
101
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Scheme 23: Synthetic route to compound 116
101
 
 
Using the reported method
101
 a two and a half fold excess of free base cyclen 6 
was dissolved in anhydrous toluene and heated under reflux with one equivalent 
of the electrophile 119. This methodology uses the stoichiometry of the reagents 
i.e the excess of macrocycle to facilitate the mono substituted cyclen 115 being 
the main product. Indeed 115 was isolated in 49% yield without recourse to 
chromatographic separation. The product has much higher solubility in organic 
solvents such as dichloromethane and much lower solubility in water compared 
to cyclen (both free base and protonated), allowing isolation of the product by the 
simple procedures of extraction and washing. 
 
Again following the procedure reported
101
 compound 115 was dissolved in 
anhydrous acetonitrile with 3.5 equivalents of methyl bromoacetate and sodium 
carbonate as base. The mixture was heated to 60 °C under a nitrogen atmosphere 
and was monitored by TLC. A single product formed with the expected Rf value 
and was duly isolated by column chromatography. However, both 
1
H and 
13
C 
NMR analysis indicated that a mixture was present. As mentioned previously, 
these types of macrocyclic compounds often exhibit broadened signals in their 
1
H spectra, so the 
13
C spectra are generally used as a primary resource for 
identification purposes. Figure 26 shows two areas of the 
13
C spectra for the 
mixture initially isolated and the pure sompound 116 as a comparison. It can be 
clearly seen that the carbonyl (ester) region shows four peaks in the mixture and 
only the expected two in the pure compound. At lower chemical shift values, two 
peaks can be seen in the mixture which correspond to the carbonyl peak within 
the Boc protecting group, whereas only one is expected and indeed seen in the 
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pure compound. This indicated that the reaction was not complete and the 
isolated material was probably a mixture of the dialkylated macrocycle and the 
desired product, even though it appeared as a single spot by TLC analysis. 
Hence, the material was treated with a further 1.5 equivalents of methyl 
bromoacetate in the same manner as before which after workup and isolation, 
furnished a pure sample of compound 116 in 72% yield. 
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Figure 26: 
13
C spectra of reaction mixture and pure compound 116 
 
Although the route to compound 116 was successful, it required the use of a 
large excess of the starting macrocycle cyclen. This is a relatively expensive 
reagent and although some of the excess was recovered, an alternative route 
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which gave the product in a similar overall yield without using any excess cyclen 
was desirable. Hence a synthetic route using the bisaminal methodology 
described earlier was attempted (Scheme 24). 
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Scheme 24: Synthetic route to compound 115 using bisaminal methodology 
 
Cyclen was rigidified with a two carbon bridge in the cis configuration by 
reaction with glyoxal at 0-5 °C following literature methods.
98
 This is an almost 
quantitative reaction yielding the rigidified macrocycle 109 with only two of the 
amine groups remaining nucleophilic as discussed previously in this report. 
Compound 117 was formed by treatment of 109 with one equivalent of 
compound 119 in dry acetonitrile at room temperature.
103
 The alkylation of such 
macrocycles must be carried out at room temperature since they are susceptible 
to degradation when heated. The reaction was monitored by TLC and after 14 
days athough some starting materials remained, no further reaction appeared to 
be taking place. The product was easily isolated in 74% yield by successive 
washing and trituration due to its vastly differing solubility in diethyl ether when 
compared to both starting materials. Since the symmetry of the macrocycle has 
now been broken and compound 117 also exists as a pair of optical isomers both 
the 
1
H and 
13
C spectra are very complex. However, the spectrum could be 
partially assigned by combining using 2D NMR experiments alongside literature 
interpretation
103
 of analogous compounds. Mass spectrometry was used to 
confirm the identity of the molecule.   
Compound 117 then required deprotection to form the free alkylated macrocycle. 
This was initially attempted using aqueous KOH (20% w/v) with heating to 60 
°C under a nitrogen atmosphere, using the method described by Petillo et al.
103
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This conversion proceeded smoothly and after workup the product 115 was 
isolated in 41% yield by column chromatography on neutral alumina. The NMR 
analysis could be compared directly with that of compound 115 synthesised by 
the previous route.  The mechanism for this reaction has not yet been elucidated 
but Petillo et al. have proposed the mechanism shown in Scheme 25.  
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Scheme 25: Proposed mechanism of bisaminal deprotection
103
 
 
They reported high yields when the R group was a simple alkyl chain, but in a 
reaction where the side arm had acidic protons they reported no ring expansion, 
but an elimination product and the glyoxal bridged macrocycle were recovered. 
They conclude that the formation of the ylide is competing with any possible 
elimination pathways. This may help to explain the relatively low yield in the 
reaction as although the only product isolated was the desired compound 115, the 
elimination pathway shown in Scheme 26 is consistent with the findings of their 
report.
103
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As an alternative to the ring expansion of compound 117 using aqueous KOH, 
the macrocyclic salt was dissolved in hydrazine monohydrate and heated to 120 
°C. This yielded the desired product 115 in a higher yield (51%) but this time 
without any need for chromatographic separation. The overall yield from free 
base cyclen to compound 115 via this protection-deprotection strategy was 37%. 
Thus it gave a lower yield than the direct monoalkylation route (49%) but it was 
much less wasteful of the expensive starting material cyclen.  
 
Comopund 116 was then treated with trifluoroacetic acid in dichloromethane in 
order to remove the N-Boc group and restore the free primary amine on the 
pendant arm. This procedure was fairly unremarkable and deprotected the amine 
in 95% yield without interfering with the methyl ester groups also present in the 
molecule. 
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2.1.5 Synthesis of aryl bromide and aryl amine bearing macrocycles, 57, 58, 
59 and 60  
 
2.1.5.1 Synthetic strategy 
The synthetic routes used to obtain compound 57, 58, 59 and 60 are shown in 
Scheme 27 below. 
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Scheme 27: Synthetic routes used to prepare substituted cyclam macrocycles 
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The three target compounds were once again asymmetrically substituted cyclen 
macrocycles, with one arm containing a reactive functional group to be used to 
attach a porphyrin moiety. The aim was to obtain one compound with an 
aromatic amine (compound 57) and one with an aromatic bromide (compound 
58), both in the free base form macrocycle, and as the metal ion complexes 
(compounds 59 and 60).  
The key intermediate in their syntheses was the known compound 127
104
, which 
was then alkylated with the relevant electrophile successfully at the remaining 
reactive ring amine to give compounds 58, 132 and 135.  
 
Compound 57 was already reported in the literature and the aromatic amine was 
furnished by substituting compound 127 with nitrobenzyl bromide followed by 
reduction of the aromatic nitro group.
105
 However, following problems with the 
published method, an alternative reducing reagent (NaBH2S3) was found and 
ultimately used for this transformation. The problems with this route lead to the 
synthesis of compound 134, which although not an original target molecule, is a 
close analogue of compound 57, just differing by an amide bond on the aromatic 
amine pendant arm.  
 
Compound 58 was obtained in a straightforward manner from compound 127 by 
alkylation with p-bromobenzylbromide, as was compound 135 from alkylation of 
127 with 2,4-dibromoacetophenone. The metallation of compound 135 was done 
by standard procedures used in our group to give the gadolinium(III) and 
lanthanum(III) complexes.  
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2.1.5.2 Results and discussion 
 
Compound 127 was synthesised from free base cyclen by a known literature 
method.
104
 Slow addition of a threefold excess of the electrophile to a solution of 
cyclen at room temperature maximised the yield of the trialkylated product, 
which was isolated by column chromatography in a yield of 55%. The stock of 
this compound was synthesised prior to the improved method by Li et al.
91
 
coming to the author‟s attention. This key intermediate was then used to 
ultimately prepare compounds 57, 58, 59, 60 and 134. (Scheme 28). 
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Scheme 28: Synthetic route to compound 57
105
 
 
The route to the aminobenzyl derivatised cyclen 57 (Scheme 28) was already 
known in the literature, and indeed the published procedure
105
 was used to obtain 
compound 132 in almost quantitative yield (95%). The subsequent reduction of 
the aromatic nitro group in compound 132 to the free amine was much more 
problematic however. Initial attempts were made using a 5% loaded Pd/C 
catalyst, methanol solvent and hydrogen delivered via a balloon as described in 
the published report
105
 but this method appeared to have no effect on the starting 
material when monitored by TLC (the product was expected to be significantly 
more polar than the starting material). A change to ethanol as solvent gave two 
products by TLC, one was non-polar with respect to the starting material and still 
UV active, the other was more polar but not UV active. This appeared to show 
that N-debenzylation was occurring, instead of / as well as the reduction of the 
aromatic nitro group. This is consistent with the literature since amines are often 
protected using benzyl groups and one of the commonly used deprotection 
procedures is catalytic hydrogenation.
106
 However, as shown by the successful 
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literature report
105
 it should be feasible to hydrogenate the aromatic nitro group 
without removing the benzyl arm. Further attempts were made using 
combinations of 5-10% loaded Pd/C catalysts and methanol/ethanol as solvents 
but none were successful. The working hypothesis at this time was that the 
catalyst was perhaps too active. A search of the literature found a report 
involving the synthesis of a Pd/C catalyst poisoned with ethylenediamine 
reported by Hirota et al.
107
 Their work showed that this catalyst could be used to 
chemoselectively hydrogenate nitro groups (among many others) in the presence 
of O-benzyl and N-carboxybenzyloxy functionalities. Although N-benzyl groups 
were not mentioned it their report, it seemed feasible that this catalyst could 
provide the chemoselectivity required. The catalyst was duly prepared and used 
but appeared to produce several different products when analysed by TLC and 
when the reaction mixture was analysed by 
1
H NMR - the aromatic region 
showed several sets of doublets. Repeated attempts using differing amounts of 
this catalyst and changing solvent systems did not give the required 
transformation either. So, the reaction was then repeated using 10% Pd/C and 
ethanol as solvent and this time analysed at regular intervals by 
1
H NMR. Figure 
27 shows the aromatic region of the reaction mixture over a period of 30 hours.  
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Figure 27: 
1
H NMR of reaction mixture showing aromatic nitro group reduction over 30 hours 
 
It can be seen that the doublets 1 and 2 from the starting material are consumed 
and initially two main product peaks (3 and 4) are produced. These are 
subsequently consumed and eventually the peaks 5 and 6 are formed. No further 
change occurred after this time. The interpretation of this was that peaks 3 and 4 
were the desired product (the aromatic amine) and that peaks four and five 
belonged to the aromatic species formed after debenzylation. Careful analysis of 
the reaction by TLC was consistent with this hypothesis. Since the NMR shows 
that the desired product and the debenzylation were being formed at similar 
times, the problem appeared to be stopping the reaction at the optimal time to 
give the highest yield of the desired product. 
 
The reaction was therefore repeated under the same conditions and stopped after 
3 hours when the initial product seemed to be at its maximum yield. After work 
up and separation by silica gel chromatography the desired product 57 was 
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finally isolated in 70% yield, its identity being confirmed by 
1
H and 
13
C NMR in 
conjunction with mass spectral analysis.  
 
While this reaction was being investigated and optimised, compound 133 was 
synthesised to give an analogous compound with an amide linking group that 
was more robust under the conditions used for catalytic hydrogenation. (Scheme 
29) 
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Scheme 29: Synthetic route to compound 134 
 
 
Compound 133 was formed by treatment of p-nitrobenzoyl chloride (made in 
situ) with compound 127 and triethylamine in dry dichloromethane. After work 
up, and column chromatography, the product was isolated in 54% yield as a 
yellow solid.   
When this compound was hydrogenated under the same conditions used for 
compound 132 (5% Pd/C, EtOH solvent), the reaction produced one main 
compound after only two hours. Allowing the reaction proceed for longer had no 
further effect. The isolated product, obtained in 71% yield, was identified as 
compound 134 by 
1
H and 
13
C NMR and confirmed by mass spectometry, which 
reinforces the likelihood that compound 132 was cleaving at the benzylic 
position when hydrogenated.  
 
Although compound 57 had been successfully synthesised, another method for 
the desired transformation was investigated from a report by Laliberté et al.
108
 
They described a method for preparing the reducing agent NaBH2S3 (sodium 
trithioborate) and investigated its chemoselectivity. This reagent was reported to 
reduce aromatic nitro groups while leaving other groups untouched except for  
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aldehydes, ketones, lactones and epoxides – none of which were present in this 
reaction scheme. Initially NaBH2S3 was prepared in situ and treated with 
compound 132 in a 1:1 ratio as described in the report.
108
 TLC analysis appeared 
promising but showed an incomplete reaction, even after 24 hours. So the 
reaction conditions were changed and it was found that a double excess of the 
reducing agent gave the highest yield of the desired compound. Macrocycle 57 
was isolated after basic work up and chromatography in 78% yield, without the 
problems inherent in the catalytic hydrogenation route.  
 
A small modification to the procedure used to form macrocycle 132 gave the 
previously unreported compound 58 in 90% yield after chromatographic 
separation. (Scheme 30). The maximum yield of 58 was obtained when a slight 
excess of the bromobenzyl bromide (1.1x) was used instead of a stoichiometric 
amount as used in the synthesis of 132. This same adapted procedure was used to 
give access to the previously unreported bromo-acetophenone derivatised cyclen 
135, in a yield of 97%. The ester groups in compound 135 were hydrolysed by 
treatment of a dichloromethane solution of 135 with concentrated HCl, followed 
by neutralisation with base. The product was subsequently extracted into water 
and heated with an excess of the lanthanide trichloride salt to give the 
gadolinium complex 59 in a yield of 60% and the lanthanum complex 60 in 52% 
yield. Mass spectral analysis of these complexes showed characteristic isotopic 
patterns for the lanthanoid ions in the molecular envelope.  
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Scheme 30: Synthetic routes to compounds 58, 59 and 60 
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2.2 Synthesis of a rigidified cyclam macrocyclic chelator 
 
2.2.1 Aims 
 
The aim of this synthetic scheme was to obtain the rigidified macrocycles 
1,5,8,12-tetraaza-bicyclo[10.2.2]hexadec-5-yl)-acetic acid tert-butyl ester 137 
and 4-carbo-tert-butoxymethyl-1,4,8,11-tetraazabicyclo[6.6.2]-hexadecane 138 
as shown in Figure 28.  
 
N
N HN
N
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N
NH N
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Figure 28 : Target compounds 137 and 138 
 
Compound 137 contains a two carbon bridge between two adjacent nitrogen 
atoms which is commonly referred to as a „side bridge‟ and compound 138 has 
the same ethane bridge but this time between two non-adjacent nitrogen atoms – 
this is commonly referred to as a „cross bridge‟. As discussed in the introduction 
of this report these bridges confer upon them less conformational flexibility than 
the parent macrocycle and hence improves the kinetic and thermodynamic 
stability of their metal complexes towards metal ions.
109, 110
 Both compounds and 
some of their variants are known as good chelators for copper (II) ions.
109-112
 
Compounds 137 and 138 each contain a free secondary amine functionality that 
can be exploited for further derivatisation, specifically in this case for attachment 
to a porphyrin moiety.  
Both target molecules contain a tert-butyl containing pendant arm which, once 
hydrolysed to the parent carboxylic acid will form a point of ligation for a metal 
centre.    
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2.2.2 Side Bridged Macrocycles   
        
The synthesis of the side bridged cyclam 139 was first reported in 1980 by 
Wainwright (Scheme 31).
113
 Treatment of free base cyclam with a double excess 
of 1,2 dibromopropane resulted in the isolation of compounds 139 and 140 in 
30% yield  (Scheme 31). They report that the mono bridged compound 139 was 
about 90% abundant in this mixture. 
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Scheme 31: The first reported synthesis of ‘side bridged cyclam’113 
 
The low yield was attributed to competing reactions, such as elimination and also 
the fact that both substitution and elimination reactions create acid as a side 
product which immediately quaternises the remaining amines, rendering them 
unreactive. The attempts to solve this by use of „acid scavengers‟ were reported 
to be unsuccessful.
113
 
One year later, the group of Yamamoto
114
 improved the synthesis of compound 
139 by reductive ring expansion of the tetracyclic amine 141 (Scheme 
32)Scheme 32: Reduction of glyoxal bridged cyclam to give the side bridged 
derivative
114
 By treatment of 141 with diisobutylaluminium hydride they 
obtained compound 139 in almost quantitative yield (96%).  
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Scheme 32: Reduction of glyoxal bridged cyclam to give the side bridged derivative
114
 
 
However, compound 139 still has two secondary amine groups which are equally 
reactive, so the problem of chemoselective alkylation of one of these remained 
until Kolinski
115
 published such a route in 1995 (Scheme 33).  
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Scheme 33: Chemoselective alkylation of glyoxal bridged cyclam
115
 
 
Their synthetic route selectively mono-alkylated the tetracyclic bisaminal 112 in 
good yield with either methyl iodide or benzyl bromide to give compounds 142 
and 143. With this mono-alkylation successfully achieved, reductive ring 
expansion of these compounds with NaBH4 in ethanol furnished the 
monoalkylated bridged cyclam species 144 and 145 in yields of 83 and 96%.  
The reaction pathway proposed for this reduction is shown in Scheme 34.
115
 The 
initial site of reduction is the bridge carbon bonded to the quaternary amine. The 
tricyclic tetraamine 147 formed is unstable with respect to hydrolysis and this 
creates an equilibrium with the corresponding carbinolamine 148. Subsequent 
further reduction then generates the side bridged macrocycle product 149.  
 
 77 
N
N N
N+
R
H
H
N
N N
N
R
BH4
-
N
N N
N
R
OH
H H
+ OH-
- OH-
N
N HN
N
R
BH4
-
146 147 148 149
 
Scheme 34: Proposed mechanism of glyoxal bridge reduction in the cyclam macrocycle
115
 
 
This method has since been used in our group to produce a variety of this type of 
macrocycle
110, 116
 and the remaining free secondary amine subsequently used to 
successfully functionalise the compounds further. 
 
 
2.2.3 Cross Bridged Macrocycles 
 
Incorporation of a two carbon bridge between non-adjacent nitrogen atoms in the 
cyclam ring to form the cross bridge species 150 cannot be achieved by 
nucleophilic substitution. As shown by Wainwright
113
, this route results in the 
bridge being inserted between two adjacent nitrogen atoms – forming the side 
bridged cyclam macrocycle. Similarly, reductive ring expansion of the 
monoalkylated bisaminal 146 also leads to the side bridged product 149 as shown 
by the Kolinski group.
115
  
 
However, the group of Weisman
117, 118
 discovered that by dialkylating the 
bisaminal 151, the subsequent reduction of the carbon bridge occurred at both 
quaternary amines thus facilitating the production of cross bridged species such 
as compound 153 (Scheme 35).    
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Scheme 35: Synthesis of cross bridged cyclam.
117, 118
 
 
The mechanism they proposed for the reductive ring expansion of the dialkylated 
bisaminal 152 is shown in Scheme 36. It depicts initial iminium ion formation 
leading to N-C bond cleavage followed by reduction of the ion. This is then 
repeated on the other end of the two carbon bridge, ultimately forming the cross 
bridged product.  
 
N
N+ N
N+
R
H
H
R
N
N N+
N+
R
R
HH3B
N
N N
N+
R
R
N
N N
N
R
R
H BH
3
N
N N
N
R
R
 
Scheme 36: Proposed mechanism of reductive cleavage of the glyoxal bridge to give cross 
bridge cyclam
118
 
 
Compound 153 was then debenzylated to form the free base macrocycle 150, 
which was subsequently dialkylated to give the two species 154 and 155 shown 
in Scheme 37. Thus, the benzyl arms were used to protect the non-adjacent 
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amines and therefore direct the reductive ring expansion so that it formed the 
cross bridge product.  
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Scheme 37: Examples of dialkylation of cross bridge cyclam.
118
 
 
Subsequent work in our group has adapted this method to funtionalise the 
bisaminal 112 with two different protecting groups that can both survive the 
conditions for ring expansion. Once the cross bridged species has been formed, 
one of these groups can be selectively removed and the uncovered amine 
funtionalised. This can then be repeated for the other protected amine, thus 
giving access to a cross bridged species with two different pendant arms.
119
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2.2.3.1 Synthetic strategy 
 
The synthetic routes to compounds 137 and 138 are shown in Scheme 38 below. 
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Scheme 38: Synthetic routes to side bridged and cross bridged cyclam derivatives 137 and 
138 
 
Compounds 137 and 138 both contain a tert-butyl based pendant arm. This is a 
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protected carboxylic acid, which will be unmasked and used as a point of 
coordination for a metal ion. The acid was protected throughout the synthesis to 
improve solubility in organic solvents and hence make manipulation and 
isolation of these compounds easier. The tert-butyl ester was chosen because it 
has proven to be stable to NaBH4
110
 which is required for reductive ring 
expansion to obtain 137 and 159. These esters are also resistant to attack by 
bases and nucleophiles which was also a consideration as intramolecular 
lactamisation has been reported in side bridged cyclam macrocycles containing 
an ethyl ester pendant arm (Scheme 39).
82, 120, 121
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Scheme 39: Schematic showing reported intramolecular lactamisation in a side bridges 
cyclam derivative
82, 120, 121
 
 
 
For both target molecules, the key intermediate in their synthesis is the glyoxal 
bridged cyclam 112. The restricted flexibility and the folded nature of this 
compound provides the chemoselectivity required to alkylate only one of the 
amine groups with the tert-butyl ester containing arm, as discussed previously in 
this report. This mono-substitution creates the tetracyclic salt 157 which can then 
undergo reductive ring expansion as described by Kolinski
115
 to give the side 
bridged target, compound 137.  
A modification of the procedure of Weisman et al.
117
 was used to obtain the 
cross bridged target molecule 138. Further alkylation of compound 157 can also 
be achieved with the reaction occurring on the nitrogen non-adjacent to the one 
previously substituted. The creation of a second quaternary amine causes the 
subsequent reductive ring expansion to generate the cross bridge instead of the 
 82 
side bridge. Hence, the second pendant arm is „directing‟ the placement of the 
required bridge and in this case needs to be easily removed after the cross bridge 
has been formed. Hence, a benzyl arm was used as a protecting group for this 
amine and was chosen because it can be removed in good yield by reagents and 
conditions under which the tert-butyl ester arm would remain intact. This was the 
route chosen to obtain compound 138. 
2.2.3.2 Synthesis of side bridge macrocycle 137 
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Scheme 40: Synthetic route to side bridged cyclam derivative 137 
 
The macrocycle 5 (cyclam) was synthesised by condensing the nickel(II) 
complex of 1,5,8,12-tetraazadodecane with glyoxal.
122
 (Scheme 40). The α-
diimine product of this reaction was then reduced (NaBH4) and treated with 
cyanide to remove the metal and furnish the free base cyclam 5 in a yield of  
40%. In a route analogous to the synthesis of compound 117, the macrocycle was 
rigidified with a two carbon bridge fixed in the cis configuration in order to 
effectively protect three of the amine groups.
98
 As described earlier in this report, 
the folded geometry allows differentiation of the amines groups in the 
macrocycle. Two non-adjacent amines are rendered effectively unreactive due to 
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steric hindrance by their fixed orientation. The mono-alkylated compound 157 
was obtained by treating 112 with only one equivalent of the electrophile using 
the same procedure as for compound 117.
103
 The dramatic change in solubility 
from reactant to product caused precipitation and hence facilitated easy isolation 
as well as preventing dialkylation and compound 157 was obtained in high yield 
(95%).The carbon bridge was then reduced by the method of Kolinski
115
 to give 
the partially rigidified macrocycle 137 in 91% yield. 
2.2.3.3 Synthesis of cross bridged compound 138 
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Scheme 41: Synthetic route to cross bridged cyclam derivative 138 
 
Compound 157 was substituted for a second time by benzylation of the 
remaining reactive amine (Scheme 41). This reaction was significantly slower 
than the original alkylation that produced 157 and took 6 days to reach 
completion with compound 158 being isolated in 89% yield. Previous studies
119
 
have shown that the dialkylated salt 158 can undergo ring expansion with NaBH4 
despite having an ester group that is seemingly also susceptible to reduction. The 
tert-butyl ester group is reduced slowly in comparison with the reduction of the 
carbon bridge, allowing the reaction to be controlled to give the optimal yield of 
the desired compound 159. Thus, the dialkylated salt was treated with NaBH4 in 
EtOH for 7 days giving the ring expanded cross bridge cyclam species 159 in 
62% yield after chromatographic isolation. Finally the N-debenzylation of 
compound 159 was achieved by catalytic hydrogenation to give the target 
compound 138 in 70% yield.
118
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2.3 Summary 
 
The cyclen based macrocycles 56, 57, 58, 59, 60 and 134 and the cyclam based 
macrocycles 137 and 138 have all been successfully synthesised (Figure 29).  
As already described, cyclen macrocycles functionalised with carboxylate 
containing pendant arms form stable and inert complexes with gadolinium(III) 
ions, and the rigidified cyclam based chelators form stable and inert complexes 
with copper(II). Hence, these macrocycles have potential uses in biomedical 
imaging (MRI and PET). 
The compounds also contain a functional handle which can be exploited for 
diversification of the structure.  
The alkylamino bearing compound 56 was already known in the literature but a 
new route via bisaminal methodology was designed and demonstrated for the 
synthesis of this compound.  
Although the yield was lower than the literature procedure (37% compared to 
49%), the route provides more control over the monoalkylation and therefore 
offers an improved scope for such reactions involving the cyclen macrocycle.   
Compound 57 had also been reported previously. However, difficulties were 
encountered in the synthesis of this compound, and a new method for the last 
transformation provided a cleaner reaction and an improved yield (78% 
compared to 70%). This method also led to the synthesis of compound 134, a 
previously unreported compound. 
Along with compounds 137 and 138, these macrocycles contain amino groups 
which can be utilised for further diversification of their structure.   
The aryl bromide bearing compounds 58, 59 and 60 were all previously 
unreported, and have been synthesised in good yields. This functional handle 
opens the possibility of using transition metal catalysed coupling reactions for 
further elaboration.    
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The metal ion complexes 59 and 60 have been synthesised to allow an alternative 
approach to the desired bismacrocyclic compounds. These will allow the 
coupling reaction to be the last stage in the synthesis, removing the need for the 
harsh conditions required in the ester deprotection step.    
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Figure 29: List of compounds successfully synthesised 
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Chapter 3: Coupling the cyclam/cyclen moieties to a porphyrin 
via the β-position on the porphyrin ring  
 
 
3.1 Introduction 
 
 
With the cyclen and cyclam based compounds  56, 57, 58, 59, 60, 134, 137, and 
138 already synthesised, the next requirement was to develop a route by which 
these compounds could be attached to a porphyrin macrocycle. 
 
This clearly required the synthesis of a porphyrin containing one functional 
group complementary to the reactive groups on the cyclen/cyclam compounds. 
 
Synthesis of an asymmetric porphyrin can be achieved using two main strategies: 
 
1. Synthesis of a symmetrically substituted porphyrin followed by 
subsequent mono-functionalisation 
2. Incorporation of an asymmetric substitution pattern during the initial 
porphyrin formation reaction  
 
 
Synthesis of symmetric porphyrins has the advantages of higher yielding 
reactions and less tedious and time consuming isolation than the synthesis of 
asymmetric porphyrins. However, this is counterbalanced by the more limited 
options for monofunctionalisation of the highly symmetric porphyrin molecule.  
 
This chapter covers the routes established via mono-functionalisation of a 
symmetric porphyrin. 
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3.2 Porphyrins 
3.2.1 Physicochemical properties 
 
Porphyrins are aromatic macrocycles containing  22 π electrons, 18 of which are 
involved in the delocalisation pathway as shown in Figure 30. 
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Figure 30: Delocalisation pathways in the porphyrin macrocycle 
 
The aromaticity of the porphyrin molecule defines the majority of its organic 
chemistry, with electrophilic substitution being one of the most common 
reactions this type of molecule undergoes. The porphyrin core is numbered as 
shown in Figure 31. Generally the most electron rich, and therefore reactive, sites 
are the 5, 10, 15 and 20 positions (meso positions) but the 2, 3, 7, 8, 12, 13, 17 
and 18 positions (β positions) are favoured when the meso positions are 
substituted. When the meso positions are substituted by phenyl based groups the 
greater reactivity of the porphyrin ensures that electrophilic substitution occurs 
predominantly on the periphery of the macrocycle as opposed to the substituent 
rings.  
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Figure 31: Numbering of the porphyin core 
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Free base porphyrins have characteristic absorption spectra consisting of one 
very intense band at ~420nm (Soret band) and four less intense bands between 
500 and 700nm (Q bands). 
 
 
3.2.3 Transition metal complexes of porphyrin ligands 
 
Porphyrins readily form metal complexes with a range of metal cations including 
divalent magnesium(II) and calcium(II) as well as many transition metal ions.
123
  
The metal ions increase electron density on the porphyrin macrocycle by an 
inductive effect, activating the porphyrin periphery towards electrophilic attack. 
However, the porphyrin ring is a π donor ligand and can donate electron density 
into any empty d orbitals present on the metal centre. Thus, the balance between 
these two effects determines the amount of electron density on the macrocycle 
periphery and its ultimate reactivity. Cations such as Zn(II), Cd(II) and Mg(II) 
have no available d orbitals to receive back donation of electron density and 
therefore activate the porphyrin macrocycle the most. Ions such as Ni(II) and 
Cu(II) have partially filled d orbitals (d
8
 and d
9
 respectively) and accept 
backdonation from the ligand, hence the activation of the porphyrin is somewhat 
reduced. By comparison, transition metal ions with empty d orbitals (electronic 
configuration d
1
-d
5
) deactivate the ring considerably towards electrophilic attack. 
Reactions involving functionalisation of the porphyrin ring are often done by 
using a transition metal ion complex instead of the free base porphyrin, mainly 
for this very reason but also to protect the inner nitrogen atoms from reaction. 
Common metals used for this purpose are nickel(II), copper(II) and zinc(II), but 
zinc(II) is very acid labile so in many cases the other two ions are used instead 
due to their greater stability under acidic conditions.
123
  
The insertion of a metal ion into the porphyrin macrocycle changes their 
absorption spectra compared to the free base macrocycle. The spectra contain an 
intense Soret band at ~420nm but they show only two Q bands due to the higher 
symmetry of the molecule.  
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3.3 Formation of symmetric meso-tetraarylporphyrins 
3.3.1 Alder-Longo method
124
 
 
In 1964, the group of Adler studied the formation reaction of tetraaryl porphyrins 
by condensation of aromatic aldehydes with pyrrole under acidic conditions.
125
 
Shortly afterwards they published a synthesis of meso-tetraphenyl porphyrin
124
  
(TPP) 162 which was a significant improvement on the previous synthetic route 
to this molecule.
126
 Now commonly referred to as the Adler or Adler Longo 
method, an equimolar ratio of pyrrole and benzaldehyde were added to boiling 
propionic acid and the solution heated under reflux, open to the atmosphere, for 
30 minutes. Upon cooling, the porphyrin crystallised from the acidic solution, 
facilitating easy isolation by a sequence of filtration and washing. The isolated 
yield of TPP was reported as 20% as shown in Scheme 42. 
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Scheme 42: Adler-Longo synthesis of meso-tetraphenylporphyrin
124
 
 
Their studies showed that no reaction occurred without acid and that the yield 
was significantly reduced to around 5% when a nitrogen atmosphere was used.
127
 
The reaction is known to proceed through a porphyrinogen intermediate which is 
then oxidised by oxygen in the air, forming the porphyrin.
128
 The proposed 
mechanism for this process is shown in Scheme 43. They showed that changing 
the solvent to acetic acid gave a higher yield (40-45%) over a longer reaction 
time but the porphyrin was more soluble in this solvent and hence, more difficult 
to purify, whereas butyric acid gave a much lower yield. It was also found that 
the porphyrin product contained around 2-10% of chlorin contaminant, which 
can be removed by oxidation
129
 or chromatography. The low yield is caused by 
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the formation of pyrrolic oligomers which do not cyclise to form the 
porphyrinogen and form a dark tarry residue from which the porphyrin must be 
separated. The method is scaleable and hence allows access to porphyrins on 
multigram scales.  
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Scheme 43: Proposed mechanism of porphyrin formation 
 
The boiling propionic acid solvent used in the Adler method facilitates solvation 
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of a wide variety of aldehydes, giving the reaction a wide scope. However, this 
also makes the methodology unsuitable for aldehydes which are sensitive to 
these conditions. Despite this, a large range of porphyrins have been synthesised 
by this method with diverse functionality, three of which (163-165) are shown in 
Scheme 44.
130-132
 Porphyrins have been synthesised with substituents on the 
ortho, meta and para positions of the phenyl rings, including both electron 
donating and electron withdrawing groups.
133-136
 In addition, aldehydes 
containing macrocyclic and organometallic functionalities have been 
successfully condensed via the Adler method.
137, 138
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Scheme 44: Some examples of porphyrins successfully synthesised using Adler-Longo 
conditions
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To summarise, the Adler synthesis allows access to tetraaryl porphyrins with a 
wide range of substituents on a relatively large scale in ~20% yield. However, 
the harsh conditions used limit its usefulness with acid sensitive benzaldehydes 
and isolation and purification of the porphyrin from the tar laden propionic acid 
can be very difficult and extremely time consuming. In addition to this, 
reproducibility of yield from one reaction to the next is often unreliable. 
 
 
3.3.2 Lindsey method
139, 140
 
In 1986, the Lindsey group
139
 reported a new synthesis of tetraaryl porphyrins 
developed as a result of attempts to circumvent the limitations of the Adler
124
 
method. Specifically, they were interested in developing a route which would 
give access to porphyrins in a higher yield and which was also more tolerant of 
sensitive benzaldehydes.
140
 The porphyrinogen was known to be a key 
intermediate of porphyrin synthesis
128
 and was formed by a series of equilibria 
from the starting materials of pyrrole and benzaldehyde, as shown in Scheme 43. 
The Lindsey method establishes this equilibrium under mild conditions (CH2Cl2 
or CHCl3 solvent, ambient temperature, acid catalysis, inert atmosphere) 
followed by addition of an oxidant to irreversibly convert the porphyrinogen 166  
into the porphyrin 162.
139, 140
 (Scheme 45) 
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Scheme 45: The Lindsey synthesis of meso-tetraphenylporphyrin
139, 140
 
 
A series of extensive investigations have been undertaken to understand the 
reaction and the optimum conditions required are often dependent upon the 
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structure of the desired porphyrin.
141-146
 However, a general conclusion was that 
the reaction is most efficient when concentrations of both starting materials were 
10 mM, leading to symmetric porphyrins in yields as high as 50%.
140
 This 
methodology has been used for the synthesis of a wide range of meso-substituted 
porphyrins, and has proved to be mild enough to tolerate many functional groups 
that would not withstand the Adler conditions.
140, 147-150
 Reports of the synthesis 
of porphyrins bearing electron withdrawing and electron releasing substituents 
on all positions of the phenyl rings demonstrate the wide scope and general 
utility of this methodology.
79, 150-153
 Some examples of porphyrins synthesised by 
this method are shown in Scheme 46.
152, 154
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Scheme 46: Examples of porphyrins successfully synthesised using Lindsey conditions
152, 154
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The Lindsey conditions fail when the aldehyde is insoluble in either CH2Cl2 or 
CHCl3 and the main practical drawback is that due to the high dilution conditions 
required, it is only of realistic value for making porphyrins on a scale of less than 
1g. 
 
3.3.3 Porphyrins from pyrrole-carbinols 
 
As shown in Scheme 43, a key intermediate in the formation of the porphyrin is a 
pyrrole-carbinol, and symmetric porphyrins can be synthesised by self 
condensation of these compounds under acidic conditions, as shown in Scheme 
47.
133
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Scheme 47: An example of a porphyrin synthesised by the pyrrole-carbinol route
133
 
 
This drawback to this methodology is the requirement of functionalisation of 
pyrrole prior to condensation.  However, several ways of synthesising pyrrole-
carbinols have been reported along with the porphyrins resulting from their 
subsequent condensation.
155-159
 In comparison with the Adler
124
 and Lindsey
139
 
routes, this methodology  forms the porphyrin in two steps as opposed to one. 
Hence, as long as the benzaldehyde is available and stable, one of the previous 
routes would be the route of choice to a symmetric porphyrin.  
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3.4 Selective mono functionalisation of 5, 10, 15, 20-tetraaryl porphyrins at 
the β-position 
 
3.4.1 Halogenation 
 
Tetraphenyl porphyrin (TPP) 162 can be brominated at the β-position by 
treatment with NBS in CHCl3 as shown by Callot
160
. Despite the use of only 1.1 
equivalents of the brominating agent, the macrocycle undergoes polysubstitution 
and the mono-brominated porphyrin is only isolated after lengthy 
chromatographic separation in low yield (30-40%). This method is applicable 
with many substituents  on the phenyl rings and was used by Liu et al.
161
 to 
synthesise the bromo porphyrins (171-175) shown in Scheme 48.  
 
HNN
NH N
HNN
NH N
Br
NBS (1.1 equiv)
CH2Cl2
Ref lux 5-30mins
R
RR
R
R
R
R
R
Yield (%)
40
30
35
28
25
R
H
Me
OMe
Cl
CF3
Compound
171
172
173
174
175
 
 
Scheme 48: Mono-bromination of TPP
161
 
 
Chlorination of TPP using NCS is a slower reaction than bromination and hence 
the mono chlorinated product can be obtained in a slightly higher yield. Callot et 
al.
162
 heated a dichloroethane solution of TPP and NCS under reflux conditions 
for two hours and isolated the mono-substituted product in 47% after 
chromatographic separation.  
 
These relatively low yields can be improved by using the method of van Lier et 
al.
163
 who described the treatment of the nickel complex of TPP 176 with 
PhSeBr. This reagent afforded the mono brominated product 177 in an isolated 
yield of 72-86%, Scheme 49. 
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NN
N N
Ni
NN
N N
Ni
Br
PhSeBr
CHCl3, RT
72-86%
176 177
 
Scheme 49: Mono bromination of Ni-TPP
163
 
 
These β-brominated porphyrins allow access to a range of reactions for further 
functionalisation and manipulation of the structure. Chan and Zhou
164, 165
 used 
the free base 2-bromo-TPP 178 in a palladium catalysed coupling reaction with 
the boronic ester appended porphyrin 179 to obtain the dimeric porphyrin 180  
product in good yield as shown in Scheme 50.  
NH N
HNN
Br
NH N
HNN
B
OO
NH N
HNN
HN
N
NH
N
Pd(PPh3)4
K2CO3
Toluene 90-100°C
88%
+
178 179
180
 
Scheme 50: Porphyrin dimer obtained via palladium catalysed aryl coupling reaction
164, 165
 
 
It is notable that although they used free base porphyrins, under their reaction 
conditions the porphyrin did not form a metal ion complex with the palladium(II) 
cation.  
The zinc(II) complex of 2-bromo-TPP has been shown to undergo coupling 
reactions with both alkyl and aryl zinc organometallic reagents, using the same 
Pd(PPh3)4 catalyst.
166
 Suda et al.
167
 found that when they reacted cyanoethylzinc 
bromide with 2-bromo-TPP 178 the product was the cyano substituted zinc(II)  
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complex of TPP 181 and not the expected alkylated product 182 as shown in 
Scheme 51.   
 
NH N
HNN
Br
N N
NN
NC
BrZn
N
Zn
Pd
2
(dba)
3
, PPh
3
Dioxane
95°C, 30 mins
N N
NN
Zn
NC
X
BrZn
N
Pd2(dba)3, PPh3
Dioxane
95°C, 30 mins
61%
178 181
182  
Scheme 51: 2-cyano-Zn-TPP formed when cyano ethyl zinc was reacted with with 2-bromo-
TPP
167
 
 
This unexpected reaction gave access to tetraphenyl porphyrin monosubstituted 
at the β position with a cyano group in good yield.  
The nickel(II) complex of 2-bromo-TPP has also been shown to undergo 
nucleophilic substitution with E-benzaldoxime in DMSO at 80 °C.
168
 The 
product is the nickel complex of 2-hydroxy-TPP and is isolated in 83% yield. 
The nickel(II) complex was used to protect the inner nitrogen atoms from 
protonation and also because nickel(II) does not induce enough electron density 
on the porphyrin ring to render it unreactive towards nucleophiles. According to 
the authors the reaction proceeds via a typical SNAr mechanism with the halide 
ion acting as a leaving group.
168
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3.4.2 Nitration 
 
Copper(II) TPP, 183 can be mono-nitrated at the β-position by treatment with 
Cu(NO3)2 and acetic anhydride as shown in Scheme 52
162
. Once substituted, the 
electron withdrawing nature of the nitro group deactivates the porphyrin to 
further nitration thus giving the mono nitro porphyrin 184 as the major product. 
 
N N
NN
NO2
Cu
N N
NN
Cu
Cu(NO
3
)
2
, Ac
2
O,
CH3COOH, CHCl3
35°C
68%
183 184
 
Scheme 52: Nitration of copper(II) TPP
162
 
 
An alternative reaction was developed by Crossley et al.
169
 who used 2.05 
equivalents of NO2 in CH2Cl2 to mononitrate a range of tetraaryl porphyrins and 
this method has been further optimised to give access to 2-nitro-TPP in 88% 
isolated yield.
170
 Although the isolation of the product does not involve 
chromatography, the drawback to this method is the generation and handling of 
the gaseous nitrating reagent, a fact which was acknowledged by Ostrowski and 
co-workers
171
 who developed a new method using aqueous nitric acid at room 
temperature (Scheme 53). 
 
N N
NN
NO2
M
N N
NN
M
HNO3(aq), CHCl3
Argon, RT
M Yield %
184 Cu 77
185 Ni 81
186 Co 56
 
 
Scheme 53: Nitration of M(II) TPP with nitric acid
171
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Copper(II) 2-nitro-TPP 184 can be reduced to the corresponding amine by 
treatment with Sn/HCl or NaBH4 in methanol with a 10% Pd/C catalyst, thus 
giving easy access to β–amino porphyrins.172-174 
Free base β-nitro-tetraaryl porphyrins have been shown to undergo nucleophilic 
displacement with thiophenolate and ethylthiolate anions
174
, while their 
copper(II) and nickel(II) complexes react with sodium benzaldoximate, forming 
the corresponding 2-hydroxy porphyrin derivatives.
175
 (Scheme 54) 
 
N N
NN
M
N N
NN
M
Sodium benzaldoximate,
DMSO
N2, 60°C
M Yield %
Ni 60
Cu 93
NO2 OH
187
188
 
Scheme 54: 2-hydroxy porphyrin synthesis
175
 
 
Michael type addition reactions are also well known, with metal complexes of β–
nitro porphyrins being attacked by a variety of nucleophiles. 
176-178
  
 
3.4.3 Formylation 
 
The introduction of an aldehyde functional group at the β position of TPP can be 
achieved by treatment of a metal complex of the porphyrin with a mixture of 
phosphorus oxychloride and DMF at 0 °C. The overall mechanism of 
formylation of aromatic systems using POCl3 and DMF is well known and 
proceeds via formation of a chloroiminium salt, known as the Vilsmeier 
reagent
179
, as shown in Scheme 55. 
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Scheme 55: Vilsmeier salt formation 
 
This weakly electrophilic salt is then attacked by the aromatic system, in this 
case the porphyrin, as shown in Scheme 56. 
 
N R'R
N O
P
Cl
Cl
O
Cl
N R'R
N
Cl
H
N R'R
N
Cl
N R'R
N
Cl
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N R'R
N
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H
O
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Cl
Cl
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H
-
+
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Scheme 56: Mechanism of porphyrin formylation 
 
The metal ion complex is required to push electron density to the porphyrin 
periphery, thus making it nucleophilic enough to react with the Vilsmeier salt. 
This sequence generates an iminium ion which can then be hydrolysed to give 
the formyl group. The choice of metal ion is crucial to the reaction. It must 
activate the porphyrin periphery enough for the reaction to occur and be stable 
under the acidic conditions of the formylation yet be easily removed to yield the 
free base product. With these requirements in mind, it has been shown that the 
copper(II) complex of TPP 183 can be forrmylated in high yield
180
. However, the 
authors found that attempted demetallation of the porphyrin caused an 
intramolecular cyclisation reaction between the formyl carbon with the meta 
carbon of the nearby phenyl ring as shown in Scheme 57.
180
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NN
NN
Cu
NN
NN
Cu
O
1. POCl
3
, DMF,
CHCl3
2. NaOAc
94%
NN
NN
Cu
O
H2SO4
183 189 190
 
 
Scheme 57: Formation of 2-formyl-CuTPP followed by acid treatment
180
 
 
Clearly the formyl group is more reactive towards the acid than the inner 
nitrogen atoms, but this problem was solved by Maxwell et al.
181
 who found that 
because the intermediate iminium ion was stable to acidic conditions they could 
demetallate the porphyrin in situ, by treatment with sulphuric acid, prior to basic 
hydrolysis of the iminium ion to reveal the aldehyde group
181
 (Scheme 58). 
 
NN
NN
Cu
HNN
NNH
O1. POCl3, DMF, 0°C
1,2-Dichloroethane
2. H2SO4(c onc)
3. NaOH(aq)
95%
183 191
 
Scheme 58: Optimised synthesis of 2-formyl TPP
181
 
 
 
3.4.3.1 Reactions of 2-formyl-TPP 
 
2-Formyl TPP 191 can undergo Wittig type reactions as demonstrated by 
Callot
182
 who treated the nickel(II) complex of 2-formyl-TPP with Ph3P=CH2 
(formed in situ) to give the vinyl porphyrin analogue. The same methodology 
utilising different  Wittig reagents has been used to synthesise the compounds 
shown in Figure 32.
182, 183
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NN
NN
Ni
R
1
R
2
R
1
192 H
193 H/Br
194 COOMe
195 H
R
2
H
H/Br
H
COOMe
Yield (%)
52
71 (cis+trans)
41
30
 
 
Figure 32: Products from Wittig reaction of nickel(II)-2-Formyl-TPP
182, 183
 
 
In addition to these reactions where 2-formyl-TPP 191 was reacted with a Wittig 
reagent, it  has also been converted into a Wittig reagent.
184
 Reduction with 
NaBH4 followed by chlorination gives the chloroalkyl species 197 which was 
then treated with PPh3 in CHCl3 to give the Wittig porphyrin 198 in 76% overall 
yield (3 steps)
184
 Scheme 59.  
 
NH N
N HN
O
NH N
N HN
OH
NH N
N HN
Cl
NH N
N HN
PPh3
+
Cl
-
NaBH4,
THF/H2O
SOCl2,
Pyridine ,
Et2O
10 mol equiv PPh3,
CHCl3, Ref lux
76% overall
for three steps
191 196
197 198  
Scheme 59: Synthesis of a Wittig porphyrin
184
 
 
This methodology was used by Reid et al.
185
 to form the conjugated aryl 
aldehyde appended porphyrin 199 as shown in Scheme 60.  
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NH N
N HN
NH N
N HN
PPh3
+
Cl
-
CHOOHC
DBU, CH2Cl2, RT, 1min
2. I2, CH2Cl2, RT 16h
1.
CHO
80% yield
c is / trans mixture
198 199
 
Scheme 60: Reaction of the Wittig porphyrin
185
 
 
Shinkai et al.
186
 used a reductive amination sequence to further functionalise the  
copper(II) complex of 2-formyl-TPP 189 with two different groups as shown in 
Scheme 61. Amination of the aldehyde 189 gave the imine 200 in good yield and 
they isolated this compound before reducing it with NaBH3CN in a lower yield 
of 58%. Thus, the amine 201 was synthesised from the starting material in 52% 
over the two steps. The secondary amine was subsequently alkylated with two 
different groups – benzyl bromide and a boronic ester substituted analogue in 
50% and 29% yield respectively. Finally, the metal centre was removed from the 
porphyrin in the last step. The synthesis is not discussed in the paper, so it is not 
clear why the metal centre was kept inside the porphyrin throughout this 
sequence. NMR details are not reported and the paramagnetic copper(II) centre 
would make the analysis by 
1
H NMR difficult. The low yield of the boronic ester 
appended compound 202 is likely to be due to the Lewis acid nature of this 
reagent.   
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Scheme 61: Reductive amination using Cu(II)-2-formyl-TPP
186
 
 
Cavaleiro et al.
187
 used a similar methodology to synthesise 208 as shown in 
Scheme 62. They used a triple excess of amine and La(OTf)3 as a Lewis acid to 
form the imine 207, which was then reduced using NaBH4 to yield the amine 208 
in 66% over the two steps.  
N N
N N
O
Ni
N N
N N
N
Ni
206 207
(3 equiv)
La(OTf)3, K2CO3
Toluene, ref lux
O
O
N N
N N
NH
Ni
208
O
O
NaBH
4
,
MeOH / CH2Cl2
0°C
66%
(2 steps)
O
O
ClH.H2N
 
Scheme 62: Reductive amination of Ni(II)-2-Formyl-TPP
187
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Compound 208 was treated with paraformaldehyde, creating the ester stabilized 
azomethine ylide 209,
 188
 followed by the dipolarophile dimethyl fumarate, to 
give compounds 210 (a 50:50 steroisomeric mixture) in 60% yield.
187
 (Scheme 
63) 
 
N
NH
Ni
O
O
N
N
Ni
O
O
CH2
H N
N
Ni
MeOOC
COOMe
COOMe
N
N
Ni
MeOOC
COOMe
COOMe
+
Paraformaldehyde
Dimethyl fumarate
Toluene, reflux 60% overall yield
50:50 mixture
ester stabilized
azomethine ylide
208 209
210
 
Scheme 63: Formation and cycloaddition reaction of a porphyrin substituted azomethine 
ylide.
187
 
 
A similar methodology has been used to append a C60 functionality onto the β-
position of TPP.
189
 As shown in Scheme 64, free base 2-formyl-TPP 191 was 
condensed with N-methylglycine to form an unstabilised azomethine ylide
190
, 
which was then trapped with the dipolarophile C60 to give 211 in 40% yield. 
Note that in contrast to the above work, the porphyrin was used as the formyl 
component in the reaction.
189
 
 
NH N
N HN
O
NH N
N HN
N
CH3NHCH2COOH
C60
Toluene, reflux
40%
191 211
 
Scheme 64: Appending C60 onto the β-position of TPP via 1,3-dipolar cycloaddition
189
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3.5 Synthetic strategy  
 
Taking the literature procedures described above and the requirements of this 
project into account, it was decided to explore a route to a coupled 
cyclam/cyclen-porphyrin conjugate via 2-formyl-TPP 191. As already shown, 
this is a known compound which can be synthesised on a multigram scale using a 
reliable literature procedure. Since five of the cyclam/cyclen compounds already 
synthesised contain an amino group (56, 57, 134, 137 and 138), the ubiquitous 
reductive amination reaction appeared to offer a direct synthetic route to the 
desired cyclam/cyclen-porphyrin target. Additionally, although 2-formyl-TPP 
191 is a well known molecule, reductive amination onto the porphyrin ring has 
not been reported in any significant depth in the current literature on porphyrin 
synthesis and modification.  
 
3.6 Synthesis of 2-formyl TPP   
 
The synthetic route used to synthesise 2-formyl-TPP 191 is shown in Scheme 65. 
 
NN
NN
Cu
HNN
NNH
1. POCl3, DMF,
0°C
2. H2SO4(conc)
3. NaOH(aq)
74%
O
HNN
NNH
Cu(OAc)2
CHCl3, MeOH
Reflux
95%
N
H
O
Propionic acid
Reflux, 30mins
20%
+
162
183 191
 
Scheme 65: Synthesis of 2-Formyl-TPP
181
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5,10,15,20-Tetraphenylporphyrin (TPP) 162 was synthesised in 20% isolated 
yield by the method of Adler and Longo
124
 and then converted into the copper(II) 
complex by adding a methanolic excess of copper(II) acetate to a heated solution 
(70 °C) of 162 in chloroform. After work up, the copper(II) complex 183 was 
obtained in high yield (95%). This complex was then formylated according to the 
method of Bonfantini et al.
181
 As described earlier, this procedure follows three 
clear steps:-  
 
1. treatment of the porphyrin with POCl3 and DMF forms an intermediate 
iminium ion which is resistant to acidic conditions 
2. at this point, H2SO4(conc) is added to remove the copper(II) ion from the 
porphyrin 
3. basic hydrolysis of the intermediate iminium ion yields the free base 
mono-formylated porphyrin in good yield.  
 
The copper (II) metal ion was utilised to increase the reactivity of the porphyrin 
by increasing electron density at the periphery, whilst also protecting the inner 
nitrogen atoms from protonation. The yield of this reaction was 74% which was 
somewhat lower than the reported yield of 94%, but the three steps represent a 
very satisfactory route to a monofunctionalised, unsymmetrically substituted 
porphyrin. The downfield region of the 
1
H NMR spectrum of compound 191, 
where the β protons appear, is shown in Figure 33. 
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ppm (f1)
8.708.808.909.009.109.209.309.40
Formyl-H
3-H
7,8,17,18-H
12,13-H
 
Figure 33: 
1
H NMR of 2-formyl-TPP 
 
The proton in the 3-position (α to the formyl substituent) is seen as a singlet and 
at 9.22ppm is the highest of the β protons, as expected. The protons in positions 
12 and 13 on the porphyrin ring are almost equivalent magnetically and appear as 
the AB system around 8.70-8.80, since these are the furthest from the formyl 
substituent they appear at the lowest δ value. The other four protons appear in the 
multiplet between 8.82 and 8.94ppm. The δ values and integrations are consistent 
with the literature, but the fine structure is seen more clearly than was previously 
reported.
181
 
 
With a stock of compound 191 in hand, the objective was to utilise this species to 
develop a method by which a cyclen or cyclam macrocycle could be attached to 
the porphyrin via the formyl functionality. Several cyclen / cyclam macrocycles 
had already been synthesised bearing a mixture of 1°, 2°, alkyl and aromatic free 
amines as shown in Figure 34.  Since 1° and 2° amines are known to react with 
aldehydes directly to form imines, a one pot reductive amination sequence was 
proposed to link these two macrocycles together. 
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Figure 34: Cyclen and cyclam macrocycles bearing free amine functional groups 
 
 
3.7 Reductive amination 
 
Reductive amination is a well known reaction
191
 involving the condensation of 
an aldehyde or ketone with ammonia, or 1° and 2° amines as shown in Scheme 
66.  
 
R H
O
+ NH2R'
R H
NH
R'
+ H2O
CH3COOH,
NaBH3CN,
MeOH
 
Scheme 66: Reductive amination 
 
As shown in the mechanism below (Scheme 67), the reaction involves acid 
catalysed iminium ion formation with subsequent reduction to the amine 
occurring in the final step. Imine formation is an equilibrium process favoured by 
acidic conditions. Acetic acid is often used to protonate the carbonyl compound, 
thus activating it to nucleophilic attack. However, if the concentration of acid is 
too high the amine will be protonated too, rendering it unreactive, and hence 
inhibiting the reaction. Due to this, a catalytic amount of acid is used to set up an 
equilibrium between protonated carbonyl and protonated amine, leaving some of 
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the amine free to act as a nucleophile. The reducing agent needs to be stable 
under acidic conditions and able to react with imines/iminium ions, but not with 
the carbonyl containing starting material. Sodium cyanoborohydride is often used 
as the reductant because, in addition to being acid stable, it reduces imines more 
quickly than aldehydes or ketones. Since the reduction step is the only non-
equilibrium step, the reductant is effectively driving the reaction forward.  
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Scheme 67: Reductive amination mechanism 
 
3.7.1 Synthetic strategy 
Both literature reports of reductive aminations on tetraphenyl porphyrin 
derivatives have used a two step procedure whereby the imine is generated and 
then isolated before being reduced, although neither paper explains why this 
methodology was used
186, 187
. The initial aim was to improve this protocol and try 
to generate the amine product in a one pot reaction. The two obvious ways to do 
this are: 
1. allow the imine to form in high yield, then add the reductant in situ (one 
pot, two steps) 
2. mix all the reactants, including the reducing agent, at the beginning of the 
reaction (one pot, one step) 
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The first option needs a method of driving the equilibrium formation of the imine 
to obtain as high a yield as possible, such as removal of water from the reaction. 
In the second case, the reductant is actually driving the equilibrium forward by 
removing the imine from the mixture. However, this method also relies on the 
reducing agent being stable to the acidic conditions of the reaction and the 
elevated temperatures used.  
 
 
3.7.2 Attempted direct attachment of compound 127  
 
The first reaction attempted is shown in Scheme 68. 
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NH N
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O
NNH
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O
O
O
O
O
CH3COOH (cat)
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NaBH3CN
MeOH
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X
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127
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N
N
N
N
N
O
O
O
O
O
O
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Scheme 68: Attempted reductive amination of 2-formyl-TPP with DO3A tris-tert-butyl ester 
 
The cyclen based compound 127, bearing a secondary amine on the macrocyclic 
ring was initially reacted with compound 191. Both compounds were dissolved 
in toluene with 127 in a twofold excess, a few drops of acetic acid were added 
and the solution was heated under reflux conditions. The porphyrin starting 
material is non-polar compared to 127, thus making it very easy to monitor the 
reaction by TLC (the imine formed would be very polar in comparison to 
porphyrin 191). However, after several hours of heating, TLC analysis showed 
no consumption of starting materials. The reaction was cooled to ambient 
temperature, a Dean-Stark trap was fitted and activated 4Å molecular sieves 
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added to try to drive the equilibrium imine formation forward, and heating was 
resumed. After heating for a further three hours no change was seen. The 
reaction was repeated using anhydrous THF in place of toluene and heated under 
an inert (N2) atmosphere. This time the amine 127 was washed with aqueous 
NaHCO3 solution to ensure it was not protonated, before being added to the 
reaction mixture. After several hours of heating no imine formation could be 
detected. Since the macrocycle 127 had been used in several reactions previously 
where the 2° amine had proved nucleophilic (see previous chapter), the 
hypothesis was that there was too much steric hindrance between the 
macrocycles for the reaction to occur. A similar attempt using macrocycle 137 
had the same ineffectual result. Hence it was decided to try to attach a spacer 
group to the porphyrin to which the cyclen/cyclam macrocycles could be 
appended in a subsequent step.  
To this end, a set of readily available alkyl and aromatic amines were used to 
allow investigation of the reductive amination reaction with porphyrin 191. Each 
amine also contained a second functional group to which the cyclam/cyclen 
macrocycles could potentially be attached. 
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3.7.3 Reductive amination with alkyl amines 
 
The reactions attempted with alkyl amines are shown below (Scheme 69). 
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Scheme 69: Reductive amination attempts with alkyl amines 
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3.7.3.1 Reaction using 2-aminoethanol, attempted synthesis of 213 
 
A twofold excess of 2-aminoethanol and compound 191 were reacted together 
using anhydrous THF as the solvent, a catalytic amount of acetic acid, 4Å 
molecular sieves to absorb water and the heating was carried out under a nitrogen 
atmosphere. However, no change could be detected over a period of several 
hours when monitoring by TLC. Thus it appeared once again that imine 
formation was not taking place. A methanolic solution of NaBH3CN was added 
in case the TLC result had been misinterpreted, but this had no effect. An aliquot 
was taken from the reaction mixture and the porphyrin fraction collected by 
preparative TLC. It was identified as the starting material 191, hence the reaction 
appears to be completely ineffective. The reaction was repeated using a toluene / 
methanol (1:1) mixed solvent system, but this also failed.  
3.7.3.2 Reaction using 6-aminohexanoic acid, attempted synthesis of 214  
 
A twofold excess of 6-aminohexanoic acid and compound 191 were dissolved in 
anhydrous THF, three drops of CH3COOH and activated 4Å molecular sieves 
added and the solution was heated under an inert atmosphere (N2). TLC 
monitoring showed a change after one hour, with one main porphyrin product 
appearing which was considerably more polar than the starting porphyrin 191. 
This was consistent with the expected imine formation. Heating was allowed to 
continue until, after approximately 5 hours, no further change could be seen, but 
the mixture still contained a considerable amount of the porphyrin starting 
material. At this point the reaction was left to cool to ambient temperature, still 
under the nitrogen atmosphere. When cool, a methanolic solution of sodium 
cyanoborohydride was added in one portion and the reaction mixture stirred for 2 
hours. Further monitoring by TLC showed no discernable change. However, 
since the polarity difference of the imine intermediate and the final amine was 
unknown, this in itself did not necessarily indicate a failure of the reduction step. 
Additionally, if the reduction step had failed, it could be reattempted if the imine 
could be isolated. After work up, TLC showed the same two spots still present 
(starting porphyrin and the proposed imine/amine), and the mixture was 
subjected to column chromatography in order to isolate the more polar fraction. 
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However, during this process, the spot could clearly be seen degrading as it 
travelled down the column and no product was could be collected. This was 
consistent with failure of the reduction step, since imine compounds are known 
to be more stable when both sides of the imine double bond are substituted with 
an aryl group.  
3.7.3.3 Reaction using 1,6-diaminohexane, attempted synthesis of 215 
 
The initial reaction with 1,6-diaminohexane was carried out using the same 
reaction conditions as for 6-aminohexanoic acid, except a larger excess (5 
equivalents) of the diamine was used to try to inhibit dimer formation. This time, 
two spots appeared on the TLC plate after only ten minutes and over the course 
of five hours, the starting porphyrin reduced in concentration while the more 
polar product appeared to increase in concentration. After no further change was 
detectable, the reaction mixture was again cooled to ambient temperature and 
then treated with a methanolic solution of NaBH3CN. After stirring for ten 
minutes, TLC showed a mixture of seven porphyrin spots. Column 
chromatography was used to try to isolate the fractions, but degradation appeared 
to occur, with most of the material sticking to the top of the column, and it could 
not be isolated. The reaction was repeated using a  toluene / methanol (1:1) 
mixed solvent system and the same initial two spots could be seen clearly by 
TLC. An aliquot was removed from the reaction mixture and the remainder was 
treated with the methanolic reductant solution as previously described. The 
aliquot which had not been reduced was subjected to preparative TLC in order to 
try to isolate the proposed product, but once again the compounds appeared to 
degrade very quickly and no pure fraction could be isolated. After aqueous work 
up, some of the remaining solution was loaded onto a preparative TLC plate in 
an attempt to obtain enough material for analysis and to gain some insight into 
the reaction. Although the compound degraded quickly, a very small amount 
(~1mg) was obtained and was analysed by 
1
H NMR.  Although this turned out to 
be impure, it did appear to have some of the desired product present. Figure 35 
shows the aromatic region and two parts of the alkyl region. The aromatic region 
was quite clean, with peaks a-d showing the β-protons in a pattern typical of a 
mono-β-substituted porphyrin. Peaks e and f are assigned to the 2,6-protons on 
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the phenyl rings while the signals g and h represent the 3,4 and 5-protons. 
Moving to the alkyl regions, the spectrum was not well resolved but three signals 
could clearly be identified. Peaks j and k are clearly non-first order signals, 
which are consistent with the inner protons of the diamino chain connected to the 
porphyrin. Peak i is in the correct region to be the two protons directly attached 
to the porphyrin 2-position. Although this analysis is only partial and the sample 
was clearly a mixture, it suggested that the reaction was probably working, but 
the product was unstable when subjected to silica gel chromatography. 
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Figure 35: 
1
H NMR of mixture formed from attempted reaction between 2-formyl-TPP and 
1,6-diaminohexane 
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3.7.3.4 Reaction using S-4-nitrophenylalanine-synthesis of compound 216 
 
The amino acid starting material had very low solubility in most organic 
solvents, but was soluble in methanol and sparingly soluble in warm THF. Thus, 
in order to solubilise both the porphyrin and the amino acid, a mixture of THF 
and methanol (2:1) was used as the solvent system for the reaction. The reaction 
was carried out in an analogous manner to the previous attempts, but without any 
water scavengers present. After being heated for ten hours under an inert 
atmosphere (N2), TLC analysis showed a mixture was present which contained a 
very polar porphyrin spot, which looked promising as the expected imine 
product. The reaction was cooled to ambient temperature, the reductant solution 
added and the mixture left to stir for two hours. After aqueous work up, the 
mixture was separated by column chromatography and the product isolated in 
54% yield. In an attempt to improve the yield the reaction was repeated, but this 
time carried out as a single step process as described above, by adding the 
starting materials and the reductant together at the beginning of the reaction. 
After heating for 24 hours, TLC analysis showed what appeared to be a more 
favourable conversion for the reaction. Indeed, after chromatographic work up 
the product was isolated in 75% yield. The product was insoluble in many 
organic solvents, the exception being THF, hence NMR analysis was only 
possible in d8-THF. The 
1
H spectrum and the peak assignments are shown in 
Figure 36 and Figure 37. The aromatic region shows a clear pattern of β-proton 
peaks, characteristic of a β-mono-substituted TPP. The singlet peak 1 was easily 
assigned to the proton at the 3-position and peak 2 (AB system) is assigned to the 
β–protons farthest away from the substituted position. The other peaks 3-6 could 
not be assigned individually, but represent the other four β–protons (shown in 
blue in Figure 36). The other aromatic signals were assigned using DQF COSY 
NMR. The substitution of the single β-position breaks the symmetry of the 
molecule and hence the signals for the phenyl protons split accordingly. The 
ortho protons split into two signals (peak 7, integral 6H and peak 8, integral 2H) 
and the meta and para protons overlap in a complex multiplet (peak 10). 
However, the small multiplet (peak 11, integral 2) is assigned to the two meta 
protons nearest to the β-substituent, which is corroborated by coupling to peak 8 
in the 2D spectrum. Peaks 9 and 12 are typical aromatic doublets from the nitro-
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phenyl ring.  
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Figure 36: Aromatic 
1
H peaks and assignments for compound 216 
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Figure 37: Alkyl peaks and assignments for compound 216 
 
 
The protons on the amino acid group were also assigned with the aid of the 2D 
COSY spectrum. The chiral centre confers a diastereotopic relationship onto 
protons a, b, d, e and f and the splitting patterns reflect this (Figure 37). Peaks a 
and b both show an integral value of one and couple strongly to each other with a 
relatively large coupling constant of 15.6Hz (typical of geminal relationship) and 
are assigned as the CH2 protons directly attached to the β-carbon on the 
porphyrin. Peak d couples to both e and f with coupling constants of 7.7 and 
5.5Hz, (consistent with vicinal couplings) whereas peaks e and f couple together 
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with a coupling constant of 13.4Hz, typical of geminal coupling. Both peaks e 
and f split into a further doublet with the 7.7 and 5.5 Hz constants. Hence peak d 
is assigned to the proton attached to the chiral carbon, whereas e and f are 
assigned to the protons bonded to the adjacent carbon. It should be noted that the 
peak labelled c is a satellite peak from the THF solvent (
13
C-
1
H coupling).  The 
peaks for the inner porphyrin NH protons is seen as a broad singlet at -2.80 ppm 
and the carboxylic acid proton is seen at 11.0 ppm, also as a broad singlet.  
 
3.7.3.5 Reaction using S-4-nitrophenylalanine methyl ester-synthesis of 
compound 217 
 
The methyl ester of S-4-nitrophenylalanine was synthesised from the amino acid 
by a published procedure
192
 and was isolated in 71% yield. (Scheme 70) 
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Scheme 70: Esterification of S-4-nitrophenylalanine
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Compound 218 was significantly more soluble in organic solvents than the free 
amino acid and it was hoped that this would improve solubility of the porphyrin 
conjugate as well. The reaction between 191 and S-4-nitrophenylalanine  was 
carried out using the same one-step method that was used for the free amino acid. 
Although the reaction appeared to be slower, after 48 hours the starting material 
had been consumed and after chromatographic work up, the product 217 was 
isolated in 61% yield. 
1
H NMR analysis was similar to compound 216 but there 
was a change to the signals for the proton on the chiral carbon (proton d) and the 
protons on the carbon adjacent to it (protons e and f in Figure 38). Protons e and f 
still showed double doublet signals, but their chemical shift values had 
converged, the overlapping signals giving the complex AB type signal shown. 
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They coupled together with a 
2
J value of 13.3 Hz, but coupled with proton d with 
coupling constants of 6.7 Hz and 7.0 Hz. Due to these similar J values, the signal 
for proton d was seen as a triplet. 
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Figure 38: 
1
H NMR analysis of compound 217 
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3.7.4 Reductive aminations with aryl amines 
 
The reactions attempted with aryl amines are shown below.  
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Scheme 71: Reductive aminations with aryl amines 
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3.7.4.1 Reaction with aniline-synthesis of compound 219 
 
Initially, aniline was reacted with compound 191 using the same one pot, two 
step method that had been used for the alkyl amines. The two reagents were 
heated in toluene with acetic acid as catalyst and a Dean Stark trap to drive the 
equilibrium forward. After 24 hours, TLC analysis of the reaction mixture 
showed almost all of the porphyrin starting material had been consumed, so the 
mixture was cooled to ambient temperature before the methanolic reductant 
solution was added. After stirring for a further 2 hours at room temperature, 
aqueous work up and chromatography gave the product in 77% yield. In this case 
there was no apparent degradation of the porphyrin on the silica gel column. The 
reaction was repeated but adding all the reagents at the start, including the 
reductant solution, but this gave a lower yield of 60%. Compound 219 gave a 
clearly resolved 
1
H NMR spectrum, the relevant parts of which are shown, along 
with the peak assignments in Figure 39. All assignments were made by reference 
to the 2D DQF COSY spectrum. It can be seen that the β-substituent splits the 
ortho protons of the porphyrin phenyl rings into two signals integrating to four 
protons each (signals a and b). These have been assigned on the basis that the 
chemical shift of the protons nearest to the substituent will be affected the most, 
and these are likely to have the most well resolved fine structure. This 
assignment is also consistent with the assignment for the amino acid porphyrin 
derivative discussed above (compound 216). The newly introduced phenyl ring 
substituent could be seen clearly from the peaks d, e and f and the methylene 
protons directly attached to the porphyrin β-carbon appear as the singlet g. 
 
3.7.4.2 Reation with  ethyl 4-amino benzoate-synthesis of compound 220 
 
Since the one pot, two step procedure described above gave the highest yield of  
compound 219, the same method was applied to the reaction with ethyl 4-amino 
benzoate. The reaction was followed by TLC anlaysis which revealed a high 
conversion to the imine intermediate after approximately 30 hours. After cooling 
to ambient temperature, the reductant solution was added and stirred for a further 
2 hours. After aqueous work up, once again, there was no degradation of the 
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product as it was purified by silica gel column chromatography, and compound 
220 was isolated in 72% yield. The 
1
H NMR spectrum was very similar to 
compound 219 and was assigned again using 2D DQF COSY spectrum and high 
resolution mass spectrometry was used to confirm the identity of the product.  
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Figure 39 : 
1
H NMR for compound 219 
 125 
From the higher yields and the lack of any apparent complications due to 
degradation during work up and separation of the products, it appeared that 
aromatic amines were indeed a better choice of reagent for these reactions when 
compared to the alkyl amines previously tested. Hence, the two cyclen 
compounds 57 and 134 were chosen as the most likely candidates for direct 
coupling to the formyl porphyrin in this manner.  
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3.7.4.3 Reaction with 1,4,7-tris(tert-butoxycarbonylmethyl)-10-(4-
aminobenzoyl)-1,4,7,10-tetraazacyclododecane, 134 –synthesis of compound 
221  
 
Compounds 134 and 191 were dissolved in anhydrous THF and a few drops of 
acetic acid were added. The choice of THF was due to compound 134 having 
low solubility in toluene. The reaction was closely monitored by TLC analysis. 
After heating for 24 hours, a mixture had formed but with a significant amount of 
starting material still present. The imine intermediate appeared to be present but 
in very low yield and no further change could be seen occurring. Some activated 
4Å molecular sieves were added to the reaction in order to remove water from 
the equilibrium and hence increase the amount of imine formed. However, this 
did not have any noticeable effect on the equilibrium mixture. The reaction was 
allowed to cool, the methanolic reductant solution was added and after 2 hours of 
stirring, aqueous work up and silica gel chromatography the product was isolated 
in 15% yield. The reaction was repeated using a double excess of the amine 
starting material under the same conditions and this led to a lower yield (9%) of 
product being isolated. The highest yield was obtained when a equimolar ratio of 
191 and compound 134, the acid catalyst and the reductant, were all added at the 
start of the reaction in a mixture of THF and methanol (3:1 vol:vol). The reaction 
was allowed to progress for 72 hours, after which time no further change 
occurred. After aqueous work up, the product was isolated in a yield of only 
20%. The low yields of these reactions could be a consequence of the low 
nucleophilicity of the aromatic amine in 134. The lone pair on the nitrogen atom 
can be delocalised through the phenyl ring and onto the carbonyl oxygen atom, 
as shown in Figure 40, thus making it less available. 
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Figure 40: Delocalisation pathway in compound 134 
 
As shown in Figure 41, the aromatic region of the 
1
H NMR spectrum of 
compound 221 is very similar to that of compound 219, which was expected 
since the porphyrin structures are almost identical. Peaks a and b represent the 
ortho protons of the phenyl substituents on the porphyrin, peak c is the meta and 
para protons on the same phenyl rings, and the β-protons appear in exactly the 
same pattern as compound 219. The assignment of protons on cyclen / cyclam 
units is usually very difficult because the flexibility of the ring system leads to 
the appearance of very broad peaks in the spectrum. Figure 42 shows the 
1
H 
NMR cyclen regions for the nitro precursor compound, the reduced amine and 
compound 221. In the nitro compound, the electron withdrawing nature of the 
nitro group confers a visible fine structure to the peaks which is not seen in the 
other two compounds. 2D COSY NMR shows that peak a couples with peak e, 
and b couples with f. Protons c and d, as expected, show no coupling partners, 
and multiplet g shows coupling within the signal. Protons a and b are therefore 
assigned to the protons nearest to the amide bond, due to having the highest 
chemical shift. Their coupling partners e and f are assigned to the methylene 
groups adjacent to the protons a and b. Singlet c integrates to 4 protons and is 
assigned to the two methylene groups on the pendant arms, while peak d is 
assigned to the remaining protons on the third pendant arm. These signals are 
split due to the symmetry of the molecule. Multiplet g represents the remaining 
eight ring protons which cannot be assigned individually. When this spectrum is 
compared to the analogous amino compound it can be seen that the electron 
releasing amino group causes the peaks to converge and they now appear as 
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broadened signals. Peaks a and b have converged as have e and f leaving two 
broad peaks integrating to four protons each. The 2D spectrum confirms that 
these two peaks still correlate. Peak g has become a more broadened signal also, 
losing the fine structure that could be seen in the nitro compound. The singlet c 
still remains fairly distinctive, but the singlet d has now collapsed into a 
broadened signal. The porphyrin derivative, compound 221, has similar signals 
which can only be assigned by this retrospective analysis of the precursor 
compounds.  
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Figure 41: 
1
H NMR of compound 221 
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Figure 42: 
1
H NMR comparison between compound 221 and the analogous precursor 
compounds 
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3.7.4.4 Synthesis of compound 222 - Reaction with 1,4,7-tris(tert-
butoxycarbonylmethyl)-10-(4-aminobenzyl)-1,4,7,10-tetraazacyclododecane 
–compound 57 
 
The reaction with compound 57 was performed using the same conditions as for 
the synthesis of compound 221. An equimolar ratio of compounds 191 and 57 
was used and the reductant was added at the start of the reaction. After heating 
for two days, TLC analysis showed a more promising reaction, with a much 
higher conversion of starting materials apparent. However, after aqueous work 
up, significant problems were encountered when isolation of the product was 
attempted. The purification was carried out by column chromatography on silica 
gel, using an eluent of 4% MeOH in CH2Cl2. A purple band was duly collected 
which corresponded to the expected fraction, but upon further TLC of this 
fraction, two overlapping spots appeared. A 2D TLC plate showed that the faster 
running spot always seemed to split into two spots as it travelled up the plate, 
indicating that the compound may be unstable on silica. An attempt at 
purification with alumina (both basic and neutral) did not yield the separation 
required even after several attempts with different eluent systems. However, after 
repeating the reaction, it was found that pure product could be obtained by using 
a silica column which had been pre-eluted with a solution of CH2Cl2 and a few 
drops of triethylamine. Flash chromatography on a very short column allowed 
access to the pure compound which was identified by NMR analysis. The 
compound appeared to be stable on this column for short periods of time only, 
circa ~30 mins. After this purification, the yield obtained was 52% which was an 
improvement over compound 221, but was disappointing when compared to the 
yield anticipated from TLC of the reaction mixture. The 
1
H and 
13
C NMR were 
assigned using 2D correlation spectra and by comparison to precursor 
compounds as for compound 221.  
 
3.7.4.5 Further reactions of compounds 219 and 220 
 
Shinkai et al.
186
 synthesised the copper(II) complex of compound 219 as shown 
in Scheme 61 and used the 2° aromatic amine to further functionalise the 
 131 
porphyrin with benzyl substitutents. Thus, it was of interest to investigate 
whether the free base porphyrins 219 and 220 would react in a similar fashion, 
allowing incorporation of a cyclen unit onto the porphyrin structure. As shown in 
Scheme 72, compound 219 was dissolved in CH2Cl2, a few drops of NEt3 were 
added followed by one equivalent of dibromoxylene. The reaction mixture was 
stirred at room temperature and, after consumption of the starting material was 
seen by TLC, a CH2Cl2 solution of compound 127 was added and the reaction 
heated under reflux. TLC analysis indicated several products being formed, one 
of which showed the correct polarity for the desired product. Another non-polar 
porphyrin spot was also formed which was consistent with the porphyrin dimer. 
After aqueous work up and chromatographic separation, the more polar fraction 
was collected and identified as compound 223 by NMR analysis. The overall 
yield was 51%. 
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Scheme 72: Further derivatisation of compounds 219 and 220 
 
However, the result was unsuccessful when the same procedure was undertaken 
with compound 220, using the same reaction conditions. TLC analysis showed 
no consumption of either compound 220 or the dibromoxylene. When the 
reaction was repeated using K2CO3 and DMF, after one hour TLC monitoring 
showed consumption of the dibromoxylene starting material but no new 
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porphyrin formation. After cooling, an aliquot was removed and the porphyrin 
isolated by column chromatography was found to be the starting material. This 
leads to the conclusion that the electron withdrawing nature of the ethyl ester 
group in compound 220 reduces the nucleophilicity of the amine to the extent 
that it does not react with the dibromoxylene.   
 
3.7.4.6 Attempted hydrolysis of compounds 222 and 223 
 
In both compounds 222 and 223, the tert-butyl ester groups needed to be 
hydrolysed in order to allow synthesis of a metal ion complex of the cyclen based 
ligand. The two common literature procedures for this involve acidic hydrolysis 
using TFA in dichloromethane at room temperature or heating under reflux with 
6M HCl.
105, 193
 The milder TFA procedure was chosen, and compound 222 was 
dissolved in CH2Cl2. After addition of TFA, the reaction was closely monitored 
by TLC. However, after only 5 mins TLC indicated possible degradation of the 
porphyrin starting material. One major porphyrinic spot developed with a 
significantly lower polarity in comparison with the starting material. After 
aqueous work up, the porphyrin was still soluble in organic solvent. 
1
H NMR 
analysis of the crude organic layer showed that although it contained a β-
substituted porphyrin, no other peaks confirming the presence of the cyclen 
moiety could be distinguished. In addition to this, the polarity change indicated 
that the compound did not contain the cyclen moiety. Several repetitions of the 
reaction with varying amounts of TFA gave the same outcome, as did heating 
with 6M HCl(aq).   
The reaction with compound 223 using the same conditions as for compound 222 
gave similar results. Neither of the porphyrin products could be positively 
identified by NMR or mass spectrometry analysis, but the lack of any peaks 
relating to the cyclen moiety leads to the hypothesis that the compounds are 
cleaving at the benzylic position α to the 2-position of the porphyrin ring. 
Cleavage at another position would most likely leave an amino substituent on the 
porphyrin, giving rise to a more polar fraction when analysed by TLC.     
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3.8 Summary 
 
A methodology has been developed to monofunctionalise tetraphenyl porphyrin, 
a symmetric molecule, via a known reaction sequence (β-formylation followed 
by reductive amination) with a variety of substrates, giving access to a range of 
previously unreported compounds (216, 217, 219-223 - Figure 43). 
 
This work has shown that reductive amination on 2-formyl-TPP can be used to 
introduce a range of functionality and diversity into the porphyrin core. 
As expected, aryl amines seem to be more suited to this type of reaction than 
alkyl amines, with the notable exceptions of the amino acid derivatives 216 and 
217. 
The reactions work with substrates that contain additional reactive groups that 
may be used to further elaborate the porphyrin structure, and this was 
demonstrated by the transformation of the aniline derivative 219 into the cyclen 
containing conjugate, compound 223.  
 
Direct reductive amination of an amino bearing macrocycle with the formyl 
porphyrin offers easy access to bismacrocyclic systems, and this was 
demonstrated by the synthesis of target molecules 221 and 222.  
 
However, the conjugates 222 and 223 were not stable under the acidic conditions 
required for deprotection of the tert-butyl esters, and so the gadolinium(III) 
complexes could not be formed.   
 
  
 
 134 
HNN
NH N
HN
HNN
NH N
HN
COOEt
N
N N
N
O
O
OO
O
O
HN
HNN
NNH
N
N N
N
O
O
OO
O
O
HN
HNN
NNH
O
219 220
221 222
HNN
NH N
HN
O
OH
NO2
HNN
NH N
HN
O
O
NO2
216 217
NH
HNN
N
N
N
N
N
N
O
O
O
O
O
O
223
 
Figure 43: Novel compounds synthesised by the reductive amination of 2-formyl TPP 
 135 
Chapter 4: Coupling the cyclam/cyclen moieties to a porphyrin 
via the phenyl ring of a tetraaryl porphyrin  
 
 
4.1 Introduction 
 
The cyclen/cyclam based compounds synthesised previously (compounds 56, 57, 
58, 59, 60, 134, 137 and 138) are derivatised with amino and aryl bromide 
groups, so the requirement was for a porphyrin to be synthesised containing a 
functional group complementary to these.  
 
In the previous chapter, work was described that involved the 
monofunctionalisation of a symmetric porphyrin with a reactive formyl group, 
and the subsequent reactions used to couple this porphyrin with the 
cyclam/cyclen compounds. The alternative option was to incorporate an 
unsymmetrical substitution pattern at the point of porphyrin formation, a 
methodology which would allow more diversity to be incorporated into the 
porphyrin structure.  
 
Hence, the work here describes the syntheses of porphyrins using this approach, 
and their subsequent coupling reactions with the cyclam/cyclen derivatives. 
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4.2 Formation of unsymmetrically substituted meso-tetraarylporphyrins 
 
4.2.1 Alder-Longo method
124
 
 
This type of reaction was discussed in the previous chapter in relation to the 
synthesis of symmetric porphyrins. It can also be used to synthesise 
unsymmetrically substituted porphyrins by condensing pyrrole with two different 
aldehydes. In this situation there are, in principle, six porphyrin products 
obtained as shown in Figure 44. If an equimolar ratio of aldehydes is used and 
the aldehydes are equally reactive, then the yields of these porphyrins follow a 
binomial distribution with the expected yields shown in Figure 44. By using 
approximately a 3:1 ratio of aldehydes, the AB3 or the A3B porphyrin yields may 
be maximised to around 40%.  However, it must be remembered that these yields 
are percentages of the total porphyrin yield which is of the order of 20% of the 
total reaction yield and in practise the isolated yield of the A3B porphyrin is often 
around 5%. 
   
A
A
A
B B
B
B
B
A
A
AA
B
BB
A
A
A
B
B
A
BB
A
aldehydes A + B + pyrrole
= porphyrin inner core
A4
6.25%
A3B
25%
cis-A2B2
25%
trans-A2B2
12.5%
AB3
25%
B4
6.25%
 
 
Figure 44: Products formed from a mixed aldehyde porphyrin synthesis 
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The main drawback to mixed aldehyde condensations using Adler
124
 conditions 
is the amount of tarry side products produced leading to extensive 
chromatography to isolate the desired porphyrin fraction from the mixture 
produced. The success of such chromatography may depend on the difference in 
polarity between the aldehydes used. The relatively wide scope of the Adler 
reaction is limited by the stability of the aldehydes used under the boiling 
propionic acid conditions. In spite of this, many porphyrins bearing a wide range 
of functional groups have been synthesised this way and some examples from 
literature reports are shown in Scheme 73 (compounds 224-226).
194-196
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Scheme 73: Examples of unsymmetric porphyrins formed by mixed Adler condensations
194-
196
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4.2.2 Lindsey method
139, 140
 
 
As discussed in the previous chapter, the Lindsey reaction
139
 is more tolerant of 
sensitive benzaldehydes than the Adler
124
 method due to the milder conditions 
under which the reaction proceeds. By using two different benzaldehydes in the 
correct ratio, this method can also be used to synthesise asymmetric 
porphyrins.
150, 197-200
 Two examples of porphyrin synthesis using Lindsey 
conditions which illustrate the advantages of this methodology over the Adler 
method are shown in Scheme 74. Fish et al.
150
 exploited the mild Lindsey 
conditions to synthesise porphyrin 227 which contained the dithianyl group-an 
acid sensitive moiety which is unlikely to be amenable to the harsher Adler 
conditions. Krausz et al.
197
 used the same methodology to obtain the asymmetric 
porphyrin 228, containing an acetyl protected hexose, in 15% yield. They also 
reported the synthesis of this compound using Adler conditions, but the yield was 
only 4-6%, thus nicely illustrating the advantage of using the Lindsey synthetic 
route.       
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Scheme 74: Examples of unsymmetric porphyrins synthesised by the Lindsey method
150, 197
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The Lindsey conditions fail when the aldehyde is insoluble in either CH2Cl2 or 
CHCl3 and the other main practical drawback is that due to the high dilution 
conditions required, it is only of realistic value for making porphyrins on a scale 
of less than 1g.  
 
 
4.2.3 Unsymmetrically substituted porphyrins via nucleophilic substitution 
 
An alternative versatile route to unsymmetric porphyrins has been developed by 
Senge et al.
201
 which exploits nucleophilic substitution at the meso positions of a 
preformed porphyrin. As shown in Scheme 75, treatment of 5,15-
diphenylporphyrin with phenyllithium followed by hydrolysis and oxidation gave 
access to the 5,10,15-triphenylporphyrin, both as the nickel(II) complex 231 and 
in the free base form 232, in high yields.
202
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Scheme 75: Formation of 5,10,15-Triphenylporphyrin
202
 
 
The reaction is successful with a wide range of substituents on the lithium 
reagent, such as ethers, alcohols, amines and dioxolane groups.
201
 This 
methodology was subsequently developed to allow two successive substitutions 
at the meso positions as shown in Scheme 76.
203, 204
 As these examples illustrate, 
the reaction can be achieved using either the free base 230 or the nickel(II) 
complex of the porphyrin 229. The order in which the reagents are added and the 
reaction conditions are, however, different in each case. For the free base 
porphyrin 230, successive treatment of a THF solution of the porphyrin with an 
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organolithium reagent, organic iodide, water and oxidant (DDQ) gave access to 
A2BC type porphyrins eg 233.
204
 Although the lithiation is carried out at 0 °C, 
after addition of the organic iodide, the reaction mixture is heated to 70 °C for 12 
hours before hydrolysis and oxidation. In the case of the nickel(II) complex 229, 
the hydrolysis is carried out prior to the addition of the organic iodide after which 
the reaction is stirred for 60 minutes at ambient temperature before oxidation.
203
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Scheme 76: Synthesis of porphyrins bearing an A2BC substitution pattern
203, 204
 
 
 
These differences in the reaction sequence and conditions can be understood by 
the mechanism of the reaction. Senge et al. proposed the mechanism shown in 
Scheme 77  for the reaction with the free base porphyrin.
205
 The initial addition 
of the lithium reagent gives the phlorin type intermediate 235, which they believe 
to have a planar conformation giving an sp
2
 character to the carbon on the 20 
position of the porphyrin ring.
206
 The resonance hybrid 236 carries a negative 
charge on this carbon, and is thus sp
3
 hybridised, giving it nucleophilic character, 
and it is this form which is thought to attack the organic iodide electrophile. 
Experiments done by the Senge group showed that the nucleophilic form 236 is 
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formed when the metal ion complex of the porphyrin is lithiated, whereas the 
non-nucleophilic form 235 is formed when the free base porphyrin undergoes the 
same procedure.
205
 Hence, the nickel(II) porphyrin can be alkylated at ambient 
temperature after hydrolysis, whereas this procedure with the free base porphyrin 
results in no reaction. However, by raising the temperature of the  alkylation to 
70 °C, the desired product was duty formed after subsequent hydrolysis and 
oxidation. The conclusion is that 235 is the kinetic intermediate product of the 
free base reaction, whereas 236 is the thermodynamic product. By giving the 
reaction mixture extra energy by heating, it allows the nucleophilic inermediate 
236 to form which then attacks the electrophile.  
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Scheme 77: Postulated mechanism of disubstitution of free base 5,15-diarylporphyrins
205
 
 
 
Using this synthetic route, several A2BC type porphyrins have been reported with 
a wide range of functionality incorporated onto the meso substituents of the 
phenyl rings,
201
 and these porphyrins are finding uses as building blocks for 
many types of porphyrin based systems.
207
 This methodology gives the 
advantage of a much higher yield of unsymmetrical porphyrins in comparison 
with the mixed condensations of the Adler and Lindsey routes. Additionally, the 
basic conditions used allow diversification of the porphyrin with functional 
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groups which are not tolerated by the acidic condensation reactions otherwise 
used. 
 
It should be noted for completeness that several other synthetic routes towards 
unsymetrically substituted porphyrins exist, whereby the porphyrin macrocycle is 
built up from its component parts, such as the MacDonald 2+2
208
 or rational total 
syntheses.
209
 Taking into account the aims of this project, these are not 
considered further here. 
  
4.3 Aim 
 
An unsymmetrically substituted porphyrin with an electrophilic group that could 
react with the amino bearing cyclam/cyclen compounds already synthesised was 
the initial synthetic target. It was also desirable to have additional functionality 
on the porphyrin periphery that could be used to attenuate aqueous solubility of 
the final coupled target compound if required. To these ends, it was decided that 
compound 237 (Figure 45) was the desired initial target molecule.  
 
HN
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Figure 45: Target porphyrin compound containing an electrophilic group 
 
The 1° alkyl bromide group was chosen as it was expected to have the desired 
reactivity towards the amino bearing cyclam/cyclen macrocycles 56, 57, 134, 
137 and 138. The methoxy substituents are protected hydroxyl groups which give 
an option for increasing the aqueous solubility of the final coupled compound.  
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4.4 Literature reports on nucleophilic substitution reactions of halomethyl 
porphyrins  
 
Substitution reactions of halomethyl porphyrins with various nucleophiles have 
been reported in the literature
210-212
 including two papers where the nucleophile 
was a sterically bulky amine are shown below in Scheme 78 and Scheme 79.  
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Scheme 78: Reaction of tetra-(4-bromomethyl)phenyl porphyrin with brucine
211
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Scheme 79: Reaction of a dihalomethyl porphyrin with an amido-azonia cryptand
210
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As shown in Scheme 78, Král et al.
210
 mixed the halomethyl porphyrin 238 and 
an excess of brucine 239 in chloroform and heated the solution under reflux for 
24 hours. No auxiliary base was used and the ionic product 240 precipitated from 
solution, allowing easy isolation and purification. The same group also reported 
the dialkylation of porphyrin 241 with the cryptand 242 as shown in Scheme 
79.
211
 This time the methodology involved the slow addition of a chloroform 
solution of the porphyrin to an excess of the cryptand in acetonitrile over 8 hours. 
Once again, no auxiliary base was used and the product 243 was isolated in good 
yield (71%).  
These two reports clearly showed that it was feasible to react the cyclam and 
cyclen based macrocycles 127, 137 and 138 directly with the bromomethyl 
porphyrin 237 (Scheme 80). Reaction of these amino containing macrocycles 
with primary alkyl bromides have been reported in the literature
105, 109
 and as 
discussed in chapter 2, the conditions often used are an equimolar ratio of amine 
to electrophile and an excess of auxiliary base (usually Na2CO3 / K2CO3 or 
NEt3), and heating to 60-70 °C in anhydrous MeCN solvent.
85, 90, 105
 Hence with 
these two differing scenarios in mind, Scheme 80 shows the reactions which 
were attempted to couple the porphyrin 237 to the cyclam/cyclen based 
compounds 127, 137 and 138. 
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Scheme 80: Reactions undertaken between porphyrin 237 and compounds 127, 137 and 138 
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4.5 Results and discussion of coupling reactions via nucleophilic substitution 
reactions 
 
Porphyrin 247 was synthesised by condensation of methyl(4-formyl) benzoate 
and 3,5-dimethoxybenzaldehyde with pyrrole under Adler-Longo
124
 conditions 
(Scheme 81). After chromatographic separation, pure 247 was obtained in 5% 
yield and treated with LiAlH4 in dry THF to give the hydroxy porphyrin 248 in 
75% yield. Bromination of porphyrin 248 with phosphorus tribromide proceeded 
with a large variation of yields, despite using the same reaction conditions. The 
reaction was performed four times with the lowest yield of 40% and the highest 
86% of compound 237. Each time the side product was collected and it appeared 
to be a very polar porphyrin species. NMR analysis of the side product proved 
inconclusive, but a peak of 1616 m/z from mass spectrometry suggested a 
dimeric porphyrin species.  
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Scheme 81: Synthesis of the bromomethyl porphyrin 237 
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The reaction of phosphorus tribromide with an alcohol requires the alcohol to be 
in a three fold excess over the brominating agent, and proceeds through creation 
of an alkoxy tervalent phosphorus species, which is then dealkylated by 
hydrogen bromide created in situ (Scheme 82).
213
 One third of the alcohol is 
converted to the bromide in a fast step, and further reaction converts the further 
two thirds, but in two slower, rate determining, steps.
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Scheme 82: Mechanistic steps in the bromination of an alcohol by phosphorus tribromide
213
 
 
With the electrophilic porphyrin 237 in hand, the next step was to attempt to 
attach it to a cyclam/cyclen macrocycle. The initial nucleophilic substitution 
reactions undertaken using porphyrin 237 are shown in Scheme 80.  
 
A typical protocol
105, 109
 was adopted for the reaction between compounds 237 
and 137. Both reactants were dissolved in anhydrous MeCN, excess Na2CO3 
added and the mixture heated at 50 °C under an inert atmosphere. TLC analysis 
showed the reaction progressed quite slowly, but after 4 hours consumption of 
the starting material became apparent. The reaction was also monitored by HPLC 
as shown in Figure 46. 
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Figure 46: Formation of compound 244 shown by HPLC 
 
The peak showing a retention time of 11 minutes corresponds to the starting 
material, compound 237, which is consumed over a period of three days with the 
production of three new compounds. Upon complete consumption of compound 
237, silica gel chromatography was used to isolate the three products. The first 
fraction isolated turned out to be the hydroxymethyl porphyrin (compound 248), 
indicating nucleophilic attack by hydroxide ion on compound 237. The second 
 149 
fraction appeared to decompose on the column and it was only possible to isolate 
a small amount (~1mg). 
1
H NMR suggested this was a mixture, but did show the 
presence of the expected peaks for the desired product 244. A sample was thus 
sent for analysis by mass spectrometry and the major peaks present were m/z 
1147 and 1160, M
+
 and (M+Na)
+
 respectively, for the desired compound 244. 
The third fraction could not be recovered from the column. These results showed 
that compound 244 was possibly being formed in the reaction, but was too 
unstable to be isolated in reasonable quantities by chromatography on silica gel. 
When the reaction was repeated using the cross bridged cyclam analogue 138 
with the same procedure and conditions, the results were similar. A porphyrin 
fraction of the expected polarity accounted for approximately 50% of the 
reaction yield by TLC analysis. However, when isolation was attempted, this 
compound degraded and only a small amount could be collected. Once again, 
1
H 
NMR showed this to be an impure fraction, but it contained the desired 
compound 245. A significant amount of the hydroxymethyl porphyrin 248 was 
also recovered. 
These two attempts indicated two problems, firstly the products were unstable on 
silica and a significant side reaction was occurring. The major side product was 
most likely due to the inorganic base producing hydroxide ions which 
preferentially attacked the porphyrin, generating compound 248. The next 
reaction was attempted using the more readily accessible cyclen derivative 127 
and the base used was changed to triethylamine in order to try to solve this 
problem. An excess of compound 127 was dissolved in CH2Cl2 along with 
compound 237 and one molar equivalent of NEt3 was added. The reaction 
appeared to occur readily at room temperature and one major product had formed 
after 3 hours. However, upon isolation this compound turned out to be the 
triethylamine adduct of the porphyrin as shown in Scheme 83. The yield of the 
undesired compound 249 was 65%, so clearly the triethylamine was considerably 
more nucleophilic than the macrocycle 127. The minor product was also 
collected and although analysis by 
1
H and 
13
C NMR analysis alongside ESI mass 
spectrometry confirmed its identity as the desired compound 246, the isolated 
yield was only ~1%.  
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Scheme 83: Formation of triethylamine adduct of compound 237 
 
 
The reaction was repeated with a 5 times molar excess of compound 127 but 
without the auxiliary base present. TLC showed no reaction progress after five 
hours heating under reflux conditions, so one equivalent of inorganic base 
(K2CO3) was added and the porphyrin starting material was quickly consumed. 
Unfortunately, the main product was again the hydroxymethyl porphyrin, 
compound 248. A series of small scale reactions using THF, CH2Cl2 and toluene 
as solvents with inorganic base gave similar results. A final attempt was made 
using pyridine as solvent with no added base and although this led to some 
product appearing on TLC, the reaction was very slow and decomposition of 
compound 127 was seen to occur before a significant amount of product had 
been formed. These problems seem to imply that the secondary amine in 
compound 127 has low nucleophilicity which would explain why the auxiliary 
bases attack the porphyrin preferentially. This type of problem has been reported 
before as discussed in chapter 2.
85, 90
 Although the authors do not discuss where 
they suspect the problems arise, in this case it seems logical that the steric factor 
involved in bringing two large macrocycles together in close proximity may be 
the decisive factor.  
 
Hence, the next attempt to couple the macrocycles together was done using 
cyclen derivative 56, containing a free amine on a pendant arm, separated from 
the parent macrocycle by a two carbon chain (Scheme 84). The working 
hypothesis was that there would be less steric hindrance in the reaction because 
the two macrocycles would not be required to approach one another so closely, 
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hence facilitating a faster reaction. Compound 56 was used in excess (2.5 
equivalents) to inhibit multiple alkylation reactions and anhydrous THF was used 
as the solvent due to its ability to solvate both macrocyclic starting materials. It 
was decided to use an auxiliary base to ensure the amine was not present in the 
protonated form and also to consume the HBr produced in the reaction. The 
initial attempt was made with excess inorganic base (Na2CO3) due to the 
reactivity towards the porphyrin that was shown by NEt3 in the previous 
reactions. The coupling was attempted at room temperature but after several 
hours TLC analysis showed no change to the starting materials, so heat was 
applied (60 °C) and although the consumption of porphyrin 237 was slow, it was 
completed over a 4 day period. One main porphyrin product was produced which 
appeared to have a polarity consistent with the expected product. However, after 
work up and chromatographic isolation the polar product was again identified as 
the hydroxymethyl porphyrin 248. Once more, the base appeared to have 
preferentially attacked the porphyrin, indicating low nucleophilicity of the amine. 
A second attempt was made without any additional base, but using five 
equivalents of compound 56. Prior to the reaction, a dichloromethane solution of  
56 was washed with an aqueous solution of Na2CO3 in order to ensure the amine 
was not protonated. However, despite heating for two days there was no 
significant change to the starting porphyrin although some degradation of 
compound 56 was noted.   
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Scheme 84: Conditions used for the attempted coupling of compounds 237 and 56 
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The reaction was then attempted using the sterically hindered organic base DBU, 
with a view to having a base present which would not attack the porphyrin. The 
other conditions were unaltered and after three days at 60 °C, TLC analysis 
showed consumption of the porphyrin starting material with one major polar 
porphyrin spot being produced. After work up this product was isolated by silica 
gel chromatography and analysed by NMR.  
The crucial areas of the NMR spectra for this compound are shown in Figure 47. 
The aromatic region of the 
1
H spectum clearly shows the porphyrin is substituted 
at the para position of one of the phenyl rings. These protons are assigned as 
shown in Figure 48. The aliphatic  peaks are clearly not from a cyclen moiety 
attached to the porphyrin. Peak a is from the CH2 group attached directly to the 
4-position of the porphyrin phenyl ring and peak b represents the methoxy 
protons on the porphyrin. The signals c to h seemed consistent with DBU, 
implying DBU had attacked the porphyrin instead of compound 56. A 
comparison of the 
13
C spectra of the compound and the DBU starting material 
confirmed this theory (Figure 49). The peaks are labelled according to the 
1
H-
13
C 
correlations shown in the HSQC spectrum, and the peaks in both spectra are 
shown as CH2 groups by DEPT except peak b which is the carbon from the 
methoxy groups on the porphyrin. The main difference, however, is the lack of 
the imine carbon in the product which is found in DBU at 161ppm (not shown). 
This clearly indicated that the imine bond is no longer present in the product. 
Mass spectrometry showed the main peak at m/z 977 which corresponds to the 
hydroxy compound 251 as shown in Figure 50. The structure is consistent with 
the 
1
H spectrum aliphatic signals. There are eight CH2 groups, of which four 
would be expected to be at significantly lower ppm, which are indicated by * in 
Figure 50. So although peaks c-h cannot be assigned they are consistent with the 
structure given and this assignment is borne out by the four lower signals in the 
13
C spectrum.  
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Figure 47: 
1
H NMR spectrum of compound 251 
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Figure 48: Assignment of aromatic protons in compound 251 
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Figure 49: 
13
C NMR comparison of DBU and compound 251 
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Figure 50: Porphyrin-DBU adduct (proposed structure of compound 251 
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A search of the literature revealed that although DBU is often used as a non-
nucleophilic base, there have been several reports of it acting as a nucleophile.
214-
219
 In 1981, McCoy and Mal
215
 reported unexpected products from the reaction 
of 1-halocyclopropane-1,2-diesters with DBU. Their proposed mechanism 
showed DBU acting as a nucleophile, and the enamine 254 subsequently formed 
undergoing an intramolecular cyclisation reaction with the proximal ester group 
(Scheme 85). A similar mechanism has been proposed in a paper by 
Sutherland.
218
 Hence, the hydroxyl group could have been formed by 
nucleophilic attack by water on the iminium ion during the aqueous work up, as 
shown in Scheme 86. 
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Scheme 85: Nucleophilic behaviour of DBU
215
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Scheme 86: Proposed mechanism of formation of compound 251 
 
The reaction was attempted a final time, reverting to inorganic base (excess 
K2CO3) but using anhydrous DMF as the solvent. Three equivalents of amine 56 
were used and the reaction was heated to 70 °C for 12 hours. After this time TLC 
analysis showed three new polar porphyrin compounds had formed. After 
aqueous work up, isolation was attempted by silica gel chromatography. 
However, the compounds seemed once again to decompose on the column and 
only small amounts could be obtained. 
1
H NMR analysis showed that this was 
clearly a mixture of two porphyrins. After exhaustive TLC analysis, using silica 
and also neutral and basic alumina, it was not possible to find an eluent system 
which would separate the mixture. Mass spectrometry results showed a main 
peak at m/z 2045 which is consistent with the dialkylated compound 259 shown 
in Figure 51. A smaller peak at m/z 1239 was also present which is consistent 
with the desired product 250. Hence, this result combined with the NMR analysis 
indicate the mixture contained the desired compound but also the dialkylated 
product.  
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Figure 51: Postulated structure of product formed from coupling compounds 237 and 56 
 
The cyclen derivative was then changed to the aminobenzyl species 57 and the 
reaction was attempted as shown in Scheme 87.  
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Scheme 87: Attempted coupling reaction between compounds 237 and 57 
 
Five equivalents of 57 and the porphyrin were dissolved in anhydrous THF and 
excess NaHCO3 was added along with a catalytic amount of KI. TLC analysis 
appeared to show the reaction was proceeding at room temperature, so the 
reaction was not heated. After two days, although there was still a small amount 
of the porphyrin starting material present, no further change appeared to be 
taking place, so the reaction was subjected to aqueous work up and the product 
isolated by column chromatography on silica gel. However, 
1
H NMR analysis of 
the fraction collected showed a mixture of two porphyrins. Despite repeated 
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separation attempts using preparative TLC with a range of eluent systems, a pure 
fraction could not be isolated. Mass spectrometry (ESI) showed a molecular ion 
peak at 2055 m/z, which corresponds to the Na
+
 adduct of the dialkylated species 
261 shown in Scheme 87. A peak was also seen at 1449 m/z which corresponds 
to the Na
+
 adduct of the desired product 260. This information was consistent 
with the 
1
H NMR spectrum which showed the two compounds were 
approximately a 50:50 mixture. Since the nucleophile was used in a 5x molar 
excess, this was a surprising result, but one that was consistent with the result for 
the aminoethyl cyclen derivative 56. The conclusion that can be drawn is that 
increased steric hindrance in the 2° amine desired products is not 
counterbalancing the increased nucleophilicity and they are much more 
nucleophilic than the starting cyclen derivatives, 56 and 57.  
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Figure 52: Postulated structure of the product formed by coupling compounds 237 and 57 
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Due to the problems encountered, it was decided to synthesise a new 
electrophilic porphyrin. To this end, a synthetic route via an activated ester was 
chosen and the reactions attempted are shown in Scheme 88 
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Scheme 88: Couplings attempted via activated ester bearing porphyrins 
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4.6 Results and discussion of coupling reactions via activated esters 
 
The carboxylic acid substituted porphyrin 262 was synthesised by using Adler-
Longo
124
 methodology in 10% isolated yield (Scheme 89).  
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Scheme 89: Synthesis of the carboxylic acid appended porphyrin 262 
 
Compound 262 gave a range of options for transformation into an activated ester, 
two of which were used for attempted coupling to cyclen derivatives 56 and 57 
as shown in Scheme 88. Equimolar amounts of porphyrin 262 and DCC were 
dissolved in CH2Cl2 at 0 °C and a solution of excess cyclen 56 was added. After 
stirring for 5 hours, monitoring by TLC showed two main new porphyrin 
fractions, one of which showed a polarity consistent with the desired product. All 
the starting porphyrin 262 had been consumed and after a further three hours, 
there appeared to be no further reaction taking place. The reaction was stopped 
and the products were isolated by silica gel chromatography. 
1
H NMR analysis 
of the less polar fraction showed it was the DCC-porphyrin intermediate. 
Unfortunately, once again the polar fraction appeared to degrade rapidly on silica 
gel. Only a small amount could be collected and a poorly resolved 
1
H NMR 
spectrum revealed peaks characteristic of the coupled cyclen-porphyrin product 
which was confirmed by the 
13
C NMR spectrum. However, attempts to further 
purify the product by preparative TLC led to further degradation of the 
compound. The reaction was repeated and this time the crude product was split 
into three portions. Isolation and purification was attempted by column 
chromatography using neutral alumina, basic alumina and silica gel pretreated 
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with base (NEt3). However, none of these attempts were successful, with the 
compound which appeared as one spot by TLC, splitting into several bands as it 
moved down the column.   
 
The succinimide ester 264 was formed in 52% isolated yield by treatment of 
porphyrin 262 with thionyl chloride followed by N-hydroxysuccinimide. An 
equimolar mixture of compounds 264 and 57 was then dissolved in anhydrous 
pyridine under an inert atmosphere and stirred at ambient temperature. Close 
analysis by TLC showed no reaction was occurring, so the mixture was heated to 
70 °C. However, after 24 hours there was still no change to either of the starting 
materials, prolonged heating over seven days led to decomposition of the cyclen 
species 57 with no apparent product formation. A second reaction was 
undertaken using anhydrous THF as the solvent, with the amine 57 washed 
thoroughly with base (NaHCO3(aq)) prior to addition to the reaction mixture. 
Once again no reaction appeared to occur, either at room temperature or after 
prolonged heating at 70 °C.   
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4.7 Buchwald-Hartwig methodology 
4.7.1 Introduction 
 
Due to the lack of success attaching the amino bearing cyclam/cyclen derivatives 
to the bromomethyl porphyrin 237 and the failure of the activated ester route, it 
was decided to try a new approach using palladium catalysed coupling reactions. 
Since the  amino based cyclen/cyclam macrocycles had already been synthesised, 
synthesis of an aryl bromide porphyrin would give access to the use of 
Buchwald-Hartwig chemistry to afford the desired compounds.     
 
4.7.2 Palladium catalysed aryl amination 
 
In a series of papers beginning in 1994, Buchwald and Hartwig
220, 221
 
independently discovered and developed new chemistry based on palladium 
catalysed aryl-nitrogen and aryl-oxygen bond formation using a phosphine based 
ligand system as shown in Scheme 90. Development of this methodology over 
the last decade has led to all aspects of the reaction being investigated including 
different combinations of base, ligand and solvent system as well as the scope of 
the reaction in terms of substrates used. It has been demonstrated that primary, 
secondary and aromatic amines can be coupled to aryl chlorides, bromides, 
iodides and triflates, with a variety of phosphine ligands, of which racemic 
BINAP is one of the most common. The base originally employed was NaO
t
Bu, 
but further studies have shown that the milder bases Cs2CO3 and K3PO4 can also 
be utilised to good effect.  
  
X + HNR'R''
R
NR'R''
R
Pd cat
Phosphine ligand
Base
X + HOR'
R
OR'
R
Pd cat
Phosphine ligand
Base
X=Cl, Br, I, OTf  
Scheme 90: General transformations via Buchwald-Hartwig chemistry
220, 221
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The catalytic cycle is shown in Scheme 91.
222
 The active catalytic species in the 
reaction is palladium(0) which is reductively formed in situ from Pd2(dba)3 or 
Pd(OAc)2. An equilibrium is established between the four coordinate 
Pd(BINAP)2 which lies off the catalytic cycle, and the two coordinate 
Pd(BINAP) 266. This species undergoes oxidative addition with the aryl bromide 
substrate giving the four coordinate palladium(II) complex 267. The amine is 
deprotonated by the base and subsequently exchanges with the bromide ligand 
generating 268 which then undergoes reductive elimination, forming the product 
containing the new aryl-nitrogen bond and regenerating the palladium(0) catalyst 
266.
222
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Scheme 91: Catalytic cycle through which palladium(0) catalysed aminations are believed 
to proceed
222
 
 
The first report of Buchwald-Hartwig chemistry being used within porphyrin 
chemistry came in a paper by van Lier et al. in 2001.
223
 The zinc(II) porphyrin 
complex 269 was aminated with two different cyclic secondary amines as shown 
in Scheme 92.
223
 Although the reason for using the metal complex of the 
porphyrin was not discussed in the paper, presumably this was an attempt to 
prevent the palladium(II) metal ion being encapsulated by the porphyrin under 
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the basic conditions of the reaction.   
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Scheme 92: The first example of Pd(0) catalysed aminations involving a porphyrin
223
 
 
A large study of the applicability and scope of this chemistry to porphyrin 
substrates was done by the group of Zhang and in two papers in 2003 they 
examined the amination of porphyrins both directly on the porphyrin core and 
also on the para position of the phenyl substituents of both TPP and DPP.
224, 225
 
Some of their results are shown in Scheme 93.
224, 225
 The first paper
224
 focussed 
on the reaction of meso-bromo diphenylporphyrin (both free base and zinc(II) 
complex) with a variety of amino bearing nucleophiles. They reported that 
DPEphos and rac-BINAP (Figure 53) were both equally effective ligand systems 
and that Pd(OAc)2 and Pd2(dba)3 were both active catalysts. Their choice of 
Cs2CO3 was due to the occurrence of side reactions when the stronger base 
NaO
t
Bu was employed and THF was preferred over toluene due to greater 
solubility of the porphyrins. Their reactions successfully coupled a wide variety 
of amines in good yield, including electron rich and electron poor aromatic 
amines, demonstrating the extensive applicability of this reaction. They did note, 
however, that although they initially used the zinc(II) ion as an inorganic  
protecting group for the porphyrin, the results showed it was not required when 
Cs2CO3 was used as base.  
The second paper
225
 extended this study to multiple aminations on the para 
positions of the phenyl substituents on both diphenyl and tetraphenyl porphyrin. 
In these cases they discovered that the DPEphos ligand was no longer effective, 
giving very low conversion of starting material. However, a systematic study of 
the reaction found that racemic Binap or Xantphos (Figure 53) were the most 
effective ligands when used in conjunction with Pd(OAc)2 and either Cs2CO3 or 
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NaO
t
Bu as base. The reaction could be done in toluene or THF successfully at 
elevated temperatures between 68 °C and 100 °C.  
P(Ph)2
P(Ph)2
O
P(Ph)2
P(Ph)2
O
P(Ph)2
P(Ph)2
Xantphos BINAP DPEphos  
Figure 53: Structures of common phosphine based ligands used in Buchwald-Hartwig 
chemistry 
 
Both TPP and DPP were aminated using these conditions with a series of amines 
of varying structure and electronic properties which once again demonstrated the 
scope of this reaction for use with porphyrin subtstrates. A selection of their 
results with aryl amines are shown in Scheme 93. 
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Scheme 93: Examples of the Pd(0) catalysed aminations on porphyrin substrates
224, 225
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Following this work, several reports of the use of Buchwald-Hartwig chemistry 
to functionalise porphyrin substrates have been published
226-228
 and one recent 
example by the group of Cavaleiro
228
 is shown in Scheme 94. They used 
palladium(0) catalysed amination of porphyrins as a route to the porphyrin-
phthalocyanine dyads 284 and 286. Although in both syntheses the conditions 
were analogous to those proposed by Zhang et al.,
224, 225
 they used a 
stoichiometric amount of both ligand and catalyst, as well as a four fold molar 
excess of the aryl iodide 283 (phthalocycanine). Metal complexes of both 
macrocycles were also used and the products were obtained in 41% and 70% for 
the phenyl coupled and β-coupled dyads respectively (284 and 286).    
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Scheme 94: Porphyrin-phthalocyanine dyads synthesised via palladium(0) catalysed 
amination reactions
228
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4.7.3 Results and discussion of Buchwald-Hartwig coupling – synthesis of 
compound 287 
 
 
An aryl bromide bearing porphyrin was required for the Buchwald-Hartwig 
coupling attempts and it was decided to keep the methyl ether groups present on 
the periphery of the porphyrin. Hence, the desired porphyrin was an aryl bromide 
analogue of the bromomethyl porphyrin 237. As shown in Scheme 95, the aryl 
bromide containing porphyrin 288 was synthesised via a mixed condensation 
using Adler-Longo
124
 conditions in 7.3% isolated yield. The zinc(II) complex 
was then formed by gently warming (35 °C) mixed solutions of 288 in CHCl3 
and Zn(OAc)2 in MeOH. As stated previously, the basic conditions of the 
Buchwald coupling reaction, combined with the nature of the precatalyst, a 
palladium(II) salt, gave the possibility of the porphyrin sequestering the 
palladium(II) ion from solution and therefore inhibiting the coupling reaction. 
Hence, the zinc complex 289 was formed to prevent this.  
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Scheme 95: Synthetic route to compound 289 
 
The Buchwald-Hartwig type coupling reaction was performed using the 
conditions shown in Scheme 96. An excess of the aminobenzyl cyclen species 57 
was used along with Cs2CO3 as base and, after heating for 30 hours, the reaction 
mixture was cooled to ambient temperature and subjected to aqueous work up. 
However after careful TLC analysis, it became apparent that isolation by column 
chromatography would be difficult due to the product fraction streaking on the 
silica. A brief (10mins) treatment of the crude mixture with TFA removed the 
zinc(II) ion from the porphyrin and improved the behaviour on silica, allowing 
isolation of 287 in 44% yield.  
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Scheme 96: Synthesis of compound 287 
 
Figure 55 and Figure 54 show the aromatic and aliphatic regions of the 
1
H NMR 
spectrum of compound 287 respectively, along with the peak assignments in 
Figure 56.  
 
 
Figure 54: Aliphatic region of 
1
H NMR spectrum of compound 287 
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Figure 55: Aromatic region of 
1
H spectrum of compound 287 
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Figure 56: 
1
H NMR peak assignments for compound 287 
 
 
Assignment of the aromatic region was quite straightforward, with peak a being 
assigned to the β–protons from the porphyrin ring and peak f to the three protons 
on the para positions of the phenyl rings on the porphyrin. Four doublets were 
expected from the two phenyl rings linking the macrocycles and three of these 
are seen as signals b,c and e. The fourth signal is overlapped by signal d, which 
is assigned to the ortho protons on the porphyrin phenyl rings. The expansion of 
this area (Figure 55) shows overlapping signals and this is confirmed by the 
integration of peak d which gives a relative value of 8H (instead of 6H), as well 
as the 2D DQF COSY spectrum which showed a coupling between peaks d and 
e. The 2D spectrum also showed coupling between peaks b and c. These 
coupling interactions alongside the relative chemical shift values allowed 
assignment of protons b, c and e as shown in Figure 56. The aliphatic region 
shown in Figure 54 could not be fully assigned due to the broad signals caused 
by the protons on the cyclen macrocycle and the methylene groups on the 
pendant arms. However, the methoxy protons g and the tert-butyl protons i could 
be clearly identified. Peak h is due to water in the sample.  
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The 
13
C NMR spectrum of compound 287 is shown in Figure 57 and the peak 
assignments are shown in Figure 58. The characteristic peaks that can be 
immediately identified are the ester carbons (peaks 1 and 2), the quaternary 
carbons of the tert-butyl groups (peaks 11), the tert-butyl carbons (peaks 12) and 
the methoxy carbons on the porphyrin (peaks 10). Peaks 3, 8 and 9 are the 
signals generated by the carbons on the methoxy-substituted phenyl rings on the 
porphyrin. Peak 3 is from the 6 carbons substituted with the methoxy groups, 
peak 8 is from the 6 carbons in the adjacent ortho position and peak 9 is from the 
three carbons in the adjacent para positions. Peak 3 was assigned due to its 
integration value, chemical shift and DEPT signal alongside its presence in the 
starting material (porphyrin 19), while peaks 8 and 9 were assigned from the 
DEPT and 
1
H-
13
C correlation spectrum. The 
1
H-
13
C correlation spectrum 
alongside the DEPT spectrum allowed assignment of peaks 4,5,6 and 7 due to 
their correlations with the protons b,c,d and e. The unassigned peaks in the 
aromatic region are all quaternary carbon signals comprising of carbons from the 
porphyrin macrocycle and the phenyl ring adjacent to the cyclen moiety. The 
DEPT spectrum indicated that the four unassigned signals between 49 ppm and 
59 ppm are all CH2 carbons and are typical of signals found in cyclen 
macrocycles with pendant arms, and more specifically they are consistent with 
the starting macrocycle 57. 
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Figure 57: 
13
C NMR spectrum of compound 287 
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Figure 58: 
13
C NMR peak assignments for compound 287 
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Hence, although once again not all the signals can be assigned, the evidence is 
consistent with both macrocycles being present in this compound, with 
characteristic signals from both parts of the molecule present and moreover, 
showing the correct relative integration values in the 
1
H spectrum. Although 
NMR analysis of cyclen type macrocycles is fraught with difficulty due to the 
broadened signals, the 
13
C spectrum shows enough detail to be confident of the 
macrocycle being present in the desired form.  
 
Compound 287 was submitted for electrospray mass spectrometry analysis and a 
solvent system of CH3CN/H2O with 0.1% formic acid was used which gave rise 
to some interesting results. Since ESI usually creates protonated cations, the 
major peak was expected to be at 1413 m/z corresponding to the species [M+H]
+
. 
However, this peak was not seen, but the molecular envelope showed peaks at 
m/z 1414 (100%), 1415 (85%), and 1416 (45%). The spacing of the peaks one 
unit apart indicated that these species carried a single positive charge yet had 
apparently gained two protons to correspond to the signals from the species 
[M+2H]
+
, [M+3H]
+
, and [M+4H]
+
. This seemed to imply a reduction process had 
occurred either in the synthesis and isolation of the molecule or in the mass 
spectrometry analysis. A search of the literature found that this phenomenon had 
been reported before within mass spectrometry analysis of porphyrins.
229-231
 
Musselman and co-workers
229
 had observed a peak corresponding to the 
[M+2H]
+
 species in their analysis of porphyrins using fast atom bombardment. 
They proposed a mechanism in which the porphyrin was protonated twice, 
followed by a one electron reduction to give the uni-charged species. The 
mechanism was consistent with the structure of the analyte molecule in that the 
presence of basic sites on the porphyrin would allow the initial double 
protonation and other groups with electron affinity would facilitate the electron 
capture. Cerny and Gross
232
 had already proposed a general mechanism for the 
formation of  [M+2H]
+
 and [M+3H]
+
 species in molecules containing several 
basic sites. They reported that reduction of protonated species should only occur 
for compounds containing low energy molecular orbitals available to accept the 
electrons. This is clearly the case for porphyrin macrocycles, which contain an 
extended system and hence have low energy LUMOs. Cavaleiro et al.
230
 studied 
the effect of the matrix in liquid secondary ion mass spectrometry on a range of 
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porphyrin dimers linked by ester and amide groups. They observed  [M+H]
+
, 
[M+2H]
+
, [M+3H]
+
, and even [M+4H]
+
 peaks for the dimeric porphyrin species 
but found that changing the matrix changed the relative abundance of the peaks. 
They found that in a matrix of 3-nitrobenzyl alcohol the [M+H]
+
 peak was the 
most abundant, but in more acidic matrices such as thioglycerol the relative 
abundance of both the [M+2H]
+
 and [M+3H]
+
 peaks increased with the [M+2H]
+
 
peak giving the highest relative abundance. Compound 287 clearly fits the 
criteria of having several basic sites for protonation and, since it contains a 
porphyrin subunit, it also has low energy unoccupied orbitals to act as electron 
acceptors. The acidic solvent used in the ESI analysis also fits well with the 
conclusions of Cavaleiro et al.
230
, implying that the peaks seen in ESI are indeed 
an artefact of the analysis.  
 
Having formed the bis-macrocyle 287, the next step was to attempt insertion of a 
metal ion into the cyclen ring. This initially required hydrolysis of the tert-butyl 
ester groups which is commonly achieved in literature reports by treatment of a 
dichloromethane solution of the macrocycle with TFA at room temperature.
105, 
193
 However, after stirring with TFA for 1 hour, followed by basic aqueous work 
up, the starting material was still intact. The procedure was repeated and the 
reaction time extended to 10 hours at room temperature, but TLC analysis 
showed no other products had formed and once again only starting material was 
recovered from the reaction mixture. The reaction was then repeated twice at 
ambient temperature using THF and CHCl3 as solvents. In both cases after 4 
hours no reaction was seen to occur, so the reactions were heated to 40 °C for 
one hour. However, TLC analysis showed degradation of the compound and no 
starting material was recovered.   
Another sample of compound 287 was then dissolved in THF and treated with 
HCl(aq) (~6M) at ambient temperature. However, once again 
1
H NMR analysis 
showed that the starting material was unchanged by the acid, including the tert-
butyl ester peaks.  
 
These results showed that surprisingly, compound 287 was stable to Bronsted-
Lowry acids at room temperature, so a further attempt at hydrolysis was 
subsequently made using the reagent trimethylsilyl iodide (TMSI). This reagent 
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combines a hard acid and weak nucleophile within the same molecule and 
literature reports show it can be used to cleave esters under neutral conditions, 
while tolerating a wide range of functional groups.
233-235
 Aprotic solvents such as 
CCl4 or CDCl3 are used and it has been shown to be especially effective with 
sterically hindered substrates such as tert-butyl esters.
233, 235
 However, when 
compound 287 was dissolved in freshly distilled CDCl3 and treated with TMSI 
under anhydrous conditions a reaction occurred immediately.  TLC analysis 
showed around eight porphyrin spots had been formed from the starting material. 
The reaction was left to continue for 1 hour on the basis that partial hydrolysis of 
the starting material could account for the number of products present. However, 
after this time, no further change was observed. Preparative TLC was used to 
attempt to isolate the two most prominent fractions. Only one could be isolated, 
but 
1
H NMR analysis did not identify the compound. At this point the reaction 
was abandoned and it was concluded that the starting material had degraded 
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4.8 Suzuki coupling reactions 
 
4.8.1 Introduction 
 
In light of the failed attempts hydrolysing the esters in compound 287, it was 
decided to change the coupling reaction in order to create a different linkage 
between the macrocycles. The palladium(0) catalysed Suzuki reaction was 
chosen partly due to the success of the Buchwald-Hartwig coupling reaction and 
also for the direct aryl-aryl linkage that is formed from these couplings. This was 
expected to be a very stable, robust linkage which would stand up to the acidic 
conditions of the ester deprotection reaction. Additionally, the cyclen compounds 
58, 59 and 60 each contain an aryl bromide group which is suitable for reaction 
with a boronic ester appended porphyrin. 
 
4.8.2 Aryl-aryl linkages from Pd(0) catalysed reactions 
 
The Suzuki-Miyaura
236
 reaction is a palladium catalysed coupling between an 
aryl/vinyl halide or triflate with an aryl/vinyl boronic acid or ester and is a 
common methodology used for carbon-carbon bond formation. The reaction is 
carried out in the presence of base to activate the boronic acid/ester and effective 
couplings can be achieved in a wide variety of solvent systems.
237-239
 The broad 
scope of the reaction allied to the stability and low toxicity of the organoboron 
compounds are the main advantages that have led to the widespread use of this 
chemistry.
237, 238
 The active catalytic species is palladium(0) and the reaction is 
often carried out with a palladium(0) catalyst such as Pd(PPh3)4 or a 
palladium(II) precatalyst and a reducing agent (Scheme 97).
240
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Scheme 97: An example of a Suzuki coupling reaction
240
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The catalytic cycle is shown below (Scheme 98) and consists of four main 
steps.
238
 The palladium(0) catalyst undergoes oxidative addition to palladium(II) 
with the organohalide partitioning between the organic residue and the halide 
ion, which is then substituted by base (metathesis). The base also activates the 
boronic acid/ester, forming a four coordinate negatively charged boronate species 
which undergoes transmetallation with the palladium(II) complex. The new 
carbon-carbon bond is formed by reductive elimination in the last step, which 
also regenerates the palladium(0) catalyst.
238
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Scheme 98: Catalytic cycle for the Suzuki reaction
238
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4.8.3 Suzuki coupling in porphyrin chemistry  
 
Halide bearing porphyrins have been widely used as the coupling partner to 
boronic esters in Suzuki couplings.
241-246
 Porphyrins with halo groups directly on 
the porphyrin core (both beta and meso positions) and on a phenyl ring 
substituent have all been successfully coupled with a variety of boronic esters.
241, 
242, 246
It was not until 1994 however, that a porphyrin with a boronic ester 
appended group was synthesised and used in a Suzuki coupling reaction.
247
 As 
shown in Scheme 99, Chan and Zhou
165, 247
 synthesised the porphyrin 293 by 
condensation of a statistical mixture of benzaldehyde, pyrrole and p-(1,3-
dioxaborane)benzaldehyde using Lindsey
139
 methodology.  They went on to 
couple this to β-bromo-tetraphenyl porphyrin 178 under Suzuki conditions 
obtaining the dimer 294 in 88% yield, thus demonstrating the efficacy of 
porphyrin boronic esters in this type of reaction.
165
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Scheme 99: Porphyrin dimers synthesised via Suzuki coupling 
165, 247
 
 
 
A more recent but similar example was reported by Lu and co-workers
248
 who 
synthesised the pinacol boronate ester porphyrin 295 (Scheme 100) using 
Lindsey
139
 conditions in 15% yield. This porphyrin was then used as the 
monomer building block from which the authors synthesised hyperbranched 
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conjugated porphyrin arrays by a one pot Suzuki polycondensation.
248
 The alkyl 
chains were used to aid organic solubility of the polymers. 
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2. DDQ
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R = -C8H17
 
Scheme 100: Boronic ester appended porphyrin used subsequently to form hyperbranched 
conjugated porphyrin arrays via Suzuki polymerisation reactions
248
 
 
Lindsey et al.
209
 synthesised the trans-A2B2 type porphyrin 296 containing two 
pinacol boronic esters by acid catalysed condensation of 5-
mesityldipyrromethane with p-(1,3-dioxaborane)benzaldehyde followed by 
oxidation as shown in Scheme 101. The subsequent Suzuki coupling with the 
iodo-porphyrin 297
 
proceeded smoothly to give the porphyrin trimer 298 in 66% 
yield.
209
    
 
 180 
NH
HN
N
N
I
t
Bu
t
Bu
t
Bu
t
Bu
HN
NH
N
N
NH
HN
N
N
t
Bu
t
Bu
t
Bu
t
Bu
Pd(PPh3)4,
K2CO3
Toluene / DMF (2:1)
90°C
66%
O H
B
OO
HNNH
NH
HN
N
N
B
O
O
B
O
O
+
1. BF3OEt2, CHCl3
2. DDQ
27%
296
298
HN
NH
N
N
t
Bu
t
Bu
t
Bu
t
Bu
297
 
 
Scheme 101: Synthesis of a porphyrin triad via a Suzuki coupling
209
 
 
  
In 1998, Therien et al.
249
 were the first group to report the synthesis and reactions 
of a boronic ester appended on the meso position of a porphyrin. (Scheme 102) 
The Masuda group had previously reported the use of pinacolborane to transform 
aryl halides into aryl boronates using a palladium catalysed cross coupling 
reaction.
250
 As shown in Scheme 102, Therien and co-workers
249
 extended this 
methodology to the zinc(II) complex of 5-bromo-10,20-diphenyl porphyrin 299  
to synthesise the pinacol boronic ester appended porphyrin 300 in 79% yield. 
They subsequently coupled 300 to several substrates under Suzuki conditions in 
good yields and one of these transformations, the reaction with N-Boc protected 
4-iodo-L-phenylalanine, is shown in Scheme 102. Compound 301 was obtained 
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in 79% yield, thus demonstrating that porphyrins with boronic esters on the meso 
positions are also able to undergo these type of coupling reactions .   It should be 
noted that, to date, there have been no examples reported in the literature of 
porphyrins bearing boronic ester or boronic acid groups on the β-positions of the 
macrocycle.   
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Scheme 102: The first example of a porphyrin meso-substituted with a boronic ester
249
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4.8.4 Synthetic strategy 
 
The aryl bromide cyclen derivatives that have already been synthesised directed 
the need for a boronic ester appended porphyrin. To this end, a boron pinacol 
ester was chosen as this is known to be stable. It was also decided to substitute 
the remaining porphyrin phenyl rings with methyl ester groups. When the 
coupled product has been synthesised, this would facilitate a one step hydrolysis 
of both the tert-butyl esters on the cyclen moiety and the methyl esters on the 
porphyrin at the same time. Porphyrin 303 was thus chosen as the target 
molecule (Scheme 103).  
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Scheme 103: Synthesis and attempted coupling reactions of pinacol boronic ester porphyrin 
303 
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4.8.5 Results and discussion 
 
Compound 302 was synthesised using the method reported by Yu et al.
209
 in 
good yield (Scheme 103). This was subsequently condensed with pyrrole and 
methyl(4-formyl)benzoate using Lindsey
139, 230
 conditions to form the pinacol 
boronic ester appended porphyrin 303. During chromatographic isolation 
compound 303 appeared to decompose and this led to a very low yield of 3%. 
This was surprising since the pinacol group is electron releasing and should 
stabilise the electron deficient boron atom, and analogues of this porphyrin have 
been reported before, such as compound 296 (Scheme 101). It is feasible that the 
electron withdrawing ester groups in compound 303 negate the effect of the 
electron releasing pinacol group and destabilise the porphyrin. In spite of this 
however, enough compound was collected to use in the following steps of the 
synthetic route. The initial attempt at Suzuki coupling was carried out with the 
lanthanum complex 60. Pd(PPh3)4 was used as the catalyst, in the presence of  
K2CO3 in a toluene / DMF (2:1) solvent system. The reaction was heated to 90 
°C and TLC analysis after 4 hours showed complete consumption of the starting 
material and a new porphyrin spot. However, when this was isolated, the 
1
H 
NMR did not correlate with the expected compound. The pinacol ester peaks had 
disappeared, but the porphyrin remained intact and there were no peaks 
representative of the cyclen species. A 
11
B NMR showed a strong peak and so 
this evidence pointed towards hydrolysis of the boronic ester to the boronic acid. 
Although this species should still be reactive, no coupled product was formed. 
Since the base in the Suzuki reaction must be strong enough to activate the 
boronic ester, but must not interfere with any base sensitive groups in the 
substrate, the reaction was attempted twice more with first K3PO4 (a weaker 
base) and then with Cs2CO3 (a stronger base). However, neither of these changes 
affected the outcome of the reaction. Finally, the cyclen moiety was changed to 
the free base compound 135 and the coupling conditions from the initial reaction 
were used, but this was to no avail. The hypothesis at this time was that the 
stability of the boronic ester may preclude these reactions from taking place. 
Hence, attention was switched at this point to synthesising an alternative boronic 
ester substituted porphyrin. As shown in Scheme 104, 1,3-
dioxaboranylbenzaldehyde 304 was synthesised in 78% yield using a known 
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literature method.
251
 This was condensed using Lindsey conditions
139
 to give 
porphyrin 305 in 7.2% yield. Although this was again a low yield, the porphyrin 
did not degrade on the silica column during purification.   
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Scheme 104: Synthetic route to boronic ester appended porphyrin 305 
 
 
Compound 305 was subsequently heated to 90 °C with 135 in a mixture of 
toluene and DMF (2:1) using Pd(PPh3)4 as catalyst in the presence of K2CO3. 
(Scheme 105) After 17 hours, the product was isolated by column 
chromatography and identified by NMR and mass spectrometry as the coupled 
product 306.  
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Scheme 105: Suzuki coupling reaction affording cyclen-porphyrin conjugate 306 
 
The 
1
H NMR spectrum and the proton assignments are shown in Figure 59, and 
as expected it is very similar to the spectrum for compound 287. The assignments 
for the aromatic protons have been made with reference to the 2D DQF COSY 
correlation spectrum. The cyclen protons appear as a broad signal which cannot 
be assigned, but which is characteristic of this type of compound.  
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Figure 59: 
1
H NMR spectrum of compound 306 
 
Hydrolysis of the ester groups within compound 306 was attempted with a 
dichloromethane solution of compound 306 being treated with concentrated HCl 
at room temperature. After 1 hour, TLC analysis appeared to show only one very 
polar spot, indicating this compound did not degrade under strongly acidic 
conditions. 
1
H NMR confirmed that all ester groups had been hydrolysed. Water 
was added to the reaction mixture, excess GdCl3.6H2O added and the mixture 
heated to 60 °C for 8 hours under inert atmosphere. Unfortunately, the compound 
did not sequester the metal ion and no metal ion complex was formed. Time 
constraints for this project did not allow for further attempts at formation of the 
metal ion complex. Although the desired metal complex was not synthesised, 
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compound 306 was stable to acidic hydrolysis whereas the conjugates that had 
been synthesised previously, were not. This suggests that, as expected, the aryl-
aryl linkage is more robust and that this route is the most promising for the 
syntheses of these types of bismacrocyclic systems.  
 
 
4.9 Summary 
 
Nucleophilic substitution of the electrophilic porphyrin 237 with the amino 
bearing cyclen/cyclam compounds was unsuccessful. The reactions appeared to 
be limited by the nucleophilicity of the amine groups. In the one reaction where 
the amine was reactive enough, the reaction could not be controlled and a 
mixture of the desired product and the dialkylated compound was produced.  
 
Reactions using activated esters were equally ineffective, with problems again 
being encountered with the seemingly low reactivity of the amino compounds.  
 
Two successful routes to the desired coupled products have been developed 
using Pd(0) catalysed reaction sequences, and the compounds produced by these 
routes are shown in Figure 60.  
 
Buchwald-Hartwig aryl amination afforded the cyclen-porphyrin conjugate 287 
in reasonable yield. However, the gadolinium(III) complex could not be formed 
due to the instability of the compound under the conditions required for 
deprotection of the tert-butyl ester groups.  
 
The second successful route to the coupled cyclen/porphyrin molecules was 
achieved by using the ubiquitous Suzuki coupling reaction. The effectiveness of 
this methodology was demonstrated by the synthesis of compound 306 in 
reasonable yield. The aryl aryl bond created was demonstrated to be robust, as 
expected, as this compound did not degrade when the ester groups were 
deprotected. Although the desired metal ion complex was not synthesised, this 
route fulfils all the necessary requirements for the synthesis of bismacrocycles 
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for medical imaging and therapy. Access to a large range of analogous 
compounds can be forseen due to the wide scope of the coupling reaction.     
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Figure 60: Bismacrocycles successfully synthesised through palladium(0) catalysed coupling 
reactions 
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Chapter 5: Concluding remarks 
 
A convergent synthetic methodology has been developed to give access to bis-
macrocyclic systems comprising a porphyrin and a cyclen based moiety. 
A series of novel macrocyclic chelators based around the cyclen framework have 
been successfully synthesised, each containing a functional handle for further 
elaboration of the structure. 
Reductive amination reactions of 2-formyl TPP were undertaken with a variety 
of amino bearing substrates in order to investigate the applicability of this 
reaction towards obtaining the desired porphyrin-cyclen conjugates. These 
reactions showed that this methodology can be used to introduce a range of 
functionality and diversity into the porphyrin core. This was demonstrated by the 
direct reductive amination of amino bearing cyclen derivatives to give the 
desired bis-macrocyclic compounds 221 and 222. 
Unfortunately, these compounds were not stable under the acidic conditions 
required for deprotection of the tert-butyl ester groups and so the metal ion 
complexes could not be formed.   
Attempts to couple the amino bearing cyclams with electrophilic porphyrins 237 
and 262 were unsuccessful and appeared to be limited by the reactivity of the 
amine groups. 
Buchwald-Hartwig aryl amination afforded the cyclen-porphyrin conjugate 287 
in reasonable yield, but once again the gadolinium(III) complex could not be 
formed due to the instability of the compound under the conditions required for 
deprotection of the tert-butyl ester groups.  
Suzuki coupling of the aryl bromide appended cyclen 135 and the boronic ester 
bearing porphyrin 305 was successful and gave access to the target compound 
306. The aryl-aryl linkage between the two macrocycles in this compound 
proved more robust and allowed the deprotection of the ester groups without 
degradation of the rest of the compound.  
Since cyclen macrocycles bearing carboxylate pendant arms are known to form 
stable and inert complexes with gadolinium(III) and porphyrins are known 
photosensitisers, compound 306 possesses the basic elements required to be 
investigated as a dual imaging-therapy agent (MRI-PDT).  
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Moreover, the synthetic route to 306 has wide scope due to the coupling reaction 
and conditions being tolerant of a range of different functional groups and this 
will allow many analogues of compound 306 to be synthesised.  
5.1 Future work 
 
The initial direction for future development of this work is to resynthesise 
compound 306 to obtain a larger quantity. The subsequent deprotection and 
complexation reactions need to be optimized for lanthanide(III) ions and once 
this has been achieved, a series of experiments could be undertaken to determine 
the effect that linking the two components has had on their individual properties.  
The physical analysis required for the contrast agent would include a relaxivity 
measurement, which can be compared with the value obtained for the 
unconjugated gadolinium(III) complex.  Synthesis of the europium(III) complex 
would allow luminescence studies to determine the number of inner sphere 
bound waters (Q value), which is the main component of relaxivity. Due to the 
larger size of the conjugate compound, a decrease in the rotational correlation 
time would be expected with a concomitant increase in relaxivity, and attempts 
to quantify this effect could also be undertaken. The cyclen derivatised 
macrocycle would be expected to form a stable complex with the gadolinium(III) 
ion and any change caused by coupling of the porphyrin could be measured by 
determination of the stability constant with respect to dissociation of the metal 
ion. Potentiometric titrations could be used to evaluate competitive binding by 
the zinc(II) ion, a process which occurs in vivo.   
In terms of the porphyrin moiety, any changes to the luminescence properties of 
the molecule on coupling can be probed, for example shifts in the absorption and 
emission spectra maxima. Measurement of singlet oxygen production as well as 
light/dark toxicity studies need to be carried out. Cellular uptake can be 
measured by optical microscopy or MR imaging of cell pellets.  
The broad scope of the coupling reaction allows for a series of analogues to be 
synthesised, and the specific target molecules would be dependent on the results 
of the aforementioned studies. However, one obvious candidate would be to 
couple several gadolinium(III) complexes to one porphyrin, in effect increasing 
the imaging „payload‟. Relaxivity measurements could be taken to measure any 
 191 
possible synergistic effects on contrast enhancement. Another option is to change 
the porphyrin moiety, substituting for one with an absorption band at a longer 
wavelength to allow more efficient light penetration through tissue, to enhance 
the effectiveness of PDT.        
 
 
 
 
  
 192 
Chapter 6: Experimental 
 
All starting materials were purchased from Lancaster Synthesis or Sigma 
Aldrich. 
 
NMR spectra were obtained from a Jeol JNM-ECP 400 MHZ FT-NMR 
spectrometer, with chemical shifts reported in ppm relative to a tetramethylsilane 
standard. 
 
Ultra violet/visible absorption spectra were recorded on an Agilent 8453 
spectrometer. 
 
Analytical TLC was carried out using aluminium backed silica gel 60 F254 and 
visualised using UV light (254 / 365 nm). Column chromatography was 
performed using ICN silica 32-63, 60Å.  
 
Mass spectrometry results were obtained via services provided by : 
 
EPSRC National Mass Spectrometry Service Centre, 
Chemistry Department 
University of Wales 
Swansea 
Analyses were made using the following instrumentation: 
 
MALDI Applied Biosystems Voyager 
Electrospray Waters ZQ-4000 
FAB  Finnigan MAT 95XP 
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6.01 Synthesis of 1,4,8,11-tetraazacyclotetradecane (5)
122
  
 
HNNH
NH HN
 
 
 
To a solution of nickel (II) perchlorate (54.7g, 0.15mol) in water (400ml) was 
added 1,5,8,12-tetraazadodecane (26g, 0.15mol) with stirring. The solution was 
cooled to 5 °C, glyoxal (40% w/v, 22.5ml) added then left to stand at room 
temperature for 18 hours. The mixture was cooled again to 5 °C and sodium 
borohydride (11g, 0.3mol) added slowly over 1 hour. Upon addition, the mixture 
was heated to 90 °C for 15 minutes, filtered through a hot sinter, sodium cyanide 
(29g, 0.6mol) added and heated under reflux conditions for 2 hours. Upon 
cooling, sodium hydroxide pellets (15g, 0.38mol) were added and the water 
removed in vacuo. The solid was taken up in chloroform, filtered and dried 
(MgSO4) before being concentrated in vacuo to yield a crude off white solid. 
This was recrystallised from chlorobenzene (150ml) to yield fine white crystals 
of compound 5 (10.6g, 35%). m.p. 185-187°C 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.69 (4H, q, 
3
J=5.3Hz, CH2-β-N), 2.32 (4H, br s, 
NH), 2.64 (8H, s, CH2-α-N), 2.71 (8H, t, 
3
J=5.4Hz, CH2-α-N) 
13
C N.M.R. [100MHz, CDCl3] δ 29.5 (CH2-β-N), 49.4 (CH2-α-N), 50.8 (CH2-α-
N) 
MS (ESI) m/z 201 (M+H)
+
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6.02 Synthesis of 1-aminoethyl-4,7,10-(tris-methoxycarbonylmethyl)-
(1,4,7,10-tetraazacyclododecane) (56) 
N N
N N
O
O
O
O
O
O
NH2
 
 
116 (0.5g, 0.94 mmol) was dissolved in anhydrous CH2Cl2 (4 mL) under an 
argon atmosphere. TFA (1mL) and TFA anhydride (1 drop) were added dropwise 
and the reaction mixture stirred for one hour at ambient temperature. The solvent 
was then removed in vacuo and ethyl acetate (5mL) added. The solvent was then 
removed carefully by pipette and the washing procedure repeated three times. To 
the insoluble residue was added a solution of NaHCO3(aq) (10mL) and the 
mixture stirred for 30 minutes under argon at ambient temperature. The resulting 
mixture was extracted with CH2Cl2 (3 x10mL) and the organic extracts combined 
and concentrated to give the product as a white semi-solid. (0.40g, 99%)  
 
1
H N.M.R. [400MHz, CDCl3] δ 2.31-2.62 (16H, m, NCH2 (ring) ), 2.63-2.73 (2H, 
m, NCH2CH2NH2 (pendant arm)), 2.84 (2H, bs, NCH2CH2NH2 (pendant arm)), 
3.38-3.42 (4H, m, CH2COOMe), 3.46 (2H, bs, CH2COOMe), 3.61 (3H, s, 
COOCH3), 3.66 (6H, s, COOCH3) 
13
C N.M.R. [100MHz, CDCl3] δ 37.1, 45.9, 49.6, 50.1, 51.1, 51.3, 51.6, 54.96, 
55.01, 171.5, 172.1 
MS (ESI) m/z 432 (M+H)
+
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6.03 Synthesis of 1,4,7-(tris-tert-butoxycarbonylmethyl)-10-(4-aminobenzyl)-
1,4,7,10-tetraaza-cyclododecane (57) 
 
N N
N N
O
O
O
O
O
O
NH2
 
 
Method 1
108
 
 
To a mixture of sulphur (66mg, 2.05mmol) and NaBH4 (26mg, 0.69 mmol) under 
a nitrogen atmosphere was added anhydrous THF (60mL) and the resulting 
yellow suspension stirred for one hour. A solution of 132 (0.22g, 0.34mmol) in 
anhydrous THF (80mL) was added and the mixture heated under reflux for ten 
hours, during which time the suspension turned a grey/green colour. After 
cooling to room temperature the solvent was removed in vacuo and CH2Cl2 
(100mL) added to the residue. After several extractions with NaOH(aq) (5% w/v, 
5x50mL) to remove the excess sulphur, the organic layer was dried over MgSO4 
and after removal of the dessicant, concentrated down to a small volume (~5mL). 
The product was isolated by gravity column chromatography (silica, eluent : 
CH2Cl2/MeOH, 99:1) as a sticky, pale yellow semi-solid (0.16g, 78%).  
 
Method 2.  
 
Compound 132 (1.2g, 1.86mmol) was dissolved in MeOH (50mL) and Pd/C 
(10wt%, 64mg) added. H2 gas was bubbled directly through the suspension and 
the reaction was followed by TLC (eluent : CH2Cl2/MeOH, 99:1). After three 
hours the solvent was removed in vacuo and the residue dissolved in CH2Cl2 
(40mL). The organics were extracted with NaHCO3 solution several times before 
being dried over Na2SO4. After removal of the dessicant by filtration, the solvent 
was concentrated down to a small volume (~5mL). The product was isolated by 
gravity column chromatography (silica, eluent : CH2Cl2/MeOH, 98:2) as a 
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yellow oil which was solidified by trituration with diethyl ether to give a pale 
yellow hygroscopic solid. Yield : 0.79g, 69.3% 
1
H N.M.R. [400MHz, CDCl3] δ 1.43-1.50 (27H, m, (CH3)3), 2.18-3.20 (24H, br 
m, CH2C(O) x3 , NCH2 x8, CH2PhNO2), 6.63 (2H, d, 
3
J = 8.4Hz, C(O)-Ar-2,6-
H), 7.21 (2H, d, 
3
J = 8.4Hz, C(O)-Ar-3,5-H) 
13
C N.M.R. [100MHz, CDCl3] δ 27.9, 28.0, 53.4, 55.6, 55.9, 58.9, 82.2, 82.7, 
115.1, 126.6, 131.0, 146.1, 171.2, 172.4 
MS (ESI) m/z 620 (M+H)
+
 
HRMS : calculated for C33H57N5O6 : 620.4382, found 620.4383 
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6.04 Synthesis of 1,4,7-tris(tert-butoxycarbonylmethyl)-10-(4-bromobenzyl)-
1,4,7,10-tetraazacyclododecane (58)
105
   
 
N
N
N
N
O
O
O
O
O
O
Br  
 
 
 
To a solution of 127 (1g, 1.9 mmol) and 4-bromobenzyl bromide (0.53g, 2.13 
mmol) in acetonitrile (100mL) was added Na2CO3 (1.65g, 16mmol) and the 
mixture heated at 70 °C for 3 days. After this time, TLC (silica, CH2Cl2 : MeOH, 
95:5) showed complete consumption of starting material 127. The solids were 
filtered off, the solvent removed in vacuo and the residue dissolved in 
dichloromethane (100mL). This was washed successively with water (2x100mL) 
and brine (50mL) and dried over MgSO4. Following removal of the dessicant, the 
solution was concentrated down to a small volume (~10ml) and purified by 
gravity column chromatography (silica, eluent: CH2Cl2/MeOH, 98:2). Relevant 
fractions were identified by TLC (silica CH2Cl2/MeOH, 95:5), (Rf=0.4), 
collected and concentrated to give a pale yellow oil. Trituration with diethyl 
ether gave the product as a sticky, hygroscopic yellow semi-solid (1.2g, 90%) 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.36-1.45 (27H, m, OC(CH3)3, 2.1-3.4 (24H, m, 
NCH2, CH2COO
t
Bu, CH2PhBr), 7.33 (2H, d, 
3
J = 8.2Hz, Br-Ar-3,5-H), 7.38 (2H, 
d, 
3
J = 8.2Hz, Br-Ar-2,6-H)  
13
C N.M.R. [100MHz, CDCl3] δ 27.7, 27.8, 49.7, 50.5, 53.3, 55.6, 55.8, 58.8, 
82.2, 82.8, 121.4, 131.6, 131.7, 136.6, 172.4, 173.4 
MS (ESI) m/z 683 
79
Br(M)
+
, 685 
81
Br(M)
+
, 705 
79
Br(M+Na)
+
, 707 
81
Br(M+Na)
+ 
HRMS : calculated for C33H55
79
BrN4O6 : 683.3378, found 683.3376
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6.05 Synthesis of Gadolinium complex of 10-(4'-Bromo-2-acetophenone)-
1,4,7,10- tetraazacyclododecane-1,4,7-triacetic acid (59) 
 
N
N
N
N
O
O
O
O
O
O
Gd
O
Br  
 
 
To a solution of 135 (0.51g, 0.73mmol) in dichloromethane (15mL) was added 
concentrated HCl (2mL) and the reaction was stirred at ambient temperature 
under an N2 atmosphere for 2 hours. The solvent was then removed in vacuo and 
water (10mL) added to the yellow residue. This was filtered and the resulting 
solution adjusted to pH 7 by careful addition of Na2CO3(aq). An aliquot was 
removed for NMR analysis and the remainder used straight away in the 
following procedure. 
 
1
H N.M.R. [400MHz, D2O] δ 3.02-3.63 (16H, m, NCH2), 3.67 (2H, s, 
NCH2C(O)), 3.84 (4H, s, NCH2C(O)), 4.40 (2H, s, NCH2C(O)), 7.72 (2H, d, 
3
J = 
8.7Hz) 7.86 (2H, d, 
3
J = 8.7Hz)   
13
C N.M.R. [100MHz, D2O] δ 43.0, 48.3, 48.6, 51.7, 51.8, 54.3, 54.4, 55.9, 57.0, 
58.3, 128.8, 129.9, 132.3, 134.2, 170.7, 175.9, 198.8 
 
To the above solution was added dropwise a solution of GdCl3.6H2O (0.30g, 
0.8mmol) in water (5mL) with vigorous stirring. The resulting solution was 
heated to 60 °C under an argon atmosphere for 24 hours. After cooling to 
ambient temperature the solution was concentrated to ~2mL and passed down a 
size exclusion column (Sephadex LH20, eluent : H2O). Relevent fractions were 
collected, combined and concentrated to give the product as a yellow semi-solid. 
(0.3g, 60%). 
MS (FAB) m/z 695.04 (M+H)
+
 
HRMS : calculated for C22H28Br
155
GdN4O7 : 695.0440, found 695.0435 
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6.06 Synthesis of Lanthanum complex of 10-(4'-Bromo-2-acetophenone)-
1,4,7,10- tetraazacyclododecane-1,4,7-triacetic acid (60) 
 
N
N
N
N
O
O
O
O
O
O
La
O
Br  
 
This compound was synthesised in exactly the same way as compound 59. 
(Yield: 52%) 
MS (ESI) m/z 696 (M+NH4)
+
 
HRMS : calculated for C22H32Br
139
LaN5O7 : 696.0543, found 696.0549 
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6.07 Synthesis of 1,4,7-(tris-methoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane(90)
101
 
 
 
N HN
N N
O
O
O
O
O
O
 
 
To a suspension of cyclen 6 (3g, 17.4 mmol) and NaHCO3 (4.39g, 52.2 mmol) in 
acetonitrile (800mL) was added dropwise a solution of methylbromoacetate (8g, 
52.2 mmol) in acetonitrile (200 mL) over 6 hours. The reaction misture was then 
stirred for 3 days at ambient temperature under an inert (N2) atmosphere until 
TLC (silica, eluent : CH2Cl2 / CH3OH, 95:5) showed complete consumption of 
the alkylating agent. The mixture was filtered under suction and the solvent 
removed in vacuo. The residual yellow oil was purified by flash chromatography 
(silica, eluent : CH2Cl2 / CH3OH, 95:5) to yield a yellow oil. (Rf =0.3) Yield : 
3.38g, 50% 
 
1
H N.M.R. [400MHz, CDCl3] δ 2.78-2.98 (12H, m, NCH2 (ring ), 3.03-3.12 (4H, 
m, NCH2 (ring ), 3.39 (2H, s, NCH2COOMe), 3.47 (4H, s, NCH2COOMe), 3.66 
(9H, s, COOCH3), 9.90 (1H, bs, NH)  
13
C N.M.R. [100MHz, CDCl3] δ 47.2 (NCH2  ring), 48.4 (NCH2COOMe), [49.2, 
51.3 (NCH2  ring)], 51.6 (COOCH3), 56.9 (NCH2COOMe x2), [170.6, 171.5 
(COOCH3)] 
MS (ESI) m/z 389.2 (M+H)
+
 
HRMS : calculated for C17H32N4O6 : 389.2395, found 389.2399 
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6.08 Synthesis of Perhydro-2a,4a,6a,8a-
tetraazacyclopenta[f,g]acenaphthalene (109) 
 
N N
N N
H
H
 
 
A solution of cyclen 6 (5g, 29 mmol) in methanol (100mL) was cooled to 0 °C 
and an aqueous solution of glyoxal ( 40% w/v, 4.65 mL, 32mmol ) added 
dropwise over 30 minutes. The resulting solution was allowed to rise to ambient 
temperature and stirred for three hours. Solvents were subsequently removed in 
vacuo and diethyl ether (50mL) added to the residue. Insoluble solids were 
removed by filtration and the colourless solution concentrated to give an off 
white solid. This was triturated several times with diethyl ether to yield the 
product as a white solid. (5.35g, 97%) m.p. 91-93°C 
 
1
H N.M.R. [400MHz, CDCl3] δ 2.52-2.62 (4H, m, NCH2), 2.62-2.78 (4H, m, 
NCH2), 2.92-3.00 (4H, m, NCH2), 3.00-3.07 (4H, m, NCH2 ), 3.14 (2H, s, CH) 
13
C N.M.R. [100MHz, CDCl3] δ 50.4, 51.1, 77.5, 
MS (ESI) m/z 195 (M+H)
+ 
HRMS : calculated for C10H18N4 : 195.1604, found 195.1605
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6.09 Synthesis of Decahydro-3a,5a,8a,10a-tetraazapyrene (112)
98
 
 
N
N N
N
H
H
 
 
To a cooled (0 °C) solution of compound 5 (1g, 5mmol) in methanol (30ml) was 
added a glyoxal solution (40% w/v, 0.8g, 5.5mmol) in methanol (15ml). The 
reaction mixture was stirred for 3 hours at room temperature after which the 
solvent was removed in vacuo. Diethyl ether (200ml) was added and the 
resulting suspension filtered. The filtrate was collected and concentrated in vacuo 
to yield compound 112 as a yellow viscous oil (1.05g, 94%).  
 
1
H N.M.R. [400MHz, CDCl3] δ 1.15-1.19 (2H, m, 
3
J=2Hz, 
2
J=13.2Hz, CH2-β-
N), 2.06 (2H, t, 
2
J=11.5Hz, CH2-α-N), 2.10-2.25 (4H, m, CH2-β-N, CH2-α-N, 
CH2-β-N), 2.27 (2H, d, 
2
J=10.4Hz, CH2-α-N), 2.68 (2H, br d, CH2-α-N), 2.88-
2.90 (6H, m, CH2-α-N), 3.04 (2H, s, NCHN), 3.45-3.50 (2H, m, CH2-α-N) 
13
C N.M.R. [100MHz, CDCl3] δ 19.6 (CH2-β-N), 44.7 (CH2-α-N), 52.5 (CH2-α-
N), 54.3 (CH2-α-N), 56.0 (CH2-α-N) 
MS (ESI) m/z 223 (M+H)
+
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6.10 Synthesis of  1-(2-(tert-butoxycarbonyl)-aminoethyl)-(1,4,7,10-
tetraazacyclododecane) (115) 
 
NH N
NH HN
O
O
N
H  
 
Method 1
101
  
 
To a stirred solution of cyclen 6 (3.84g, 22mmol) in toluene (120mL) was added 
119 (1.7g, 8mmol) and the solution heated under reflux conditions for 10 hours 
under a nitrogen atmosphere. Upon cooling to ambient temperature a white solid 
precipitated out of solution. Water (100mL) was added which caused the 
precipitate to redissolve and the organic layer was then extracted twice with 
water (100mL x2) and the aqueous layer separated. This was extracted with 
CH2Cl2 (200mL), and the organic layer separated and dried over MgSO4. After 
removal of the dessicant by filtration the solvent was removed in vacuo to yield a 
white sticky solid which was triturated several times with cold diethyl ether. 
Yield 1.16g, 49% based on 119. m.p. 118-120°C 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.44 (9H, s, (CH3)3), 2.50-2.67 (14H, br m, 
NCH2,), 2.77-2.87 (4H, m, NCH2), 3.18-3.25 (2H, m, NCH2) 
13
C N.M.R. [100MHz, CDCl3] δ 28.3, 38.4, 46.0, 47.0, 47.7, 52.0, 54.0, 78.7, 
155.9 
MS (ESI) m/z 316 (M+H)
+
 
HRMS : calculated for C15H33N5O2 : 316.2707, found 316.2705 
 
 
Method 2 
 
Compound 117 (1.2g, 2.9 mmol) was dissolved in hydrazine monohydrate 
(30mL) and heated to 120 °C under an N2 atmosphere. After 10 hours CHCl3 
(50mL) was added and the chloroform layer separated and concentrated in vacuo 
to yield a yellow oil. This was washed successively with diethyl ether (20mL) 
and CCl4 (20mL), however, NMR analysis indicated a small amount of impurity 
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still present. The solvent was removed in vacuo and the resulting solid 
recrystallised from ethyl acetate to yield a white solid. (0.46g, 51%). m.p. 118-
121°C 
 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.44 (9H, s, (CH3)3), 2.50-2.67 (14H, br m, 
NCH2  (ring), NCH2 (pendant arm)), 2.77-2.87 (4H, m, NCH2  (ring)), 3.18-3.25 
(2H, m, NCH2 (pendant arm)) 
13
C N.M.R. [100MHz, CDCl3] δ 28.3, 38.4, 46.0, 47.0, 47.7, 52.0, 54.0, 78.7, 
155.9 
MS (ESI) m/z 316 (M+H)
+
 
HRMS : calculated for C15H33N5O2 : 316.2707, found 316.2706 
 
 
Method 3 
 
Compound 117 (3.0g, 7.6 mmol) was dissolved in KOH(aq) (20% w/v, 50mL) 
under an N2 atmosphere and heated to 60 °C. After three days the reaction was 
cooled to ambient temperature and extracted into CHCl3 (100mL). The organic 
layer was separated and concentrated to yield a brown oil. A small quantity of 
CH2Cl2 (~10mL) was added and the solution dried over Na2SO4. The dessicant 
was removed and gravity column chromatography (alumina, eluent : CH2Cl2/ 
MeOH 95:5) used to isolate the product as a light brown sticky oil which was 
solidified by trituration with diethyl ether. Yield 0.92g, 41% m.p. 119-121°C 
  
1
H N.M.R. [400MHz, CDCl3] δ 1.44 (9H, s, (CH3)3), 2.50-2.67 (14H, br m, 
NCH2  (ring), NCH2), 2.77-2.87 (4H, m, NCH2), 3.18-3.25 (2H, m, NCH2) 
13
C N.M.R. [100MHz, CDCl3] δ 28.3, 38.4, 46.0, 47.0, 47.7, 52.0, 54.0, 78.7, 
155.9 
MS (ESI) m/z 316 (M+H)
+
 
HRMS : calculated for C15H33N5O2 : 316.2707, found 316.2708
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6.11 Synthesis of 1-(2-(tert-butoxycarbonyl)-aminoethyl)-4,7,10-(tris-
methoxycarbonylmethyl)-(1,4,7,10-tetraazacyclododecane) (116)  
 
N N
N N
O
O
O
O
O
O
ON
H
O
 
 
Method 1
101
 
 
Compound 90 (1.5g, 3.86 mmol), compound 119 (0.87g, 3.86 mmol) and 
Na2CO3 (0.41g, 3.86 mmol) were dissolved in acetonitrile (100mL) and stirred 
under an N2 atmosphere at ambient temperature. The reaction was monitored by 
TLC (silica, eluent : CH2Cl2 / CH3OH, 95:5) but after 4 days no reaction was 
seen to occur. The reaction was subsequently heated to 60 °C and after 8 hours, 
TLC showed complete consumption of the starting materials. The mixture was 
filtered under suction and the solvent removed in vacuo. The residual brown oil 
was purified by flash chromatography (silica, eluent : CH2Cl2 / CH3OH, 95:5) to 
yield a yellow oil. (Yield: 1g). The compound isolated showed a complex, 
unassignable 
1
H NMR spectrum and was clearly not the desired compound.  
 
 
Method 2 
 
To a solution of 115 (1.15g, 3.65 mmol) in dry acetonitrile (300mL) was added 
Na2CO3 (3.1g, 29 mmol) and the mixture heated to 50 °C. To this was added 
dropwise a solution of methyl bromoacetate (2.27g, 15 mmol) in dry acetonitrile 
(50mL). Heating at 50 °C was continued and the reaction progress monitored by 
TLC (silica, eluent : CH2Cl2 / MeOH, 9:1). After 16 hours the reaction showed 
no further progress and the mixture was cooled to ambient temperature and the 
solids removed by filtration. The solvent was removed in vacuo and the residue 
dissolved in a minimum of CH2Cl2 (~10mL). The product was isolated by flash 
column chromatography (silica, eluent : CH2Cl2 / MeOH, 95:5) as a pale yellow 
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oil. (Rf =0.4) After being successively triturated with hexane and diethyl ether, 
the product was obtained as a pale yellow semi-solid. (1.40g, 72%) 
 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.45 (9H, s, C(CH3)3), 2.31-3.05 (18H, m, NCH2 
x8 (ring), NCH2 CH2), 3.20-3.28 (4H, m, NCH2CH2,  NCH2COOMe), 3.35 (4H, 
bs, NCH2COOMe), 3.79 (3H, s, COOCH3), 3.80 (6H, s, COOCH3) 
13
C N.M.R. [100MHz, CDCl3] δ 28.3 (CCH3)3, 37.6 (NCH2CH2), 50.4, (NCH2 
(ring),  51.1 (NCH2 x4 (ring), 52.2 (OCH3), 52.5 (OCH3), 54.6 (NCH2CH2), 55.2 
(NCH2COOMe x2), 55.7 (NCH2COOMe), 79.0 C(CH3)3), 156.8 (NCO), 173.8 
(COOMe), 174.1 (COOMe) 
MS (ESI) m/z 532 (M+H)
+
 
HRMS : calculated for C24H45N5O8 : 532.3341, found 532.3341
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6.12 Synthesis of 2a-(2-tert-Butoxycarbonylamino-ethyl)-decahydro-
4a,6a,8a-triaza-2a-azonia-cyclopenta[f,g]acenaphthylene bromide (117) 
 
N N
N N+
H
H
H
N
O
O
Br-
 
 
To a solution of 109 (1.3g, 6.7 mmol) in anhydrous acetonitrile (50 mL) was 
added a solution of 119 (1.5g, 6.7 mmol) in dry acetonitrile (25mL). The 
resulting solution was stirred under a N2 atmosphere at ambient temperature. The 
progress of the reaction was monitored by TLC (silica, CH2Cl2 eluent) and was 
complete after 14 days. Solvents were then removed in vacuo and the brown 
residue washed with diethyl ether (10x 20 mL). After further trituration with cold 
(0 °C) diethyl ether the product was obtained as an off white solid. (2.06g, 74%) 
m.p. 80°C decomp. 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.43 (9H, s, C(CH3)3), 22.49-2.53 (1H, m, 
NCH2), 2.66-2.73 (1H, m, NCH2), 2.74-3.20 (8H, m, NCH2, N
+
CH2), 3.27-3.32 
(2H, m, NCH2), 3.40-3.46 (1H, m, NCH2), 3.68 (1H, bs, CH), 3.70-3.88 (4H, m, 
NCH2), N
+
CH2CH2), 4.00-4.20 (3H, m, CH, N
+
CH2), NCH2), 4.50-4.62 (1H, m, 
NCH2) 
13
C N.M.R. [100MHz, CDCl3] δ 28.4, 35.6, 43.6, 47.8, 48.2, 49.2, 51.9, 56.7, 
57.6, 62.2, 72.0, 80.1, 84.1, 156.5  
MS (ESI) m/z 338.3 (M-Br)
+
 
HRMS : calculated for C17H32N5O2 (-Br
-
) : 338.2551, found 338.2550 
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6.13 Synthesis of Tert-butyl-2-bromoethylcarbamate(119)
102
  
 
O
O
N
H
Br
 
 
A solution of bromoethylamine hydrobromide (4.7g, 22.9 mmol) in saturated 
Na2CO3(aq) (40mL) was extracted with a solution of Boc anhydride (3.2g, 14.7 
mmol)  in diethyl ether (30mL), followed by two further extractions with diethyl 
ether (50mL x2). The ethereal extracts were dried over Na2SO4 and after removal 
of the dessicant by filtration, concentrated to ~40mL. This solution was stirred 
under an N2 atmosphere at ambient temperature for 6 hours. Solvent was 
removed in vacuo, CH2Cl2 (10mL) added and the product isolated by flash 
column chromatography (silica, eluent: CH2Cl2) as a white solid. Rf =0.3 Yield 
3.0g, 91% m.p. 33-35°C 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.45 (9H, s, (CH3)3), 3.46 (2H, t, 
3
J = 5.6Hz, 
CH2 ), 3.53 (2H, t, 
3
J = 5.6Hz, CH2 ), 5.00 (1H, bs, NH)  
13
C N.M.R. [100MHz, CDCl3] δ 28.3, 32.8, 42.3, 79.8, 155.6 
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6.14 Synthesis of 1,4,7-(tris-tert-butoxycarbonylmethyl)-1,4,7,10-tetraaza-
cyclododecane (127) 
N HN
N N
O
O
O
O
O
O
 
 
tert-Butyl bromo acetate (3.35g, 17.08 mmol) in CH2Cl2 (100 mL) was added 
slowly over 5 hours to a stirred mixture of cyclen 6 (1.02g, 5.69 mmol) and 
K2CO3 (0.79g, 5.69 mmol) in CH2Cl2 (300mL). The reaction mixture was 
subsequently stirred at ambient temperature for 3 days. The mixture was filtered 
and the solvent was removed in vacuo. The residue was purified by column 
chromatography (silica, eluent: CH2Cl2/ MeOH 93:7) (Rf =0.4) and after removal 
of solvents, the product was isolated as a white semi-solid. Yield 1.51g, 52% 
 
1
H N.M.R. [400MHz, (CD3)2CO] δ 1.38-1.43 (27H, m, (CH3)3), 2.62-2.75 (8H, 
m, CH2CH2), 2.80-2.88 (4H, m, CH2CH2), 2.92-3.02 (4H, m, CH2CH2), 3.33 
(4H, s, CH2CO), 3.41 (2H, s, CH2CO), 8.89 (1H, bs, NH) 
13
C N.M.R. [100MHz, (CD3)2CO] δ 27.8, 27.9, 45.5, 48.3, 49.7, 50.7, 51.9, 56.0, 
80.5, 80.6, 170.0, 170.6  
MS (ESI) m/z 515 (M+H)
+
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6.15 Synthesis of 1,4,7-(tris-tert-butoxycarbonylmethyl)-10-(4-nitro-benzyl)-
1,4,7,10-tetraaza-cyclododecane (132)
105
 
 
N N
N N
O
O
O
O
O
O
NO2
 
 
To a solution of 127 (1g, 1.9 mmol) and 4-nitrobenzyl bromide (0.42g, 1.9 
mmol) in acetonitrile (100mL) was added Na2CO3 (1.65g, 16mmol) and the 
mixture heated at 70 °C for 5 hours. After this time, TLC (silica, CH2Cl2 : 
MeOH, 95:5) showed complete consumption of starting material 127. The 
solvent was removed in vacuo and the brown residue was dissolved in 
dichloromethane (100mL), washed successively with water (2x100mL) and brine 
(50mL) and dried over MgSO4. Following removal of the dessicant, the solution 
was concentrated down to a small volume (~10ml) and purified by gravity 
column chromatography (silica, eluent: CH2Cl2/MeOH, 95:5). Relevant fractions 
were identified by TLC (silica CH2Cl2/MeOH, 95:5), Rf =0.3,  collected and 
concentrated to yield compound 132 as a yellow oil (1.2g, 95%) 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.47 (27H, s, OC(CH3)3, 2.0-3.2 (24H, m, NCH2, 
CH2COO
t
Bu, CH2PhNO2), 7.74 (2H, d, 
3
J = 8.8Hz, O2N-Ar-2,6-H), 8.19 (2H, d, 
3
J = 8.8Hz, O2N-Ar-3,5-H)  
13
C N.M.R. [100MHz, CDCl3] δ 27.8, 27.9, 53.4, 55.8, 56.0, 59.1, 82.4, 83.0, 
123.6, 131.0, 145.6, 147.2, 172.6, 173.7 
MS (ESI) m/z 672 (M+Na)
+
  
HRMS : calculated for C33H55N5Na O8 : 672.3943, found 672.3941 
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6.16 Synthesis of 1,4,7-(tris-tert-butoxycarbonylmethyl)-10-(4-nitro-
benzoyl)-1,4,7,10-tetraaza-cyclododecane (133) 
N N
N N
O
O
O
O
O
O
NO2
O
 
 
To 4-nitrobenzoic acid (0.07g, 0.4 mmol) was added thionyl chloride (10 mL) 
and the mixture stirred initially for 1 hour at room temperature, followed by 5 
hours heating under reflux conditions. When the evolution of acidic gas had 
finished the thionyl chloride was removed in vacuo and the residue triturated 
twice with toluene (2x10 mL). To the dark solid residue was added a solution of 
127 (0.2g, 0.4 mmol) in anhydrous dichloromethane (25 mL) and triethylamine 
(0.1 mL). The reaction mixture was stirred at room temperature for 8 hours under 
an argon atmosphere. After removal of solvent in vacuo the crude residue was 
taken into dichloromethane (100mL) and washed with water (2 x 50mL). The 
organic layer was separated, dried over MgSO4, concentrated to a volume of ~10 
mL and purified by gravity column chromatography (silica, eluent: 
CH2Cl2/MeOH, 97:3). Relevant fractions were identified by TLC (silica 
CH2Cl2/MeOH, 97:3), Rf =0.4, collected and concentrated to yield compound 
133 as a yellow oil (0.14g, 54%) 
 
1
H N.M.R. [400MHz, CD2Cl2] δ 1.31 (9H, s, (CH3)3), 1.35 (9H, s, (CH3)3), 1.38 
(9H, s, (CH3)3), 2.63 (8H, br t, NCH2 x 4), 2.78 (2H, t, 
3
J = 6.7Hz, NCH2),  2.89 
(2H, br t, NCH2), 2.92 (2H, s, CH2C(O)), 3.21 (4H, s, CH2C(O) x 2), 3.52 (2H, t, 
3
J = 6.7Hz, NCH2),  3.67 (2H, t, 
3
J = 5.0Hz, NCH2), 7.51 (2H, d, 
3
J = 8.9Hz, 
O2N-Ar-2,6-H), 8.15 (2H, d, 
3
J = 8.9Hz, O2N-Ar-3,5-H)  
13
C N.M.R. [100MHz, CD2Cl2] δ 28.2, 28.3, 45.1, 49.3, 52.4, 52.8, 52.9, 53.3, 
53.5, 53.5, 54.9, 55.5, 58.6, 81.0, 124.0, 128.0, 144.5, 148.2, 169.7, 170.8, 171.0 
MS (ESI) m/z 664 (M+H)
+
, 686 (M+Na)
+ 
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6.17 Synthesis of 1,4,7-(tris-tert-butoxycarbonylmethyl)-10-(4-
aminobenzoyl)-1,4,7,10-tetraaza-cyclododecane (134)  
 
N N
N N
O
O
O
O
O
O
NH2
O
 
 
To a solution of 133 (0.5g, 0.75 mmol) in ethanol (25mL) was added 5% wt Pd/C 
(0.1g) and the mixture stirred at room temperature under a H2 atmosphere. After 
2 hours, TLC (silica CH2Cl2/MeOH, 9:1) showed complete consumption of the 
starting material and the catalyst removed by filtration. After the solvent was 
concentrated in vacuo  to a volume of  ~5 mL, the crude mixture was separated 
by gravity column chromatography (silica, eluent: CH2Cl2/MeOH, initially 97:3 
rising to 93:7). Relevant fractions were identified by TLC (silica CH2Cl2/MeOH, 
97:3), Rf =0.3, collected and concentrated to yield compound 134 as a yellow 
semi-solid (0.34g, 71%). 
 
1
H N.M.R. [400MHz, CD2Cl2] δ 1.36 (27H, s, (CH3)3), 2.64 (8H, m, NCH2 x 4), 
2.87 (4H, br s NCH2 x2),  3.22 (4H, br s, NCH2 x2), 3.56 (4H, br s, CH2C(O)x2), 
3.91 (2H, br s, CH2C(O)), 6.52 (2H, d, 
3
J = 8.4Hz, O2N-Ar-2,6-H), 7.07 (2H, d, 
3
J = 8.4Hz, O2N-Ar-3,5-H) 
 
13
C N.M.R. [100MHz, CD2Cl2] δ 23.9, 24.0, 52.0 (br), 52.7 (br), 55.2, 57.8 (br), 
76.6, 109.9, 122.9, 124.3, 144.0, 166.8, 167.9 
 
 
 213 
6.18 Synthesis of 1-(4'-Bromo-2-acetophenone)-4,7,10-tris(tert-
butoxycarboxymethyl)-1,4,7,10-tetraazacyclododecane (135) 
 
 
N N
N N
O
Br
O
O
O
O
O
O
 
 
To a solution of 127 (1g, 1.9 mmol) and α-bromoacetophenone (0.59g, 2.1 
mmol) in acetonitrile (100mL) was added Na2CO3 (1.65g, 16mmol) and the 
mixture heated at 70 °C for 16 hours. After this time, TLC (silica, CH2Cl2 : 
MeOH, 95:5) showed complete consumption of starting material 127. The 
mixture was cooled to room temperature, the solids were filtered off and the 
solvent was removed in vacuo leaving a brown residue. This was dissolved in 
dichloromethane (100mL), washed successively with water (2x100mL) and brine 
(50mL) and dried over MgSO4. Following removal of the dessicant, the solution 
was concentrated down to a small volume (~10ml) and purified by gravity 
column chromatography (silica, eluent: CH2Cl2/MeOH, 95:5). Relevant fractions 
were identified by TLC (silica CH2Cl2/MeOH, 95:5), Rf =0.2, collected and 
concentrated to yield the title compound  as a yellow semi-solid (1.34g, 97%) 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.43 (27H, s, OC(CH3)3, 1.9-3.5 (22H, m, NCH2, 
CH2COO
t
Bu, CH2PhNO2), 3.9-4.1 (2H, m, NCH2C(O)), 7.55 (2H, d, 
3
J = 8.6Hz, 
Br-Ar-3,5-H), 7.75 (2H, d, 
3
J = 8.6Hz, Br-Ar-2,6-H)  
13
C N.M.R. [100MHz, CDCl3] δ 27.7, 27.8, 48.7 (br), 52.7 (br), 55.5, 55.8, 60.2, 
81.9, 82.0, 128.7, 129.2, 131.9, 134.3, 172.7, 173.0, 198.9  
 
MS (ESI) m/z 733 
79
Br(M+Na)
+
, 735 
81
Br(M+Na)
+ 
HRMS : calculated for C34H55
79
BrN4O7 : 733.3146, found 733.3150 
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6.19 Synthesis of (1,5,8,12-tetraaza-bicyclo[10.2.2]hexadec-5-yl)-acetic acid 
tert-butyl ester (137)
115
 
 
N
N HN
N
O O
 
 
To a stirred solution of compound 157 (1.02g, 2.4mmol) in ethanol (30ml) was 
added sodium borohydride (2.3g, 60mmol), dropwise over 30 minutes. The 
resulting solution was heated under reflux conditions for 1 hour, water (15ml) 
added and the solvents removed in vacuo. The residue was taken up in water 
(40ml), the solution made strongly basic (pH~14) with potassium hydroxide 
pellets and extracted with dichloromethane (40ml). The organic layer was 
separated, dried (MgSO4) and concentrated in vacuo to yield compound 137 as a 
brown viscous oil (0.75g, 91%). 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.35 (9H, s, C(CH3)3), 1.60-1.75 (4H, m, 2xCH2-
β-N), 2.08-2.14 (2H, m, CH2-α-N), 2.49-2.54 (6H, m, 3xCH2-α-N), 2.63-2.66 
(2H, m, CH2-α-N), 2.75-2.85 (6H, m, 3x CH2-α-N), 2.89-2.92 (2H, t, CH2-α-N), 
3.03-3.10 (2H, dt, CH2-α-N), 3.24 (2H, s, CH2CO) 
13
C N.M.R. [100MHz, CDCl3] δ 23.30 (CH2-β-N), 25.78 (CH2-β-N), 28.15 
(C(CH3)3), 47.01 (CH2-α-N), 48.11 (CH2-α-N), 50.59 (CH2-α-N), 50.90 (CH2-α-
N), 51.95 (CH2-α-N), 54.71 (CH2-α-N), 55.63 (CH2-α-N), 56.70 (CH2-α-N), 
77.26 (NCH2CO), 80.83 (C(CH3)3), 170.52 (C(O)O
t
Bu) 
MS (ESI) m/z 342 (M+H)
+
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6.20 Synthesis of 4-Carbo-t-butoxymethyl-1,4,8,11-tetraazabicyclo[6.6.2]-
hexadecane. (138)
118
    
 
N
NH N
N
O O
 
 
 
To a solution of 159 (1.8g, 42mmol) in ethanol (120mL) was added palladium on 
carbon (10 wt%, 100mg) and argon bubbled through the mixture for fifteen 
minutes. The reaction was then stirred at room temperature under a hydrogen 
atmosphere (balloon) for five days. When TLC monitoring showed no further 
change, the reaction mixture was filtered through celite and concentrated in 
vacuo. The brown residue was dissolved in a small volume of CH2Cl2 (10mL) 
and the crude product isolated by flash  column chromatography (silica, eluent: 
CH2Cl2/MeOH, 88:12) as a yellow oil. After trituration with diethyl ether and 
hexane, the product was isolated as a pale yellow oil (1.1g, 77%). 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.15-1.21 (2H, m, CH2-β-N), 1.39 (9H, s, 
(CH3)3),  1.60-1.72 (2H, m, CH2-β-N), 1.82-1.97 (1H, m), 2.30-2.50 (1H, m), 
2.52-3.08 (16H, m), 3.15-3.29 (2H, m), 3.49-3.50 (1H, m), 3.51-3.60 (1H, m). 
20.8 (CH2-β-N), 26.6 (CH2-β-N), 28.0 (CH3)3, [44.1, 47.1, 50.6, 50.7, 52.1, 52.7, 
53.3, 54.1, 54.7, 57.4, 58.3] (CH2-α-N), 81.06 (C(CH3)3), 170.6 (C(O)O
t
Bu) 
MS (ESI) m/z 341 (M+H)
+
 
 
 
 
 
 
 
 
 
 216 
  
6.21 Synthesis of Decahydro-3a,5a,8a,10a-tetraazapyren-3a-yl)-acetic acid 
tert-butyl ester (157)
103
 
 
N
N N
N
H
H
+
-
Br-
O O
 
 
To a stirred solution of compound 112 (0.6g, 2.7mmol) in anhydrous acetonitrile 
(30ml) was added tert-butylbromoacetate (2.1g, 11mmol) and the mixture was 
stirred for 8 hours. The solvent was then removed to yield an off-white solid, 
which after washing with diethyl ether (4x75ml), afforded compound 157 as a 
white semi-solid (1.06g, 94%). 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.51 (9H, s, (CH3)3), 1.81-5.14 (24H, m, 
CH2C(O)), CH2-β-N, CH2-α-N, NCHN) 
13
C N.M.R. [100MHz, CDCl3] δ 19.4 (CH2-β-N), 27.8 (CH2-β-N), 28.1 (CH3)3, 
42.9 (CH2-α-N), 46.8 (CH2-α-N), 50.1 (CH2-α-N), 52.2 (CH2-α-N), 54.1 (CH2-α-
N), 54.9 (CH2-α-N), 56.5 (CH2-α-N), 60.1 (CH2-α-N), 70.7 (NCH2CO), 80.9 
(NCN), 86.1 (C(CH3)3), 163.3 (C(O)O
t
Bu) 
MS (MALDI) m/z 337 (M-Br)
+
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6.22 Synthesis of 3a-benzyl-8a-tert-butylcarboxymethyl-decahydro-
3a,5a,8a,10a-tetraazapyrenium dibromide (158) 
 
N
N N
N
H
H
2Br
O O
 
 
To a stirred solution of 157 (2g, 4.8mmol) in anhydrous acetonitrile (50mL) was 
added benzyl bromide (1g, 5.8 mmol) and the solution stirred at room 
temperature under an argon atmosphere for 6 days. The solvent was reduced in 
vacuo to ~30mL and crude product was precipitated by addition of diethyl ether 
(100mL). The off white solid was collected by filtration, washed with diethyl 
ether (5x50mL) and dried under vacuum to yield 157 as a white semi-solid (2.5g, 
89%). 
 
1
H N.M.R. [400MHz, CD2Cl2] δ 1.51 (9H, s, (CH3)3), 1.91-5.86 (26H, m, 
CH2C(O), 2xCH2-β-N, 8xCH2-α-N, 2xNCHN, CH2Ph, CH2C(O)O
t
Bu ) 7.46-7.61 
(5H, m, CH2-Ar-2,3,4,5,6-H) 
13
C N.M.R. [100MHz, CD2Cl2] δ 22.7, 22.8, 31.6, 49.1, 50.5, 50.6, 50.8, 53.7, 
53.8, 61.8, 63.1, 64.4, 66.1, 78.8, 79.2, 90.1, 129.5, 133.2, 134.8, 137.3, 166.9 
MS (ESI) m/z 428 (M-Br
-
)
+
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6.23 Synthesis of (11-Benzyl-1,4,8,11-tetraaza-bicyclo[6.6.2]hexadec-4-yl)-
acetic acid tert-butyl ester (159)  
 
N
N N
N
O O
 
 
To a solution of 158 (1.10g, 1.9 mmol) in ethanol (60mL) was added NaBH4 
(0.28g, 7.5 mmol) and the mixture stirred at room temperature under argon for 7 
days. Water (20mL) was added and the solvent removed in vacuo. The residue 
was dissolved in NaOH(aq) (50mL, 0.05M) and extracted into dichloromethane 
(50mL). The solvent volume was reduced to ~10mL) and the product 159 
isolated by gravity column chromatography (silica, eluent: CH2Cl2/MeOH, 96:4), 
Rf =0.4, as an off white sticky semi-solid (0.5g, 62%). 
 
 
1
H N.M.R. [400MHz, CD2Cl2] δ 1.31 (9H, s, (CH3)3), 1.60-3.84 (26H, m, 
CH2C(O), CH2-β-N, CH2-α-N, NCHN, CH2Ph, CH2C(O)O
t
Bu ) 7.19-7.30 (5H, 
m, CH2-Ar-2,3,4,5,6-H) 
13
C N.M.R. [100MHz, CD2Cl2] δ 23.5 (CH2-β-N), 24.9 (CH2-β-N), 27.9 (CH3)3, 
46.1 (CH2-α-N), 48.8 (CH2-α-N), 49.8 (CH2-α-N), 50.9 (CH2-α-N), 51.8 (CH2-α-
N), 53.9 (CH2-α-N), 55.9 (CH2-α-N), 56.2 (CH2-α-N), 56.3 (NCH2CO), 56.4 
(C(CH3)3), 58.8 (NCN), 60.3  (NCN), 82.0 (CH2Ph), 127.5 (CH2-Ar-4-C), 128.4 
(CH2-Ar-3,5-C), 129.2 (CH2-Ar-2,6-C), 137.0 (CH2-Ar-1-C), 170.2 (C(O)O
t
Bu) 
MS (ESI) m/z 431 (M)
+ 
HRMS : calculated for C25H43N4O2 : 431.3383, found 431.3381 
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6.24 Synthesis of 5,10,15,20-Tetraphenyl-porphyrin (162)
124
 
 
HNN
NNH
 
 
Benzaldehyde (11.1g, 0.1mol) was dissolved in propionic acid (400ml) and the 
solution heated under reflux conditions. Pyrrole (7g, 0.1mol) was added 
dropwise and the dark mixture heated for a further 30 minutes. Upon cooling, the 
black tarry mixture was filtered to yield a purple solid which, after washing with 
methanol (100ml) and hot water (100ml) afforded compound 162 as purple 
crystals (3.4g, 22%). m.p. >200 °C  
 
1
H N.M.R. [400MHz, CDCl3] δ -2.72 (2H, br s, NH), 7.75-7.80 (12H, m, 
5,10,15,20-Ar-3,4,5-H), 8.24-8.26 (8H, m, 5,10,15,20-Ar-2,6-H), 8.89 (8H, s, β-
H) 
13
C N.M.R. [100MHz, CDCl3] δ 120.2, 126.7, 127.7, 131.3, 134.6, 142.2 
UV-vis (CH2Cl2) λmax/nm (log ε) 419 (5.4), 514 (4.3), 549 (4.1), 591 (4.0), 646 
(4.0) 
MS (ESI) m/z 615 (M)
+
 
 
 220 
6.25 Synthesis of 5,10,15,20-Tetraphenyl-porphyrinatocopper(II) (183) 
 
NN
NN
Cu
 
 
To a solution of compound 162 (2g, 3.3mmol) in chloroform (500ml) heated 
under reflux conditions, was added a suspension of copper (II) acetate (6.5g, 33 
mmol) in methanol (100ml). The mixture was heated for 10 hours, cooled and 
the purple precipitate filtered off. After washing with water (100ml), compound 
183 was isolated as a purple solid (1.98g, 90%). m.p. >200°C. 
 
UV-vis (CH2Cl2, nm) λmax/nm (log ε) 418 (5.4), 539 (4.2) 
MS (ESI) m/z 676 (M)
+
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6.26 Synthesis of 5,10,15,20-Tetraphenyl-porphyrin-2-carbaldehyde (191)
181
  
 
NH
HNN
N
O
 
 
Phosphorus oxychloride (13.5ml, 0.145mol) was added to dry 
dimethylformamide (16.8ml, 0.217mol) under a dry argon atmosphere, forming a 
viscous golden mixture. A cooled (0 °C) solution of compound 183 (1.5g, 
2.2mmol) in dry 1,2-dichloroethane (150ml) was then added dropwise, and upon 
addition, the mixture allowed to rise to room temperature, and subsequently 
heated under reflux conditions for 7 hours. After cooling, sulphuric acid (18M, 
28ml, 0.5mol) was added and the mixture stirred for 6 minutes. The resulting 
green two phase mixture was washed cautiously with sodium hydroxide (0.72M, 
2dm
3
), until the colour had turned red. Chloroform (1.5 dm
3
) was added, the 
organic layer separated, dried (MgSO4) and concentrated in vacuo to yield a 
crude purple solid. This was adsorbed onto silica and purified by gravity column 
chromatography (silica, eluent: CH2Cl2). Relevant fractions were identified by 
TLC (silica CH2Cl2), collected and concentrated to yield compound 191 as a 
purple solid (1.05g, 74%). Rf=0.60 (silica, CH2Cl2); m.p. >200 °C  
 
1
H N.M.R. [400MHz, CDCl3] δ -2.55 (2H, br s, NH), 7.71-7.84 (12H, m, 
5,10,15,20-Ar-2,4,6-H), 8.17-8.26 (8H, m, 5,10,15,20-Ar-2,6-H), 8.77 (1H, d, 
3
J=4.8Hz, β-H), 8.78 (1H, AB, 3J=4.8Hz, β-H), 8.84-8.94 (4H, m, β-H), 9.23 
(1H, s, β-H), 9.41 (1H, s, CHO) 
13
C N.M.R. [100MHz, CDCl3] δ 120.0, 120.3, 120.6, 122.6, 126.8, 126.9, 127.4, 
127.9, 128.1, 129.0, 134.54, 134.57, 134.6, 141.5, 141.7, 142.4, 189.3 
UV-vis (THF, nm) λmax/nm (log ε) 431 (5.5), 525 (4.2), 567 (3.8), 604 (3.7), 663 
(4.0) 
MS (EI) m/z 642 (M)
+
 
HRMS : calculated for C45H30N4O : 642.2414, found 642.2411 
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6.27 Attempted synthesis of 1-(5,10,15,20-tetraphenyl-porphyrin-2-
ylmethyl)-4,7,10-tris(tert-butoxycarboxymethyl)-1,4,7,10-
tetraazacyclododecane (212) 
 
HN
NH N
N
N
N
N
N
O
O
O
O
O
O
 
 
A mixture of compounds 191 (0.2g, 0.3mmol) and 127 (0.30g, 0.6mmol) were 
dissolved in  dry toluene (50ml), acetic acid (2 drops) added and the reaction 
mixture was heated under reflux conditions. After heating for 4 hours, no change 
to the starting materials could be seen by TLC analysis (silica, CH2Cl2), so a 
Dean Stark head was fitted to the flask and activated molecular sieves (4Å) 
added to the reaction mixture. The reaction was heated for a further 3 hours and 
monitored by TLC but no reaction was evident and the reaction was abandoned. 
The reaction was repeated using anhydrous THF solvent but this also was 
ineffective.  
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6.28 Attempted synthesis of 2-((5,10,15,20-tetraphenyl-porphyrin-2-
ylmethyl)amino)ethanol (213) 
 
HNN
NH N
HN
OH
 
Compounds 191 (0.2g, 0.3mmol) and 2-aminoethanol (36mg, 0.6mmol) were 
dissolved in  anhydrous THF (50ml), acetic acid (2 drops) and activated 
molecular sieves (4Å) were added and the reaction mixture heated under reflux 
conditions. The reaction was monitored by TLC (silica, CH2Cl2), but after 
heating for 3 hours, no change to the starting materials could be detected. A 
solution of NaBH3CN (0.11g, 1.8mmol) in methanol (50mL) was added and the 
mixture heated for a further 2 hours. However, no reaction progress could be 
seen by TLC. An aliquot of the solution was removed and the porphyrin fraction 
isolated by preparative TLC (silica, eluent: CH2Cl2), and this was identified as 
the starting porphyrin 191. 
The reaction was repeated using the same amounts of reagents but with a mixed 
solvent system of toluene / methanol (1:1, 80mL) but no reaction progress could 
be detected.  
 
 
 224 
6.29 Attempted synthesis of 6-((5,10,15,20-tetraphenyl-porphyrin-2-
ylmethyl)amino) hexanoic acid (214) 
 
HNN
NH N
HN
OH
O
 
 
A mixture of compounds 191 (0.2g, 0.3mmol) and 6-aminohexanoic acid (79mg, 
0.6mmol) were dissolved in anhydrous THF (100mL), three drops of CH3COOH 
and activated 4Å molecular sieves added, and the solution was heated under an 
inert atmosphere (N2). After heating for 5 hours, no further change could be seen 
by TLC analysis (silica, eluent CH2Cl2). The reaction mixture was allowed to 
cool to ambient temperature while under N2, followed by addition of a solution 
of NaBH3CN (0.11g, 1.8mmol) in methanol (50mL). After stirring for 2 hours, 
no further change was observed by TLC (silica, eluent CH2Cl2). The solvent was 
removed in vacuo and the residue partitioned between water and CH2Cl2. The 
organic layer was separated, washed with brine and dried over MgSO4. An 
attempt to isolate the more polar porphyrin fraction by column chromatography 
(silica, eluent CH2Cl2 : MeOH, 97:3) failed after the compound appeared to 
degrade as it moved down the column.  
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6.30 Attempted synthesis of 6-((5,10,15,20-tetraphenyl-porphyrin-2-
ylmethyl)amino) hexylamine (215) 
 
HNN
NH N
HN
NH2
 
 
A mixture of compounds 191 (0.2g, 0.3mmol) and 1,6-diaminohexane acid 
(174mg, 1.5mmol) were dissolved in anhydrous THF (100mL), three drops of 
CH3COOH and activated 4Å molecular sieves added, and the solution was 
heated under an inert atmosphere (N2). After 5 hours, TLC analysis (silica, eluent 
CH2Cl2) showed consumption of the starting materials and production of a polar 
porphyrinic spot. The reaction mixture was allowed to cool to ambient 
temperature while still under N2 and then a solution of NaBH3CN (0.11g, 
1.8mmol) in methanol (50mL) was added.  
After stirring for ten minutes, TLC (silica, eluent CH2Cl2) showed a complex 
mixture of seven porphyrin spots. Column chromatography (silica, eluent CH2Cl2 
: MeOH, 95:5)was used to try to isolate the fractions, but degradation appeared 
to occur, with most of the material sticking to the top of the column, and it could 
not be isolated. The reaction was repeated using a toluene / methanol (1:1) 
(100mL) mixed solvent system and an aliquot of the reaction mixture was 
removed prior to addition of the reductant solution, and a solution of NaBH3CN 
(0.11g, 1.8mmol) in methanol (50mL) was added to the remainder. The aliquot 
which had not been reduced was subjected to preparative TLC (silica, eluent 
CH2Cl2 : MeOH, 95:5) but the compounds appeared to degrade very quickly and 
no pure fraction could be isolated. The remaining reaction mixture was 
concentrated to a small volume (~5mL) and the residue partitioned between 
water and CH2Cl2. The organic layer was separated, washed with brine and dried 
over MgSO4. Preparative TLC (silica, eluent CH2Cl2 : MeOH, 95:5) was used to 
separate the porphyrin fractions and although degradation was seen to occur, a 
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small amount (~1mg) was obtained. Although 
1
H NMR analysis showed this to 
be an impure fraction, as described in chapter 3, partial assignment of the 
1
H 
NMR spectrum could be achieved : 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.78 (2H, br s, NH), 1.83-1.87 (5H, m), 3.72-
3.77 (4H,m), 4.00 (1H, br s), 7.58-7.80 (12H, m, 5,10,15,20-Ar-3,4,5-H), 8.02 
(2H, br d, 5,10-Ar-2-H), 8.10-8.22 (6H, m, 15,20-Ar-2,6-H and 5,10-Ar-6-H), 
8.55 (1H, d, βH), 8.72-8.91 (6H, m, βH) 
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6.31 Synthesis of 3-(4-Nitro-phenyl)-2-[(5,10,15,20-tetraphenyl-porphyrin-2-
ylmethyl)-amino]-propionic acid (216)   
O2N
OH
NH
HN
N
N
HN
O
 
To a solution of compound 191 (0.75g, 1.2mmol) and (S)-4-nitrophenylalanine 
(0.2g, 0.9mmol) in THF (100mL) was added a solution of NaBH3CN (0.11g, 
1.8mmol) in methanol (50mL) and the mixture heated under reflux conditions. 
The reaction was monitored by TLC (silica, CH2Cl2 : MeOH, 95:5) until after 
24hrs no further change was discernable. Solvent was removed in vacuo and the 
residue partitioned between water and CH2Cl2. The organic layer was separated, 
washed with brine and dried over MgSO4.  After removal of solvent, the product 
was isolated using column chromatography (silica, eluent CH2Cl2 : MeOH, 97:3) 
to yield 216 as a purple solid (0.3g, 41%). m.p. >200°C 
1
H N.M.R. [400MHz, CDCl3] δ -2.80 (2H, br s, NH), 2.95 (1H, ABX, dd,  
2
JA-B = 
13.4Hz, 
3
JA-X = 7.7Hz, O2NPhCH2), 3.06 (1H, ABX, dd,  
2
JB-A = 13.4Hz, 
3
JB-X = 
5.5Hz, O2NPhCH2), 3.44 (1H, ABX, dd, 
3
JX-A = 7.7Hz, 
3
JX-B=5.5Hz), 3.80 (1H, 
AB, d, 
2
JA-B = 15.6Hz, NHCH2), 4.1 (1H, AB, d, 
2
JB-A =15.6Hz, NHCH2), 7.39 
(2H, d, 
3
J = 8.6Hz, O2N-Ar-2,6-H), 7.60-7.86 (12H, m, 5,10,15,20-Ar-3,4,5-H), 
7.98 (2H, d, 
3
J = 8.6Hz, O2N-Ar-3,5-H), 8.02-8.06 and 8.19-8.22 (8H, m, 
10,15,20-Ar-2,6-H), 8.55 (1H, d, 
3J = 4.7Hz, βH), 8.69 (1H, d, 3J = 4.9Hz, βH), 
8.72 (1H, d, 
3J = 4.7Hz, βH), 8.77 (1H, d, 3J = 4.9Hz, βH), 8.83 and 8.85 (2H, 
AB, 
3J = 4.6Hz, βH), 8.91 (1H, s, βH)   
13
C N.M.R. [100MHz, CDCl3] δ 38.9, 47.3, 61.8, 118.9, 119.5, 120.0, 120.4, 
122.8, 125.1, 126.6, 126.7, 126.88, 126.91, 127.7, 128.0, 128.1, 128.7, 130.4, 
133.1, 133.4, 134.3, 134.4, 142.2, 142.3, 142.5, 142.9, 146.6, 146.8, 174.2  
UV-vis (THF) λmax/nm (log ε) 418 (5.8), 514 (4.8), 547 (4.2), 590 (4.2), 645 
(4.0) 
MS (ESI) m/z 837 (M+H)
+
 
HRMS : calculated for C54H41N6O4 : 837.3184, found 837.3178 
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6.32  Synthesis of 3-(4-Nitro-phenyl)-2-[(5,10,15,20-tetraphenyl-porphyrin-2-
ylmethyl)-amino]-propionic acid methyl ester (217)  
O2N
O
NH
HN
N
N
HN
O
 
 
To a stirred solution of compounds 191 (0.16g, 0.25mmol) and 218 (0.056g, 
0.25mmol) in a mixture of toluene (100mL) and methanol (30mL) was added 
acetic acid (0.25mL). The dark coloured solution was heated under reflux 
conditions and after 1 hour sodium cyanoborohydride (0.2g, 3mmol) was added 
heating continued for 48 hours. The reaction was monitored by TLC (silica, 
eluent CH2Cl2) and after complete consumption of starting materials the solvent 
was removed in vacuo. The dark solid residue was partitioned between 
dichloromethane and water, the organic layer separated and dried over MgSO4. 
After removal of solvents in vacuo, the product 217 was isolated by column 
chromatography (silica, eluent CH2Cl2) as a purple solid (0.13g, 61%). m.p. 
>200°C 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.79 (2H, br s, NH), 3.01 (2H, m, NHCH2), 3.48 
(1H, ABX, dd, 
3
JX-A = 7.0Hz, 
3
JX-B=6.7Hz), 3.56 (3H, s, COOCH3), 3.84 (1H, 
ABX, br d,  
2
JA-B = 16.2Hz), 3.98 (1H, ABX, br d,  
2
JB-A = 16.2Hz), 7.22 (2H, d, 
3
J = 8.7Hz, O2N-Ar-3,5-H), 7.75-7.78 (12H, m, 5,10,15,20-Ar-3,4,5-H), 7.99 
(4H, m, 
3
J = 8.7Hz, O2N-Ar-2,6-H, 5-Ar-2,6-H), 8.18-8.20 (6H, m, 10,15,20-Ar-
2,6-H), 8.57 (1H, d, βH), 8.76-8.84 (6H, m, βH)  
13
C N.M.R. [100MHz, CDCl3] δ 39.3, 47.2, 51.8, 61.8, 119.1, 119.2, 120.3, 
120.6, 123.4, 126.6, 126.7, 126.9, 127.0, 127.7, 127.8, 128.3, 130.1, 133.2, 
133.4, 134.5, 134.6, 141.9, 142.1, 142.2, 142.6, 145.2, 146.8, 174.3 
UV-vis (CH2Cl2, nm) λmax  420, 517, 549, 583, 646 
MS (ESI) m/z 851 (M+H)
+
 
HRMS : calculated for C55H43N6O4 : 851.3340, found 851.3329 
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6.33 Synthesis of (S)-methyl-2-amino-3-(4-nitrophenyl)propanoate
192
 (218)  
 
NO2
NH2
O
O
  
Dry HCl was bubbled through a suspension of (S)-4-nitrophenylalanine (1g, 
4.4mmol) in anhydrous methanol (30mL) at 0 °C. After dissolution (approx 
20mins) the flow of HCl was stoppedand the clear yellow solution stirred at 
room temperature under N2 for two hours. The solution was cooled to 0 °C for 
several hours, but no crystallisation occurred. The crude mixture  was separated 
by column chromatography (eluent CH2Cl2 : MeOH, 9:1), relevant fractions 
combined and solvent removed in vacuo to yield 218 as an orange solid (0.7g, 
71%). m.p. 210-214°C 
 
1
H N.M.R. [400MHz, CDCl3] δ 3.14 (1H, ABX, dd,
2
JA-B=14.0Hz, 
3
JA-X = 7.1Hz, 
O2NPhCH2), 3.23 (1H, ABX, dd,
2
JB-A = 14.0Hz, 
3
JB-X=6.5Hz, O2NPhCH2), 3.69 
(3H, s, OCH3),  4.10 (1H, ABX, dd, 
3
JX-A = 7.1Hz, 
3
JX-B=6.5Hz),  7.40 (2H, d, 
3
J 
= 8.7Hz, O2N-Ar-3,5-H), 8.13 (2H, d, 
3
J = 8.7Hz, O2N-Ar-2,6-H) 
13
C N.M.R. [100MHz, CDCl3] δ 39.9, 52.1, 54.7, 123.5, 130.0, 144.6, 146.9, 
174.1 
MS (ESI) m/z 225 (M+H)
+
 
HRMS : calculated for C10H13N2O4 : 225.0870, found 225.0867 
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6.34 Synthesis of Phenyl-(5,10,15,20-tetraphenyl-porphyrin-2-ylmethyl)-
amine (219) 
NH
HNN
N
NH
 
 
A mixture of compound 191 (0.2g, 0.3mmol), aniline (0.03g, 0.3mmol) and 
acetic acid (2 drops) in dry toluene (50ml) was heated under reflux conditions, 
using a Dean Stark head to remove water from the reaction. The reaction was 
monitored using TLC (silica, CH2Cl2) until after 24 hours no further reaction 
change was observed. After cooling, sodium cyanoborohydride (0.02g, 
0.32mmol) and methanol (10ml) were added and the mixture stirred for 2 hours. 
Water (100ml) was added, the organic layer separated, washed with brine 
(100ml) and dried (MgSO4). After removal of solvent in vacuo, the purple solid 
residue was adsorbed onto silica and separated using gravity column 
chromatography (silica, eluent: CH2Cl2). Relevant fractions were identified by 
TLC (silica CH2Cl2), collected and concentrated to yield compound 219 as a 
purple solid (0.17g, 77%). Rf=0.28 (silica, CH2Cl2); m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.84 (2H, br s, NH), 4.15 (1H, br s, PhNH),  
4.43 (2H, s, CH2NH), 6.46 (2H, d, 
3
J=7.8Hz, HN-Ar-2,6-H), 6.63 (1H, t, 
3
J=7.8Hz, HN-Ar-4-H), 7.05 (2H, t, 
3
J=7.8Hz, HN-Ar-3,5-H), 7.57-7.72 (12H, 
m, 5,10,15,20-Ar-3,4,5-H), 8.03-8.07 and 8.11-8.16 (8H, m, 5,10,15,20-Ar-2,6-
H), 8.57 (1H, d, 
3J=4.8Hz, β-H),  8.68-8.79 (5H, m, β-H). 
13
C N.M.R. [100MHz, CDCl3] δ 44.2, 113.3, 117.6, 119.3, 119.4, 120.3, 120.6, 
126.6, 126.7, 127.3, 127.6, 127.7, 128.5, 129.0, 133.2, 134.5, 134.6, 134.7, 
141.9, 142.0, 142.2, 142.3, 148.1 
UV-vis (CH2Cl2, nm) λmax/nm (log ε) 419 (5.6), 516 (4.3), 549 (3.9), 590 (3.8), 
646 (3.5) 
MS (ESI) m/z 720 (M+H)
+
 
HRMS : calculated for C51H38N5 : 720.3122, found 720.3109 
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6.35 Synthesis of 4-[(5,10,15,20-Tetraphenyl-porphyrin-2-ylmethyl)-amino]-
benzoic acid ethyl ester (220) 
NH
HN
N
N
HN
O
O
 
 
A mixture of compound 191 (0.13g, 0.2mmol), ethyl-p-amino benzoate (0.033g, 
0.2mmol) and acetic acid (2 drops) in toluene (50ml) was heated under reflux 
conditions, using a Dean Stark head to remove water from the reaction. The 
reaction was monitored using TLC (silica, CH2Cl2/MeOH, 249:1) until after 30 
hours no further reaction change was observed. After cooling, sodium 
cyanoborohydride (0.02g, 0.32mmol) and methanol (10ml) were added and the 
mixture stirred for 2 hours. Water (100ml) was added, the organic layer 
separated, washed with brine (100ml) and dried (MgSO4). After removal of 
solvent in vacuo, the purple solid residue was adsorbed onto silica and separated 
using gravity column chromatography (silica, eluent: CH2Cl2/MeOH, 249:1). 
Relevant fractions were identified by TLC (silica CH2Cl2/MeOH, 249:1), 
collected and concentrated to yield compound 220 as a purple solid (0.105g, 
66%). Rf=0.32 (silica, CH2Cl2/MeOH, 249:1); m.p. >200 °C. 
1
H N.M.R. [400MHz, CDCl3] δ -2.84 (2H, br s, NH), 1.37 (3H, t, 
3
J=7.2Hz, 
CH3), 4.33 (2H, q, 
3
J=7.2Hz, CH2CH3), 4.51 (2H, br d, CH2NH), 4.58 (1H, br t, 
PhNH), 6.46 (2H, d, 
3
J=8.8Hz, HN-Ar-2,6-H), 7.65-7.78 (12H, m, 5,10,15,20-
Ar-3,4,5-H), 7.83 (2H, d, 
3
J=8.8Hz, Ar-3,5-H), 8.10-8.13 and 8.20-8.23 (8H, m, 
5,10,15,20-Ar-2,6-H), 8.66 (1H, d, 
3
J=4.8Hz, β-H),  8.74 (1H, s, β-H), 8.78-8.87 
(5H, m, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 14.6, 43.6, 60.3, 111.9, 118.9, 119.3, 119.5, 
120.3, 120.7, 126.6, 126.7, 126.8, 127.2, 127.7, 127.8, 128.6, 131.3, 133.2, 
134.5, 134.6, 141.8, 141.9, 142.1, 142.2, 151.7, 166.9 
UV-vis (CH2Cl2, nm) λmax/nm (log ε) 420 (5.4), 516 (4.7), 550 (4.2), 590 (3.9), 
646 (4.1) 
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MS (ESI) m/z 792 (M+H)
+
 
HRMS : calculated for C54H42N5O2 : 792.3333, found 792.3321 
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6.36 Synthesis of (1,4,7-tris-tert-butoxycarbonylmethyl-10-[4-[(5,10,15,20-
tetraphenyl-porphyrin-2-ylmethyl)-amino]-benzoyl]-1,4,7,10tetraaza-
cyclododec-1-yl)-acetic acid tert-butyl ester (221) 
NH
HN
N
N
N
N N
N
O
O
O
O
O
O
HN
O
 
To a heated solution of compounds 191 (0.20g, 0.31 mmol) and 134 (0.17g, 0.27 
mmol) in tetrahydrofuran (30mL) was added acetic acid (0.1mL) followed by a 
solution of NaBH3CN (0.1g, 1.5 mmol) in methanol (10mL). The mixture was 
heated under reflux conditions and monitored by TLC (silica CH2Cl2/MeOH, 
9:1) until all the starting material 134 had been consumed (3 days). The solvent 
was removed in vacuo and dichloromethane (100mL) added to the dark solid 
residue. After washing with water (100mL) the organic layer was dried over 
MgSO4 and the volume reduced to ~10mL.  The crude mixture was separated by 
column chromatography (silica, eluent: CH2Cl2/MeOH, initially 97:3 rising to 
9:1). Relevant fractions were identified by TLC (silica CH2Cl2/MeOH, 97:3), 
collected and concentrated to yield compound 221 as a purple solid (0.07, 20%). 
m.p. >150°C decomp. 
1
H N.M.R. [400MHz, CD2Cl2] δ -2.91 (2H, br s, NH), 1.35 (27H, s, (CH3)3), 
2.50-3.28 (18H, m, NCH2, CH2C(O)), 3.51 (4H, br s CH2C(O)),  4.38 (2H,  s, 
CH2NHPh), 6.38 (2H, d, 
3
J = 8.3Hz, O2N-Ar-2,6-H), 7.06 (2H, d, 
3
J = 8.3Hz, 
O2N-Ar-3,5-H), 7.58-7.72 (12H, m, 5,10,15,20-Ar-3,4,5-H), 8.03 (4H, d, Ar-2,6-
H), 8.07-8.14 (4H, m, Ar-2,6-H), 8.56 (1H, d, 
3J = 4.8Hz, βH), 8.67-8.79 (6H, m, 
βH) 
13
C N.M.R. [100MHz, CD2Cl2] δ 28.2, 28.3, 43.8, 52.0, 54.1, 55.2, 81.1, 112.5, 
119.8, 120.0, 120.6, 120.7, 121.1, 127.1, 127.2, 127.7, 128.10, 128.14, 128.7, 
128.9, 133.6, 134.86, 134.95, 134.99, 142.2, 142.3, 142.5, 142.7, 171.0 
UV-vis (CH2Cl2, nm) λmax/nm (log ε)  419 (5.8), 516 (4.8), 549 (4.3), 591 (4.3), 
645 (4.1) 
MS (ESI) m/z 1260 (M+H)
+ 
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6.37 Synthesis of 1,4,7-tris-tert-butoxycarbonylmethyl-10-[4-[(5,10,15,20-
tetraphenyl-porphyrin-2-ylmethyl)-amino]-benzyl]-1,4,7,10-tetraaza-
cyclododecane) (222)  
 
NH
HN
N
N
N
N N
N
O
O
O
O
O
O
HN
 
 
To a heated solution of compounds 191 (0.23g, 0.36 mmol) and 57 (0.20g, 0.32 
mmol) in tetrahydrofuran (50mL) under an inert (N2) atmosphere was added 
acetic acid (0.1mL) followed by a solution of NaBH3CN (0.05g, 0.8 mmol) in 
methanol (20mL). The mixture was heated under reflux conditions and 
monitored by TLC (silica CH2Cl2/MeOH, 95:5) until all the starting material 57 
had been consumed (5 days). The solvent was removed in vacuo and 
dichloromethane (100mL) added to the dark solid residue. After washing with 
water (100mL) the organic layer was separated and dried over MgSO4 and the 
volume reduced to ~10mL.  The crude mixture was separated by gravity column 
chromatography (silica, eluent: CH2Cl2/MeOH, initially 99:1 rising to 95:5). 
Relevant fractions were identified by TLC (silica CH2Cl2/MeOH, 95:5), 
collected and concentrated to yield the desired product as a purple solid (0.21g, 
52%). m.p. >150°C decomp. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.77 (2H, br s, NH), 1.45 (27H, s, (CH3)3), 2.08-
2.78 (16H, m, NCH2 x 8), 2.98 (4H, br s, CH2C(O)), 3.58-3.65 (2H, m, NCH2Ph, 
CH2C(O)), 3.68 (1H, br s, CH2C(O)),  3.72-3.76 (1H, m, NCH2Ph ), 4.21 (1H, br 
s, NHPh),  4.47 (2H,  s, CH2NHPh), 6.46 (2H, d, 
3
J = 8.3Hz, HN-Ar-2,6-H), 7.18 
(2H, d, 
3
J = 8.3Hz, HN-Ar-3,5-H), 7.60-7.82 (12H, m, 5,10,15,20-Ar-3,4,5-H), 
8.13 (4H, d, 
3
J = 7.0Hz, Ar-2,6-H), 8.17-8.23 (4H, m, Ar-2,6-H), 8.65 (1H, d, 
3
J 
= 4.8Hz, βH), 8.73-8.88 (6H, m, βH) 
13
C N.M.R. [100MHz, CDCl3] δ 27.8, 27.9, 44.1, 49.3 (br), 55.6, 55.9, 58.7, 
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70.3, 72.5, 82.2, 82.5, 113.3, 119.2, 119.3, 120.4, 120.8, 126.1, 126.6, 126.7, 
126.8, 127.2, 127.6, 127.8, 128.4, 130.9, 133.3, 134.5, 134.6, 141.8, 142.1, 
142.5, 147.5, 172.6, 173.5 
UV-vis (CH2Cl2, nm) λmax  419, 516, 549, 593, 646 
MS (ESI) m/z 1246 (M+H)
+
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6.38 Synthesis of [4,7-Bis-tert-butoxycarbonylmethyl-10-(4-[[phenyl-
(5,10,15,20-tetraphenyl-porphyrin-2-ylmethyl)-amino]-methyl]-benzyl)-
1,4,7,10tetraaza-cyclododec-1-yl]-acetic acid tert-butyl ester (223) 
 
NH
HNN
N
N N
N
N
N
O
O
O
O
O
O
 
 
To a solution of compound 219 (0.05g, 0.07mmol) in dichloromethane (5ml) was 
added triethylamine (2 drops) and α,α-dibromoxylene (0.018g, 0.07mmol), and 
the mixture stirred at room temperature. Monitoring of the reaction mixture by 
TLC (silica, CH2Cl2) showed consumption of the α,α-dibromoxylene after 4 
hours, and a solution of (4,7-Bis-tert-butoxycarbonylmethyl-1,4,7,10tetraaza-
cyclododec-1-yl)-acetic acid tert-butyl ester (0.035g, 0.07mmol) in 
dichloromethane was added. After heating under reflux conditions for a further 3 
days, TLC (silica, CH2Cl2/MeOH, 9:1) showed consumption of starting 
compound 219. Dichloromethane (100ml) was added and the solution washed 
with water (100ml), after which the organic layer collected and dried (MgSO4). 
Following removal of the dessicant, the solution was concentrated down to a 
small volume (~10ml) and purified by gravity column chromatography (silica, 
eluent: CH2Cl2/MeOH, 9:1). Relevant fractions were identified by TLC (silica 
CH2Cl2/MeOH, 9:1), collected and concentrated to yield compound 223 as a 
purple solid (0.044g, 52%). Rf=0.4 (silica, CH2Cl2/MeOH, 9:1); m.p. >150 °C 
decomp. 
1
H N.M.R. [400MHz, CDCl3] δ -3.05 (2H, br s, NH), 1.48 (9H, s, C(CH3)3), 1.49 
(18H, s, C(CH3)3), 2.80-2.94 (12H, m, NCH2CH2N), 3.01-3.10 (4H, m, 
NCH2CH2N), 3.29 (2H, s, (CH2COO
t
Bu)), 3.38 (4H, s, (CH2COO
t
Bu)), 3.42 
(2H, s, NCH2-Ph), 4.46 (2H, s, NCH2-Ph), 4.59 (2H,  s, CH2NPh), 6.38 (2H, d, 
3
J= 7.9Hz, CH2-Ar-H), 6.83-6.89 (1H, m, N-Ar-4-H), 6.90-6.99 (4H, m,  N-Ar-
2,6-H and CH2-Ar-H), 7.24-7.31 (2H, m, N-Ar-3,5-H), 7.68-7.84 (12H, m, 
5,10,15,20-Ar-3,4,5-H), 8.00-8.04 and 8.05-8.10 (4H, m, Ar-2,6-H), 8.14-8.20 
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(4H, m, Ar-2,6-H), 8.62 (1H, d, 
3J=4.8Hz, β-H), 8.71 (1H, s, β-H), 8.75-8.80 
(2H, m, β-H), 8.83 (1H, d, 3J=4.8Hz, β-H), 8.89-8.91 (2H, m, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 28.13, 28.17, 47.4, 48.8 (br), 49.1, 49.7, 51.2, 
52.2, 53.4, 55.1, 58.0, 58.4, 81.6, 81.7, 113.5, 117.9, 119.4, 120.3, 120.7, 124.4, 
126.7, 126.8, 126.9, 127.4, 128.0, 128.8, 128.9, 129.2, 130.9, 133.1, 134.3, 
134.4, 134.5, 141.0, 141.3, 141.6, 141.8, 150.3, 169.6, 170.5 
UV-vis (CH2Cl2, nm) λmax  420, 516, 551, 589, 646 
MS (ESI) m/z 1337 (M+H)
+ 
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 6.39 Synthesis of 5-(4-Bromomethylphenyl)-10,15,20-tris(3,5-
dimethoxyphenyl) porphyrin (237) 
 
NH
N HN
N
O
O
O O
O
O
Br
 
 
To a stirred solution of compound 248 (0.28g, 0.34mmol) in anhydrous 1,4-
dioxane (100ml) was added phosphorus tribromide (30mg, 0.11mmol), and the 
mixture stirred for 12 hours under dry nitrogen. Methanol (50ml) was added 
followed by ethyl acetate (50ml) and the organic solution washed successively 
with aqueous hydrochloric acid (0.2M, 50ml), aqueous sodium hydrogen 
carbonate (50ml) and finally brine (50ml). The organic layer was separated and 
dried (MgSO4), before being concentrated to yield a crude purple solid. This was 
adsorbed onto silica and purified by gravity column chromatography (silica, 
eluent: CH2Cl2). Relevant fractions were identified by TLC (silica CH2Cl2), 
collected and concentrated to yield compound 237 as a purple solid (0.26g, 
86%). Rf=0.36 (silica, CH2Cl2); m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.91 (2H, br s, NH), 3.89 (18H, s, OCH3), 4.78 
(2H, s, CH2), 6.82-6.83 (3H, t, 
4
J=2.3Hz, 10,15,20-Ar-4-H), 7.32-7.33 (6H, d, 
4
J=2.3Hz, 10,15,20-Ar-2,6-H), 7.70-7.72 (2H, d, 
3
J=8.2Hz, 5-Ar-3,5-H), 8.10-
8.12 (2H, d, 
3
J=8.1Hz, 5-Ar-2,6-H), 8.74-8.75 (2H, d, 
3J=4.7Hz, β-H), 8.87-8.88 
(6H, d, 
3J=4.5Hz, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 55.7, 56.1, 119.3, 119.9, 127.5, 128.0, 130.8, 
131.3, 134.9, 137.3, 142.4, 144.0, 158.9 
UV-vis (THF, nm) λmax/nm (log ε) 419 (5.6), 513 (4.6), 548 (4.1), 590 (4.0) 647 
(4.0) 
MS (MALDI) m/z 887 
79
Br (M)
+
, 889 
79
Br (M)
+
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6.40 Attempted synthesis of (8-[4-[10,15,20-Tris-(3,5-dimethoxy-phenyl)-
porphyrin-5-yl]-benzyl]-1,5,8,12-tetraaza-bicyclo[10.2.2]hexadec-5-yl)-acetic 
acid tert-butyl ester (244) 
 
HNN
NH N
OO
O
O
O O
N
N
N
N
O
O
 
 
To a solution of compound 137 (0.05g, 0.15mmol) in dry acetonitrile (10ml) was 
added compound 237 (0.13g, 0.15mmol) and sodium carbonate (0.08g, 
0.75mmol) and the mixture stirred at 50 °C under a nitrogen atmosphere. 
Consumption of the starting porphyrin 237 was monitored by taking aliquots of 
the mixture and separation by HPLC (C18 column, gradient eluent: 100% water 
to 100% methanol over 20mins), uv-vis detector. After 3 days, complete 
consumption of compound 3 had taken place. Dichloromethane (10ml) and water 
(10ml) were added, and the organic layer separated and dried (MgSO4). The 
solution was concentrated down to a small volume and gravity column 
chromatography (silica, eluent: CH2Cl2/MeOH, 95:5) was used to separate the 
porphyrin components of the mixture. The first fraction was identified as 
compound 248 and the second and third fractions degraded on the silica column. 
However, enough of the second fraction was recovered for 
1
H NMR analysis. 
This indicated that although it was impure, it contained the desired compound. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.84 (2H, br s, NH), 1.45-1.51 (9H, m, (CH3)3), 
1.60-3.12 (26H, m, NCH2), 3.96 (18H, s, OCH3), 5.07 (2H, s, CH2), 6.88-6.91 
(3H, m, 10,15,20-Ar-4-H), 7.36-7.41 (6H, m, 10,15,20-Ar-2,6-H), 7.68-8.02 (2H, 
m, 5-Ar-3,5-H), 8.20-8.32 (2H, m, 5-Ar-2,6-H), 8.74-8.76 (1H, m, β-H), 8.82-
8.84 (2H, m, β-H), 8.91-8.98 (6H, m, β-H) 
MS (ESI) m/z 1147 (M)
+
, 1160 (M+Na)
+
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6.41 Attempted synthesis of (8-[4-[10,15,20-Tris-(3,5-dimethoxy-phenyl)-
porphyrin-5-yl]-benzyl]-1,4,8,11-tetraaza-bicyclo[6.6.2]hexadec-4-yl)-acetic 
acid tert-butyl ester (245) 
 
HNN
NH N
OO
O
O
O O
N
N
N
N
O
O
 
 
To a solution of compound 138 (0.05g, 0.15mmol) in dry acetonitrile (10ml) was 
added compound 237 (0.13g, 0.15mmol) and sodium carbonate (0.08g, 
0.75mmol) and the mixture stirred at 50 °C under a nitrogen atmosphere. 
Consumption of the starting porphyrin 237 was monitored by TLC (silica, 
CH2Cl2/MeOH, 95:5) After 48 hours, complete consumption of compound 3 had 
taken place. Dichloromethane (10ml) and water (10ml) were added, and the 
organic layer separated and dried (MgSO4). The solution was concentrated down 
to a small volume and gravity column chromatography (silica, eluent: 
CH2Cl2/MeOH, 95:5) was used to separate the porphyrin components of the 
mixture. The first fraction was identified as compound 248 and although the 
second fractions degraded on the silica column, enough (~1mg) was recovered 
for NMR analysis. The fraction was impure, but appeared to contain the desired 
compound. Partial assignment of the spectra are given below. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.83 (2H, br s, NH), 1.50-1.70 (13H, m, (CH3)3,  
NCH2), 2.50-3.25 (16H, m, NCH2), 3.96 (18H, s, OCH3), 6.88-6.92 (3H, m,  
10,15,20-Ar-4-H), 7.38-7.42 (6H, m, 10,15,20-Ar-2,6-H), 7.71 (2H, d, 
3
J=7.9Hz, 
5-Ar-3,5-H), 8.18 (2H, m, 
3
J=7.9Hz, 5-Ar-2,6-H), 8.79 (2H, d, 
3J=5.0Hz, β-H), 
8.91-8.99 (6H, m, β-H) 
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6.42 Attempted synthesis of (1,4,7-tris-tert-butoxycarbonylmethyl-10-[4-
[10,15,20-Tris-(3,5-dimethoxy-phenyl)-porphyrin-5-yl]-benzyl]-1,4,7,10-
tetraaza-cyclododecane (246) 
 
NH
N HN
N
O
O
O O
O
O
N
N
N
N
O
O
O
O
O
O
 
 
Compounds 237 (35mg, 0.04 mmol) and 127 (100mg 0.2 mmol) were dissolved 
in CH2Cl2 (10mL) and NEt3 (4mg, 6μL, 0.04 mmol) was added. The reaction was 
stirred at ambient temperature under an N2 atmosphere. After 3 hours, TLC 
analysis (silica,  CH2Cl2/MeOH, 95:5) showed the complete consumption of the 
starting material and the formation of one major product.   
Water (20mL) was added and organic layer was separated and dried (MgSO4), 
before being concentrated to yield a crude purple solid. This was adsorbed onto 
silica and purified by gravity column chromatography (silica, eluent: 
CH2Cl2/MeOH, 95:5). The first (minor) fraction was collected and the solvent 
concentrated to yield a purple solid. Yield <1mg. Analysis by 
1
H NMR identified 
the desired compound and this was confirmed by mass spectrometry.  
 
1
H N.M.R. [400MHz, CDCl3] δ -2.91 (2H, br s, NH), 1.37-1.40 (27H, m, 
(CH3)3), 2.75-3.07 (18H, m, NCH2), 3.22 (2H, s, NCH2), 3.31 (4H, br s, NCH2),  
3.89 (18H, s, OCH3), 6.82-6.85 (3H, m, 10,15,20-Ar-4-H), 7.28-7.32 (6H, m, 
10,15,20-Ar-2,6-H), 7.79 (2H, d, 
3
J=7.7Hz, 5-Ar-3,5-H), 8.09 (2H, m, 
3
J=7.7Hz, 
5-Ar-2,6-H), 8.63 (2H, d, 
3J=4.5Hz, β-H), 8.85-8.90 (6H, m, β-H) 
MS (ESI) m/z 1344 (M+Na)
+
 
The second fraction was collected and the solvent concentrated to yield a purple 
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solid. (24mg, 65%). Analysis by 
1
H NMR identified the compound as 249, 
shown below. 
  
N+HNN
NH N
OO
O
O
O O
Br
-
249  
 
1
H N.M.R. [400MHz, CDCl3] δ -2.84 (2H, br s, NH), 1.60 (9H, t, 
3
J=7.3Hz, 
CH2CH3), 3.65 (6H, q, 
3
J=7.3Hz, CH2CH3), 3.96 (18H, s, OCH3), 5.10 (2H, s, 
NCH2Ph) 6.87-6.91 (3H, m, 10,15,20-Ar-4-H), 7.37-7.41 (6H, m, 10,15,20-Ar-
2,6-H), 7.94 (2H, d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.31 (2H, d, 
3
J=8.1Hz, 5-Ar-2,6-H), 
8.63 (2H, d, 
3J=4.8Hz, β-H), 8.90-9.00 (6H, m, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 8.8, 46.1, 53.5, 55.7, 100.2, 114.0, 117.3, 120.2, 
120.3, 126.2, 131.0, 135.5, 143.9, 145.0, 159.0 
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6.43 Synthesis of 5-(4-Carbomethoxyphenyl)-10,15,20-tris(3,5-
dimethoxyphenyl) porphyrin
124
 (247) 
 
NH
N HN
N
O
O
O O
O
O
O O
 
 
Methyl-4-formyl benzoate (4.94g, 0.03mol) and 3,5-dimethoxybenzaldehyde 
(15g, 0.09mol) were dissolved in propionic acid (400ml) and the solution heated 
under reflux conditions. Pyrrole (8.07g, 0.12mol) was added dropwise and the 
dark mixture heated for thirty minutes. After cooling to room temperature, excess 
acid was removed in vacuo to yield a dark tarry solid. This was purified by 
gravity column chromatography (silica, eluent: CH2Cl2/EtOAc, 99:1). Relevant 
fractions were identified by TLC, combined and concentrated to yield 247 as a 
purple solid (1.2g, 5%). Rf=0.6 (silica, CH2Cl2/EtOAc, 99:1); m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.78 (2H, br s, NH), 3.98 (18H, s, OCH3), 4.13 
(3H, s, COOCH3), 6.92-6.93 (3H, t, 
4
J=2.2Hz, 10,15,20-Ar-4-H), 7.43-7.44 (6H, 
t, 
4
J=2.3Hz, 10,15,20-Ar-2,6-H), 8.33-8.35 (2H, d, 
3
J=8.2Hz, 5-Ar-3,5-H), 8.46-
8.48 (2H, d, 
3
J=8.2Hz, 5-Ar-2,6-H), 8.80-8.83 (2H, m, β-H), 8.98-9.00 (6H, m, 
β-H) 
13
C N.M.R. [100MHz, CDCl3] δ55.6, 56.1, 77.3, 77.7, 100.2, 113.9, 117.7, 
127.9, 134.6, 144.0, 145.4, 146.1, 158.9, 160.1 
UV-vis (CH2Cl2, nm) λmax 421, 515, 592, 659 
MS (MALDI) m/z 852 (M)
+
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6.44 Synthesis of 5-(4-Hydroxymethylphenyl)-10,15,20-tris(3,5-
dimethoxyphenyl) porphyrin (248) 
NH
N HN
N
O
O
O O
O
O
OH
 
 
Compound 247 (0.3g, 0.35mmol) was dissolved in anhydrous THF (150ml) 
under  dry nitrogen atmosphere, and the solution cooled to 0 °C. To this was 
added lithium aluminium hydride (0.5g, 13mmol) and the reaction stirred for 24 
hours, protected from light. Upon completion, methanol (10ml) was added, 
followed by ethyl acetate (50ml). The reaction mixture was washed successively 
with aqueous hydrochloric acid (0.2M, 150ml), aqueous sodium hydrogen 
carbonate (150ml) and finally brine (150ml). The organic layer was separated 
and dried (MgSO4), before being concentrated to yield a crude purple solid. This 
was adsorbed onto silica and purified by gravity column chromatography (silica, 
eluent: CH2Cl2/EtOAc, 93:7). Relevant fractions were identified by TLC, 
collected and concentrated to yield compound 248 as a purple solid (0.26g, 
90%). Rf=0.4 (silica, CH2Cl2/EtOAc, 93:7); m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.77 (2H, br s, NH), 3.98 (18H, s, OCH3), 5.02 
(2H, s, CH2), 6.92-6.94 (3H, t, 
4
J=2.3Hz, 10,15,20-Ar-4-H), 7.44-7.45 (6H, d, 
4
J=2.2Hz, 10,15,20-Ar-2,6-H), 7.72-7.74 (2H, d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.21-
8.23 (2H, d, 
3
J=8.1Hz, 5-Ar-2,6-H), 8.85-8.86 (2H, d, 
3J=4.8Hz, β-H), 8.97-8.98 
(6H, d, 
3J=4.5Hz, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 55.4, 55.7, 65.3, 100.2, 104.5, 113.9, 119.9, 
125.3, 131.1, 134.7, 140.3, 141.5, 144.0, 144.1, 158.9 
UV-vis (CH2Cl2, nm) λmax 420, 515, 549, 590 
MS (MALDI) m/z 824 (M)
+
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6.45 Attempted synthesis of (1,4,7-tris-methoxycarbonylmethyl-10-[-[4-
[10,15,20-Tris-(3,5-dimethoxy-phenyl)-porphyrin-5-yl]-benzyl]-1,4,7,10-
tetraaza-cyclododecane (250) 
 
HN
NH N
N
O O
O
OO
O
N
N
N
N
O
O
O
O
O
O
HN
 
 
Method 1 
Compounds 237 (114mg, 0.13 mmol) and 56 (132mg, 0.31 mmol) were 
dissolved in anhydrous THF (40mL) and Na2CO3 (0.26g, 2.5 mmol) added. The 
reaction was stirred at ambient temperature under a N2 atmosphere. Monitoring 
by TLC (silica, CH2Cl2) showed no consumption of the starting materials after 8 
hours, so the reaction was heated to 60 °C. After 4 days, TLC (silica, eluent: 
CH2Cl2) showed complete reaction and the reaction mixture was filtered and the 
solvent removed in vacuo. The product was isolated by column chromatography 
(silica, eluent: CH2Cl2/MeOH, 95:5), however NMR analysis identified it as 
compound 248. 
 
Method 2 
Compounds 237 (40mg, 0.05 mmol) and 56 (54mg, 0.13 mmol) were dissolved 
in anhydrous THF (25mL), DBU (8mg, 0.05 mmol) added and the reaction 
mixture was heated to 60 °C under N2. Monitoring by TLC (silica, CH2Cl2) 
showed consumption of the starting materials after 3 days with formation of one 
polar porphyrin spot. The solvent was removed in vacuo and the residue taken 
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into a small volume of CH2Cl2. The product was isolated by column 
chromatography (silica, eluent: CH2Cl2/MeOH, 95:5), but NMR analysis 
identified it as compound 251 shown below. 
 
NH
HN
N
N
O
O
O O
OO
N
N
HO
251  
 
1
H N.M.R. [400MHz, CDCl3] δ -2.83 (2H, br s, NH), 1.60-1.82 (6H, m, CH2), 
2.20-2.30 (2H, m, CH2), 2.58-2.63 (2H, m, NCH2), 3.00-3.09 (2H, m, NCH2), 
3.37-3.48 (2H, m, NCH2), 3.57-3.65 (2H, m, NCH2), 3.96 (18H, s, OCH3), 4.35 
(2H, s, NCH2Ph) 6.88-6.91 (3H, m, 10,15,20-Ar-4-H), 7.38-7.42 (6H, m, 
10,15,20-Ar-2,6-H), 7.93 (2H, d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.24 (2H, d, 
3
J=8.1Hz, 
5-Ar-2,6-H), 8.81 (2H, d, 
3J=4.8Hz, β-H), 8.94 (6H, br s, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 23.4, 25.7, 28.3, 29.8, 36.9, 45.0, 45.5, 50.2, 
52.5, 55.6, 100.2, 113.9, 119.2, 119.8, 119.9, 128.1, 135.0, 144.0, 158.8 
MS (ESI) m/z 977 (M)
+
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6.46 Attempted synthesis of 1,4,7-tris-tert-butoxycarbonylmethyl-10-(4-[4-
[10,15,20-tris-(3,5-dimethoxy-phenyl)-porphyrin-5-yl]benzylamino]benzyl)-
1,4,7,10-tetraazacyclododecane (260) 
 
HN
NH N
N
O O
O
OO
O
N
N
N
N
O
O
O
O
O
O
HN
 
 
Compounds 237 (44mg, 0.05 mmol) and 57 (97mg, 0.23 mmol) were dissolved 
in anhydrous THF (25mL), NaHCO3 (42mg, 0.5 mmol) added and a catalytic 
amount of KI. The reaction was stirred at ambient temperature under a N2 
atmosphere. After 2 days, TLC (silica, CH2Cl2) showed most of the starting 
porphyrin had been consumed. The reaction mixture was filtered through celite 
and the solvent removed in vacuo. The residue was taken into CH2Cl2 and the 
product isolated by column chromatography (silica, eluent: CH2Cl2/MeOH, 
95:5). 
1
H NMR analysis showed this to be a mixture of two porphyrins and the 
mixture could not be separated by preparative TLC or column chromatography. 
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6.47 Synthesis of 5-(4-carboxyphenyl)-10,15,20-tris(3,5-dimethoxyphenyl) 
porphyrin
124
 (262) 
 
HNN
NH N
OH
O
O
O O
O
O
O
 
 
4-carboxybenzaldehyde (0.45g, 3.0 mmol) and 3,5-dimethoxybenzaldehyde 
(1.5g, 9 mmol) were dissolved in propionic acid (50ml) and the solution heated 
under reflux conditions. Pyrrole (0.80g, 12 mmol) was added dropwise and the 
dark mixture heated for thirty minutes. After cooling to room temperature, excess 
acid was removed in vacuo to yield a dark tarry solid. This was purified by 
gravity column chromatography (silica, eluent: CH2Cl2/MeOH, 94:6). Relevant 
fractions were identified by TLC, combined and concentrated to yield 262 as a 
purple solid (0.25g, 10%). Rf=0.4 (silica, CH2Cl2/MeOH 94:6). m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.82 (2H, br s, NH), 3.97 (18H, s, OCH3), 6.90-
6.93 (3H, m, 10,15,20-Ar-4-H), 7.37-7.42 (6H, m, 10,15,20-Ar-2,6-H), 8.34 (2H, 
d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.50 (2H, d, 
3
J=8.1Hz, 5-Ar-2,6-H), 8.80 (2H, d, 
3J=4.8Hz, β-H), 8.91-9.00 (6H, m, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ55.6, 100.2, 113.9, 118.5, 120.1, 120.2, 128.5, 
128.9,  134.6, 143.9, 147.7, 158.9, 171.1 
UV-vis (CH2Cl2, nm) λmax 421, 516, 591, 657 
MS (MALDI) m/z 839 (M+H)
+
 
  
 249 
6.48 Attempted synthesis of 1,4,7-tris-methoxycarbonylmethyl-10-(2-(4-
[10,15,20-tris-(3,5-dimethoxy-phenyl)-porphyrin-5-yl]benzamido)ethyl))-
1,4,7,10-tetraazacyclododecane (263) 
HNN
NH N
O
O
O O
O
O
O
N
O
O
N
O
O
N
O
O
N
NH
 
 
 
 
 
To a stirred solution of compound 262 (99mg, 0.12 mmol) and DCC (25mg, 0.12 
mmol) in anhydrous CH2Cl2 (10mL) at 0 °C under N2, was added 56 (102mg, 
0.24 mmol). The reaction was stirred under N2 at ambient temperature and after 8 
hours, TLC analysis (silica, CH2Cl2/MeOH 95:5) showed complete consumption 
of starting material and two new porphyrin products. The reaction mixture was 
concentrated and column chromatography (silica, eluent CH2Cl2/MeOH 95:5) 
was used to separate the porphyrin products. The first fraction was collected and 
although it contained impurities, was identified by NMR as the porphyrin-DCC 
intermediate of the reaction. The second fraction could only be collected in a 
very small amount since  degradation occurred as it passed down the column.  
The reaction was repeated but attempted separation and isolation of the desired 
compound was not achieved, despite chromatography using neutral alumina, 
basic alumina and silica gel pretreated with base (NEt3). 
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6.49 Synthesis of 4-[10,15,20-Tris-(3,5-dimethoxy-phenyl)-porphyrin-5-yl]-
benzoic acid 2,5-dioxo-pyrrolidin-1-yl ester (264) 
 
 
HNN
NH N
O
O
O
O O
O
O
O
N
O
O
 
 
 
Compound 262 (219mg, 0.26 mmol) was dissolved in anhydrous pyridine 
(30mL) under an N2 atmosphere and SOCl2 added in one portion. After 5 mins, 
the N2 flow was removed and a CaCl2 guard tube fitted. The reaction was then 
heated to 50 °C and after 30 mins, N-hydroxysuccinimide (0.6g, 5.2 mmol) was 
added in one portion and the reaction stirred at 50 °C for a further 6 hours. The 
reaction mixture was allowed to cool to ambient temperature and the solvent was 
removed in vacuo. The residue was dissolved in CHCl3 (50mL), washed 
successively with saturated NaHCO3(aq) and brine before the organic layer was 
separated and concentrated. The desired compound was isolated by gravity 
column chromatography (silica, eluent: CH2Cl2/MeOH, 96:4). Relevant fractions 
were identified by TLC, combined and concentrated to yield 264 as a purple 
solid (0.13g, 52%). Rf=0.6 (silica, CH2Cl2/MeOH 96:4). m.p. >200 °C. 
 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.82 (2H, br s, NH), 2.80-3.00 (4H, m, CH2), 
3.96 (18H, s, OCH3), 6.89-6.93 (3H, m, 10,15,20-Ar-4-H), 7.39-7.45 (6H, m, 
10,15,20-Ar-2,6-H), 8.38 (2H, d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.54 (2H, d, 
3
J=8.1Hz, 
5-Ar-2,6-H), 8.77 (2H, d, 
3J=4.8Hz, β-H), 8.97 (6H, br s, β-H), 9.00 (2H, d, 
3J=4.8Hz, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 25.7, 55.6, 100.1, 113.8, 117.7, 120.2, 120.3, 
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124.4, 128.9, 134.8, 143.8, 149.3, 158.9, 162.1, 169.3 
UV-vis (CH2Cl2, nm) λmax 421, 516, 591, 657 
MS (MALDI) m/z 936 (M+H)
+
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6.50 Attempted synthesis of 1,4,7-tris-tert-butoxycarbonylmethyl-10-(2-(4-
[10,15,20-tris-(3,5-dimethoxy-phenyl)-porphyrin-5-yl]benzamido)benzyl))-
1,4,7,10-tetraazacyclododecane (265) 
 
 
HN
NH N
N
O O
O
OO
O
N
N
N
N
O
O
O
O
O
O
HN O
 
 
 
Compounds 264 (20mg, 0.02 mmol) and 57 (13mg, 0.02 mmol) were dissolved 
in anhydrous pyridine (5mL) and the reaction stirred under N2 atmosphere at 
ambient temperature. After 2 hours, TLC analysis (silica, CH2Cl2/MeOH 95:5) 
showed no change to the starting materials, so the reaction was heated to 70 °C. 
No change to the reactants could be detected by TLC analysis after 24 hours and 
prolonged heating only led to decomposition of compound 57.  
The reaction was repeated, but the amine 57 was washed with NaHCO3(aq) prior 
to being introduced to the reaction vessel. The solvent was also changed to 
anhydrous THF and the reaction heated at 70 °C. No reaction could be detected 
once again, and prolonged heating caused decomposition of compound 57. 
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6.51 Synthesis of 1,4,7-tris-tert-butoxycarbonylmethyl-10-(2-(4-[10,15,20-
tris-(3,5-dimethoxy-phenyl)-porphyrin-5-yl]aminophenyl)benzyl))-1,4,7,10-
tetraazacyclododecane (287) 
N
N N
N
O
O
O O
O
O
HN
NH N
N
O O
O
OO
O
HN
 
 
Compound 289 (300mg, 0.32 mmol), compound 57 (300mg, 0.48 mmol), 
Cs2CO3 (1.04g, 3.2 mmol), Pd(OAc)2 (3.6mg, 0.02 mmol) and rac-BINAP 
(16mg, 0.03 mmol) were added to a flame dried Schlenk tube and placed under a 
N2 atmosphere. Anhydrous toluene (30mL) was subsequently added and a flow 
of N2 was bubbled through the mixture for one hour. The reaction was then 
heated to 90 °C for 24 hours until TLC analysis (silica, CH2Cl2/MeOH 99:1) 
showed no further reaction. The solvent was removed in vacuo, CH2Cl2 (100mL) 
added to the residue and the solution washed with NaHCO3(aq) (100mL) and 
brine (100mL). The organic extracts were stirred at ambient temperature with 
TFA (5 drops) for 10 minutes. Saturated NaHCO3(aq) was added dropswise to 
until the solution was neutral and the organic layer was extracted and dried over 
Na2SO4. The desired compound was isolated by gravity column chromatography 
(silica, eluent: CHCl3/MeOH 95:5) as a purple solid. (Yield 198mg, 44%). 
Rf=0.3 (silica, CHCl3/MeOH 95:5). m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.81 (2H, br s, NH), 1.45-1.52 (27H, m, 
(CH3)3), 2.08-3.10 (22H, br m, NCH2), 3.97 (18H, s, OCH3), 6.89-6.91 (3H, m, 
10,15,20-Ar-4-H), 7.34-7.37 (2H, m, NCH2-Ph-2,6-H), 7.38-7.44 (8H, m, 
10,15,20-Ar-2,6-H, NCH2-Ph-3,5-H), 7.48 (2H, d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.08 
(2H, d, 
3
J=8.1Hz, 5-Ar-2,6-H), 8.87-8.95 (8H, m, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 27.8, 28.0, 28.1, 49.1 (br), 53.4, 55.6, 55.9, 
 254 
58.7, 82.3, 82.9, 100.0, 113.9, 115.6, 118.1, 119.5, 119.7, 121.0, 128.9, 131.1, 
134.1, 135.6, 142.7, 142.9, 143.9, 144.0, 158.8, 172.3, 173.2  
UV-vis (CH2Cl2, nm) λmax 421, 515, 552, 590, 648 
MS (ESI) m/z 1414 (M+H)
+
, 1415 (M+2H)
+
, 1416 (M+3H)
+
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6.52 Synthesis of 5-(4-bromophenyl)-10,15,20-tris(3,5-dimethoxyphenyl) 
porphyrin
124
 (288) 
 
NH
N HN
N
O
O
O O
O
O
Br
 
 
 
4-bromobenzaldehyde (1.86g, 10 mmol) and 3,5-dimethoxybenzaldehyde (5g, 30 
mmol) were dissolved in propionic acid (150ml) and the solution heated under 
reflux conditions. Pyrrole (2.69g, 40 mmol) was added dropwise and the dark 
mixture heated for thirty minutes. After cooling to room temperature, excess acid 
was removed in vacuo to yield a dark tarry solid. This was purified by gravity 
column chromatography (silica, eluent: CH2Cl2/Hexane, 9:1). Relevant fractions 
were identified by TLC, combined and concentrated to yield 288 as a purple 
solid (0.64g, 7.3%). Rf=0.4 (silica, CH2Cl2/Hexane 9:1). m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.83 (2H, br s, NH), 3.96 (18H, s, OCH3), 6.89-
6.91 (3H, m, 10,15,20-Ar-4-H), 7.38-7.41 (6H, m, 10,15,20-Ar-2,6-H), 7.88 (2H, 
d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.07 (2H, d, 
3
J=8.1Hz, 5-Ar-2,6-H), 8.80 (2H, d, 
3J=4.8Hz, β-H), 8.91-8.98 (6H, m, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ55.7, 100.3, 114.0, 118.2, 120.1, 122.3, 130.0, 
135.9, 140.6, 144.0, 158.9 
UV-vis (THF, nm) λmax/nm (log ε) 419 (5.8), 513 (4.7), 547 (4.2), 590 (4.2), 647 
(4.0) 
MS (MALDI) m/z 872 
79
Br (M+H)
+
,
 
 874 
81
Br (M+H)
+
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6.53 Synthesis of 5-(4-bromophenyl)-10,15,20-tris(3,5-dimethoxyphenyl) 
porphyrinato zinc(II) (289) 
 
N
N N
N
O
O
O O
O
O
Br
Zn
 
 
To a solution of compound 288 (0.64g, 0.73 mmol) in CHCl3 (200mL) was 
added a solution of Zn(OAc)2 (2g, 9.1 mmol) in MeOH (50mL) and the resulting 
solution was stirred at 35 °C for four hours. Solvents were removed in vacuo, the 
residue dissolved in CH2Cl2 and washed successively with NaHCO3(aq) 
(100mL) and brine (100mL). After drying over Na2SO4, the solvent was removed 
to give a bright purple solid. (Yield 0.69g, 100%). Rf=0.5 (silica, CH2Cl2). m.p. 
>200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ 3.92 (18H, s, OCH3), 6.81-6.84 (3H, m, 
10,15,20-Ar-4-H), 7.33-7.37 (6H, m, 10,15,20-Ar-2,6-H), 7.87 (2H, d, 
3
J=8.1Hz, 
5-Ar-3,5-H), 8.07 (2H, d, 
3
J=8.1Hz, 5-Ar-2,6-H), 8.90 (2H, d, 
3J=4.5Hz, β-H), 
9.02 (4H, br s, β-H), 9.04 (2H, d, 3J=4.5Hz, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ55.7, 100.1, 113.8, 119.5, 121.1, 122.3, 129.8, 
131.7, 132.2, 132.3, 135.8, 141.9, 144.6, 149.9, 150.0, 150.18, 150.22, 158.8 
UV-vis (CH2Cl2, nm) λmax/nm (log ε) 422 (6.0), 549 (4.5), 593 (3.8) 
MS (ESI) m/z 934 
79
Br (M)
+
, 936 
81
Br (M)
+
 
HRMS : calculated for C50H39
79
BrN4O6Zn : 934.1339, found 934.1343 
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6.54 Synthesis of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzaldehyde
209
 (302) 
 
 
O
B
O
O
 
 
4-formylphenylboronic acid (4.0g, 26.7 mmol) was suspended in anhydrous 
diethyl ether (45mL) and pinacol (3.85g, 32.6 mmol) added. The reaction 
mixture was stirred at room temperature under N2 for 24 hours after which time 
the solids had dissolved completely. The organic solution was washed with H2O 
(50mL) and the product was isolated by column chromatography (silica, eluent 
CH2Cl2) as a white solid (5.5g, 89%) m.p. 58-59°C 
 
1
H N.M.R. [400MHz, CDCl3] δ 1.33-1.36 (12H, m, CH3), 7.85 (2H, d, 
3
J=7.9Hz, 
B-Ar-2,6-H), 7.96 (2H, d, 
3
J=7.9Hz, B-Ar-3,5-H), 10.04 (1H, s, CHO) 
13
C N.M.R. [100MHz, CDCl3] δ 24.9, 84.3, 128.7, 135.2, 138.0, 192.7 
11
B N.M.R. [128.3MHz, CDCl3] δ 30.4 
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6.55 Synthesis of 5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl))-
10,15,20-tris-(4-carbomethoxyphenyl) porphyrin
139
 (303)  
 
 
NH
N HN
N
O
O
OO
O
O
O
B
O
 
 
Methyl(4-formyl)benzoate (2.59g, 15.7 mmol), pyrrole (1.41g, 21.0 mmol) and 
compound 302 (1.22g, 5.26 mmol) were dissolved in CHCl3 (2.1 dm
3
) and argon 
was bubbled through the solution for 20 mins. BF3OEt2 was added in one portion 
and the mixture stirred protected from light, under an Ar atmosphere, for 2.5 
hours. DDQ (4.76g, 21.0 mmol) was added in one portion, the inert gas flow 
removed, and the mixture stirred for 6 hours, open to air but protected from light. 
NEt3 (0.63g, 0.55mL, 6.3 mmol) was added and the solution stirred for a further 
10 mins, before being passed through a short silica pad (CHCl3 eluent) to elute 
the porphyrins. The solvent was concentrated in vacuo to a small volume and 
silica gel chromatography (silica, eluent: CH2Cl2/EtOAc, 97:3) used to isolate the 
desired compound. Despite obvious degradation as it travelled down the column, 
after removal of solvent, the product was collected as a purple solid. (144mg, 
3%). Rf=0.6 (silica, CH2Cl2/EtOAc 97:3). m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.89 (2H, s, NH), 1.48 (9H, s, CH3), 4.09 (9H, 
s, COOCH3), 8.09 (2H, AB, 
3
J=8.0Hz, 5-Ar-2,6-H), 8.12 (2H, AB, 
3
J=8.0Hz, 5-
Ar-3,5-H), 8.27, (6H, d, 
3
J=8.2Hz,  10,15,20-Ar-2,6-H), 8.42 (6H, d, 
3
J=8.2Hz, 
10,15,20-Ar-3,5-H), 8.73-8.86 (8H, m, βH) 
13
C N.M.R. [100MHz, CDCl3] δ 25.0, 52.5, 84.2, 119.0, 119.2, 120.9, 128.0, 
129.7, 133.1, 134.1, 134.5, 144.7, 146.7, 167.3, 171.2 
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11
B N.M.R. [128.3MHz, CDCl3] δ -9.05 
UV-vis (CH2Cl2, nm) λmax 420, 516, 550, 590, 646 
MS (ESI) m/z 914 (M)
+
 
HRMS : calculated for C56H47BN4O8 : 914.3481, found 914.3471 
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6.56 Synthesis of 4-(1,3,2-dioxaborinan-2-yl)benzaldehyde
251
 (304) 
 
 
O
B
O
O  
 
Propane-1,3-diol (3.61g, 47.5 mmol) and 4-formylphenylboronic acid (6.27g, 
41.8 mmol) were dissolved in anhydrous THF (60mL) and the solution stirred at 
ambient temperature under N2 for 20 mins. The solvent was removed in vacuo 
and the residue dissolved in CH2Cl2 (50mL). The organic solution was washed 
with H2O (3x50mL), separated and dried over MgSO4 and concentrated to leave 
an off white solid. Recrystallisation from CH2Cl2/hexane gave a white solid. 
(Yield: 4.92g, 62%) 
 
1
H N.M.R. [400MHz, CDCl3] δ 2.07 (2H, q, 
3
J=5.4Hz, CH2CH2CH2), 4.17 (4H, 
t, 
3
J=5.4Hz, CH2O), 7.82 (2H, d, 
3
J=7.8Hz, B-Ar-2,6-H), 7.90 (2H, d, 
3
J=7.8Hz, 
B-Ar-3,5-H), 10.02 (1H, s, CHO) 
13
C N.M.R. [100MHz, CDCl3] δ 27.3, 62.1, 128.6, 134.1, 137.7, 192.9 
11
B N.M.R. [128.3MHz, CDCl3] δ 25.7 
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6.57 Synthesis of 5-(4-(1,3,2-dioxaborinan-2-yl))-10,15,20-tris-(4-
carbomethoxyphenyl) porphyrin
139
 (305) 
NH
N HN
N
O
O
OO
O
O
B
O O
 
 
Comopund 304 (1.27g, 6.7 mmol), methyl(4-formyl) benzoate (3.28g, 20mmol) 
and pyrrole (1.79g, 26.7 mmol) were dissolved in chloroform (2.67dm
3
) and the 
solution degassed for 30 mins. BF3OEt2 (1.14g, 8mmol) was added and the 
solution stirred under N2 whilst protected from light for 2.5 hours. DDQ (6.06g, 
26.7 mmol) was added in one portion and the mixture stirred, open to the air, for 
a further 5 hours. NEt3 (0.81g, 8.0 mmol) was added and the solution stirred for 
ten minutes, before being passed through a short silica pad (CHCl3 eluent) to 
elute the porphyrins. The solvent was concentrated in vacuo to a small volume 
and silica gel chromatography used to isolate the desired compound (eluent: 
CHCl3 : MeOH, 99:1). After removal of solvent, the product was collected as a 
purple solid. (0.44g, 7.5%). Rf=0.4 (silica, CHCl3 : MeOH, 99:1). m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.88 (2H, s, NH), 2.12-2.18 (2H, d, 
3
J=5.6Hz, 
CH2CH2CH2), 4.04 (9H, s, COOCH3), 4.17 (4H, t, 
3
J=5.5Hz, CH2O), 8.08-8.14 
(4H, m, 5-Ar-2,6-H, 5-Ar-3,5-H), 8.22, (6H, d, 
3
J=8.4Hz,  10,15,20-Ar-2,6-H), 
8.37 (6H, d, 
3
J=8.4Hz, 10,15,20-Ar-3,5-H), 8.69-8.82 (8H, m, βH) 
13
C N.M.R. [100MHz, CDCl3] δ 27.7, 52.5, 62.3, 113.9, 119.0, 119.2, 121.3, 
128.0, 129.8, 132.1, 134.1, 134.6, 144.0, 146.9, 167.3, 171.2 
11
B N.M.R. [128.3MHz, CDCl3] δ 25.4 
UV-vis (CH2Cl2, nm) λmax 421, 515, 550, 592, 648 
MS (ESI) m/z 872 (M)
+ 
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6.58 Synthesis of 1,4,7-tris-tert-butoxycarbonylmethyl-10-(2-(4-[10,15,20-
tris-(4-carbomethoxyphenyl)-porphyrin-5-yl]biphenyl-4-yl)-ethyl))-1,4,7,10-
tetraazacyclododecane (306) 
 
 
NH
N HN
N
O
O
OO
O
O
N
N
N
N
O
O
O
O
O
O
 
 
 
Compounds 305 (30mg, 0.034 mmol), compound 58 (23mg, 0.034 mmol), and 
K2CO3 (66mg, 0.48 mmol) were dissolved in a mixture of toluene (2mL) and 
DMF (1mL) and argon was bubbled through the mixture for 20 mins. Pd(PPh3)4 
(12mg, 0.01 mmol) was added and the mixture pump-purged with Ar 3 times 
before and heated to 90 °C. After 17 hours, TLC analysis (silica, CHCl3/MeOH 
97:3) showed almost complete consumption of the starting material and the 
production of one major new porphyrin spot. The reaction mixture was cooled to 
ambient temperature, filtered through celite and the solvents were removed in 
vacuo. The residue was taken into a small amount (~1mL) of CH2Cl2 and silica 
gel chromatography (silica, eluent: CH2Cl2/MeOH, 97:3) used to isolate the new 
porphyrin compound, which was obtained, after removal of solvents, as a purple 
solid. (Yield 25mg, 52%). Rf=0.6 (silica, CH2Cl2/MeOH 97:3). m.p. >200 °C. 
 
1
H N.M.R. [400MHz, CDCl3] δ -2.86 (2H, br s, NH), 1.35-1.50 (27H, m, 
(CH3)3), 2.08-3.10 (24H, br m, NCH2), 4.00 (9H, s, COOCH3), 7.60 (2H, d, 
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3
J=8.1Hz,  NCH2-Ph-2,6-H), 7.81 (2H, d, 
3
J=8.1Hz,  NCH2-Ph-3,5-H), 7.91 (2H, 
d, 
3
J=8.1Hz, 5-Ar-3,5-H), 8.18-8.26 (8H, m, 5,10,15,20-Ar-2,6-H), 8.38 (6H, d, 
3
J=8.1Hz, 10,15,20-Ar-3,5-H), 8.72-8.81 (6H, m, β-H), 8.82-8.91 (2H, m, β-H) 
13
C N.M.R. [100MHz, CDCl3] δ 28.0, 28.1, 50.1, 52.7, 56.0, 56.2, 59.4, 83.0, 
83.5, 119.6, 119.7, 120.7, 125.7, 127.9, 128.3, 130.3, 131.3, 134.9, 135.4, 137.3, 
140.2, 140.4, 141.5, 146.8, 146.9, 167.4, 172.9, 173.9 
UV-vis (CH2Cl2, nm) λmax 421, 516, 551, 593, 646 
MS (ESI) m/z 1392 (M+H)
+
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